ID   ACES_HUMAN     STANDARD;      PRT;   614 AA.
AC   P22303;
DT   01-AUG-1991 (REL. 19, CREATED)
DT   01-AUG-1991 (REL. 19, LAST SEQUENCE UPDATE)
DT   15-JUL-1998 (REL. 36, LAST ANNOTATION UPDATE)
DE   ACETYLCHOLINESTERASE PRECURSOR (EC 3.1.1.7).
GN   ACHE.
OS   HOMO SAPIENS (HUMAN).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 91088577.
RA   SOREQ H., BEN-AZIZ R., PRODY C.A., SEIDMAN S., GNATT A., NEVILLE L.,
RA   LIEMAN-HURWITZ J., LEV-LEHMAN E., GINZBERG D., LIPIDOT-LIFSON Y.,
RA   ZAKUT H.;
RT   "Molecular cloning and construction of the coding region for human
RT   acetylcholinesterase reveals a G + C-rich attenuating structure.";
RL   PROC. NATL. ACAD. SCI. U.S.A. 87:9688-9692(1990).
RN   [2]
RP   PARTIAL SEQUENCE.
RC   TISSUE=ERYTHROCYTE;
RX   MEDLINE; 89232136.
RA   CHHAJLANI V., DERR D., EARLES B., SCHMELL E., AUGUST T.;
RT   "Purification and partial amino acid sequence analysis of human
RT   erythrocyte acetylcholinesterase.";
RL   FEBS LETT. 247:279-282(1989).
RN   [3]
RP   MUTAGENESIS OF CYS-611.
RX   MEDLINE; 92084699.
RA   VELAN B., GROSFELD H., KRONMAN C., LEITNER M., GOZES Y., LAZAR A.,
RA   FLASHNER Y., MARCUS D., COHEN S., SHAFFERMAN A.;
RT   "The effect of elimination of intersubunit disulfide bonds on the
RT   activity, assembly, and secretion of recombinant human
RT   acetylcholinesterase. Expression of acetylcholinesterase
RT   Cys-580-->Ala mutant.";
RL   J. BIOL. CHEM. 266:23977-23984(1991).
RN   [4]
RP   MUTAGENESIS OF ACTIVE SITE RESIDUES AND OF ASP-206 AND ASP-435.
RX   MEDLINE; 92388112.
RA   SHAFFERMAN A., KRONMAN C., FLASHNER Y., LEITNER M., GROSFELD H.,
RA   ORDENTLICH A., GOZES Y., COHEN S., ARIEL N., BARAK D.;
RT   "Mutagenesis of human acetylcholinesterase. Identification of
RT   residues involved in catalytic activity and in polypeptide folding.";
RL   J. BIOL. CHEM. 267:17640-17648(1992).
RN   [5]
RP   VARIANT BLOOD GROUP YT(B).
RX   MEDLINE; 93256075.
RA   BARTELS C.F., ZELINSKI T., LOCKRIDGE O.;
RT   "Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene
RT   accounts for YT blood group polymorphism.";
RL   AM. J. HUM. GENET. 52:928-936(1993).
CC   -!- FUNCTION: RAPIDLY HYDROLYZES CHOLINE RELEASED INTO THE SYNAPSE.
CC   -!- CATALYTIC ACTIVITY: ACETYLCHOLINE + H(2)O = CHOLINE + ACETATE.
CC   -!- SUBUNIT: OLIGOMER COMPOSED OF DISULFIDE-LINKED HOMODIMERS.
CC   -!- POLYMORPHISM: ACHE IS RESPONSIBLE FOR THE YT BLOOD GROUP SYSTEM.
CC       THE MOLECULAR BASIS OF THE YT(A)=YT1/YT(B)=YT2 BLOOD GROUP
CC       ANTIGENS IS A SINGLE VARIATION IN POSITION 353; HIS-353
CC       CORRESPONDS TO YT(A) AND THE RARE VARIANT WITH ASN-353 TO YT(B).
CC   -!- SIMILARITY: BELONGS TO THE TYPE-B CARBOXYLESTERASE/LIPASE FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M55040; G177975; -.
DR   PIR; S03959; S03959.
DR   PIR; A39256; A39256.
DR   PDB; 2CLJ; 04-MAR-98.
DR   SWISS-2DPAGE; P22303; HUMAN.
DR   MIM; 100740; -.
DR   MIM; 112100; -.
DR   PROSITE; PS00122; CARBOXYLESTERASE_B_1; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
DR   PFAM; PF00135; COesterase; 1.
KW   HYDROLASE; SERINE ESTERASE; SYNAPSE; MEMBRANE; NERVE; MUSCLE; SIGNAL;
KW   NEUROTRANSMITTER DEGRADATION; GLYCOPROTEIN; POLYMORPHISM;
KW   BLOOD GROUP ANTIGEN; ALTERNATIVE SPLICING; 3D-STRUCTURE.
FT   SIGNAL        1     31       POTENTIAL.
FT   CHAIN        32    614       ACETYLCHOLINESTERASE.
FT   ACT_SITE    234    234
FT   ACT_SITE    365    365
FT   ACT_SITE    478    478
FT   DISULFID    100    127
FT   DISULFID    288    303
FT   DISULFID    440    560
FT   DISULFID    611    611       INTERCHAIN.
FT   CARBOHYD    296    296       POTENTIAL.
FT   CARBOHYD    381    381       POTENTIAL.
FT   CARBOHYD    495    495       POTENTIAL.
FT   VARIANT     353    353       H -> N (IN YT(B) ANTIGEN).
FT   MUTAGEN     234    234       S->A: LOSS OF ACTIVITY.
FT   MUTAGEN     365    365       E->A: LOSS OF ACTIVITY.
FT   MUTAGEN     478    478       H->A: LOSS OF ACTIVITY.
FT   MUTAGEN     206    206       D->N: MISFOLDING, ABSENCE OF SECRETION.
FT   MUTAGEN     435    435       D->N: MISFOLDING, ABSENCE OF SECRETION.
FT   MUTAGEN     611    611       C->A: IMPAIRMENT OF INTERCHAIN DISULFIDE
FT                                BRIDGE FORMATION.
SQ   SEQUENCE   614 AA;  67796 MW;  0B33F244 CRC32;
     MRPPQCLLHT PSLASPLLLL LLWLLGGGVG AEGREDAELL VTVRGGRLRG IRLKTPGGPV
     SAFLGIPFAE PPMGPRRFLP PEPKQPWSGV VDATTFQSVC YQYVDTLYPG FEGTEMWNPN
     RELSEDCLYL NVWTPYPRPT SPTPVLVWIY GGGFYSGASS LDVYDGRFLV QAERTVLVSM
     NYRVGAFGFL ALPGSREAPG NVGLLDQRLA LQWVQENVAA FGGDPTSVTL FGESAGAASV
     GMHLLSPPSR GLFHRAVLQS GAPNGPWATV GMGEARRRAT QLAHLVGCPP GGTGGNDTEL
     VACLRTRPAQ VLVNHEWHVL PQESVFRFSF VPVVDGDFLS DTPEALINAG DFHGLQVLVG
     VVKDEGSYFL VYGAPGFSKD NESLISRAEF LAGVRVGVPQ VSDLAAEAVV LHYTDWLHPE
     DPARLREALS DVVGDHNVVC PVAQLAGRLA AQGARVYAYV FEHRASTLSW PLWMGVPHGY
     EIEFIFGIPL DPSRNYTAEE KIFAQRLMRY WANFARTGDP NEPRDPKAPQ WPPYTAGAQQ
     YVSLDLRPLE VRRGLRAQAC AFWNRFLPKL LSATDTLDEA ERQWKAEFHR WSSYMVHWKN
     QFDHYSKQDR CSDL
//
ID   ACTN_ACTCH     STANDARD;      PRT;   380 AA.
AC   P00785;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-JAN-1990 (REL. 13, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   ACTINIDAIN PRECURSOR (EC 3.4.22.14) (ACTINIDIN).
OS   ACTINIDIA CHINENSIS (KIWI) (YANGTAO).
OC   EUKARYOTA; VIRIDIPLANTAE; STREPTOPHYTA; EMBRYOPHYTA; TRACHEOPHYTA;
OC   EUPHYLLOPHYTES; SPERMATOPHYTA; MAGNOLIOPHYTA; EUDICOTYLEDONS;
OC   ASTERIDAE; THEANAE; THEALES; ACTINIDIACEAE; ACTINIDIA.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=CV. DELICIOSA;
RX   MEDLINE; 90045955.
RA   PODIVINSKY E., FORSTER R.L.S., GARDNER R.C.;
RT   "Nucleotide sequence of actinidin, a kiwi fruit protease.";
RL   NUCLEIC ACIDS RES. 17:8363-8363(1989).
RN   [2]
RP   SEQUENCE OF 70-371 FROM N.A.
RA   PRAEKELT U.M., MCKEE R.A., SMITH H.;
RT   "Molecular analysis of actinidin, the cysteine proteinase of Actinidia
RT   chinesis.";
RL   PLANT MOL. BIOL. 10:193-202(1988).
RN   [3]
RP   SEQUENCE OF 127-346.
RX   MEDLINE; 78256777.
RA   CARNE A., MOORE C.H.;
RT   "The amino acid sequence of the tryptic peptides from actinidin, a
RT   proteolytic enzyme from the fruit of Actinidia chinensis.";
RL   BIOCHEM. J. 173:73-83(1978).
RN   [4]
RP   SEQUENCE OF 1-13 FROM N.A.
RX   MEDLINE; 91346716.
RA   KEELING J., MAXWELL P., GARDNER R.C.;
RT   "Nucleotide sequence of the promoter region from kiwifruit actinidin
RT   genes.";
RL   PLANT MOL. BIOL. 15:787-788(1990).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS), AND REVISIONS.
RX   MEDLINE; 81072298.
RA   BAKER E.N.;
RT   "Structure of actinidin, after refinement at 1.7-A resolution.";
RL   J. MOL. BIOL. 141:441-484(1980).
CC   -!- CATALYTIC ACTIVITY: SPECIFICITY CLOSE TO THAT OF PAPAIN.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY C1; ALSO KNOWN AS THE
CC       PAPAIN FAMILY OF THIOL PROTEASES.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; X16466; G15984; -.
DR   EMBL; X13013; G15957; -.
DR   EMBL; X13139; G15959; -.
DR   EMBL; X57551; G21095; -.
DR   PIR; A00975; TAGB.
DR   PIR; S06587; S06587.
DR   PDB; 2ACT; 15-JAN-86.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PFAM; PF00112; Cys-protease; 1.
KW   HYDROLASE; THIOL PROTEASE; ZYMOGEN; SIGNAL; 3D-STRUCTURE.
FT   SIGNAL        1      ?       POTENTIAL.
FT   PROPEP        ?    126       ACTIVATION PEPTIDE.
FT   CHAIN       127    380       ACTINIDIN.
FT   ACT_SITE    151    151
FT   ACT_SITE    288    288
FT   ACT_SITE    308    308
FT   DISULFID    148    191
FT   DISULFID    182    224
FT   DISULFID    282    332
FT   CONFLICT     96     96       D -> G (IN REF. 2).
FT   CONFLICT    108    108       S -> G (IN REF. 2).
FT   CONFLICT    123    124       FG -> VS (IN REF. 2).
FT   CONFLICT    167    170       VTGV -> TSGS (IN REF. 3).
FT   CONFLICT    181    181       D -> G (IN REF. 2).
FT   CONFLICT    184    184       R -> G (IN REF. 2).
FT   CONFLICT    192    192       N -> D (IN REF. 3).
FT   CONFLICT    206    206       N -> D (IN REF. 3).
FT   CONFLICT    212    212       E -> G (IN REF. 2).
FT   CONFLICT    223    227       ECNLD -> DCDVA (IN REF. 3).
FT   CONFLICT    230    231       NE -> DQ (IN REF. 3).
FT   CONFLICT    240    240       E -> G (IN REF. 2).
FT   CONFLICT    272    274       HYS -> QYA (IN REF. 3).
FT   CONFLICT    286    286       I -> V (IN REF. 3).
FT   CONFLICT    290    291       VT -> IV (IN REF. 3).
FT   CONFLICT    301    301       I -> V (IN REF. 3).
FT   CONFLICT    307    307       K -> E (IN REF. 2).
FT   CONFLICT    349    349       H -> Y (IN REF. 2).
FT   CONFLICT    360    360       P -> S (IN REF. 2).
FT   CONFLICT    371    380       GVDDGQRYSA -> E (IN REF. 2).
FT   STRAND      131    132
FT   HELIX       133    136
FT   TURN        137    137
FT   STRAND      144    144
FT   TURN        146    147
FT   HELIX       151    168
FT   STRAND      174    174
FT   HELIX       176    182
FT   STRAND      185    185
FT   TURN        186    187
FT   STRAND      188    188
FT   HELIX       190    192
FT   HELIX       196    206
FT   TURN        207    207
FT   STRAND      209    209
FT   STRAND      211    211
FT   TURN        212    214
FT   HELIX       226    230
FT   STRAND      234    234
FT   STRAND      238    241
FT   TURN        244    245
FT   HELIX       247    256
FT   STRAND      259    263
FT   HELIX       268    272
FT   STRAND      277    278
FT   STRAND      288    298
FT   TURN        299    300
FT   STRAND      301    307
FT   STRAND      310    310
FT   TURN        312    313
FT   TURN        315    315
FT   STRAND      316    316
FT   TURN        317    318
FT   STRAND      319    323
FT   TURN        328    329
FT   HELIX       331    333
FT   TURN        334    335
FT   STRAND      339    342
SQ   SEQUENCE   380 AA;  42158 MW;  0F4C1A35 CRC32;
     MGLPKSFVSM SLLFFSTLLI LSLAFNAKNL TQRTNDEVKA MYESWLIKYG KSYNSLGEWE
     RRFEIFKETL RFIDEHNADT NRSYKVGLNQ FADLTDEEFR STYLGFTSGS NKTKVSNRYE
     PRFGQVLPSY VDWRSAGAVV DIKSQGECGG CWAFSAIATV EGINKIVTGV LISLSEQELI
     DCGRTQNTRG CNGGYITDGF QFIINNGGIN TEENYPYTAQ DGECNLDLQN EKYVTIDTYE
     NVPYNNEWAL QTAVTYQPVS VALDAAGDAF KHYSSGIFTG PCGTAIDHAV TIVGYGTEGG
     IDYWIVKNSW DTTWGEEGYM RILRNVGGAG TCGIATMPSY PVKYNNQNHP KPYSSLINPP
     AFSMSKDGPV GVDDGQRYSA
//
ID   AZUR_ALCDE     STANDARD;      PRT;   149 AA.
AC   P00280;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-NOV-1990 (REL. 16, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   AZURIN PRECURSOR.
GN   AZU.
OS   ALCALIGENES DENITRIFICANS.
OC   BACTERIA; PROTEOBACTERIA; BETA SUBDIVISION; ALCALIGENACEAE;
OC   ACHROMOBACTER.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 90337337.
RA   HOITINK C.W.G., WOUDT L.P., TURENHOUT J.C.M., DE KAMP M.,
RA   CANTERS G.W.;
RT   "Isolation and sequencing of the Alcaligenes denitrificans azurin-
RT   encoding gene: comparison with the genes encoding blue copper
RT   proteins from Pseudomonas aeruginosa and Alcaligenes faecalis.";
RL   GENE 90:15-20(1990).
RN   [2]
RP   SEQUENCE OF 21-149.
RC   STRAIN=NCIB 8582;
RA   AMBLER R.P.;
RL   SUBMITTED (DEC-1974) TO THE PIR DATA BANK.
RN   [3]
RP   PARTIAL SEQUENCE.
RA   AMBLER R.P.;
RL   (IN) PREVERIO A., PECHERE J.-F., COLETTI-PREVERIO M.-A. (EDS.);
RL   DEVELOPPEMENTS RECENTS DANS L'ETUDE CHIMIQUE DE LA STRUCTURE DES
RL   PROTEINES, PP.289-305, INSERM, PARIS (1971).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   MEDLINE; 83189162.
RA   NORRIS G.E., ANDERSON B.F., BAKER E.N.;
RT   "Structure of azurin from Alcaligenes denitrificans at 2.5-A
RT   resolution.";
RL   J. MOL. BIOL. 165:501-521(1983).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   MEDLINE; 89094855.
RA   BAKER E.N.;
RT   "Structure of azurin from Alcaligenes denitrificans refinement at
RT   1.8-A resolution and comparison of the two crystallographically
RT   independent molecules.";
RL   J. MOL. BIOL. 203:1071-1095(1988).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF GLN-141.
RX   MEDLINE; 93187997.
RA   ROMERO A., HOITINK C.W., NAR H., HUBER R., MESSERSCHMIDT A.,
RA   CANTERS G.W.;
RT   "X-ray analysis and spectroscopic characterization of M121Q azurin. A
RT   copper site model for stellacyanin.";
RL   J. MOL. BIOL. 229:1007-1021(1993).
RN   [7]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 96229903.
RA   KROES S., WAMERDAM G.C.M., CANTERS G.W.;
RT   "Paramagnetic cobalt and nickel derivatives of Alcaligenes
RT   denitrificans azurin and its M121Q mutant. A 1H NMR study.";
RL   BIOCHEMISTRY 35:1810-1819(1996).
CC   -!- FUNCTION: AZURIN, FOUND IN BACTERIA, IS THOUGHT TO TRANSFER
CC       ELECTRONS FROM CYTOCHROME C551 TO CYTOCHROME OXIDASE.
CC   -!- SUBCELLULAR LOCATION: PERIPLASMIC.
CC   -!- SIMILARITY: CONTAINS ONE PLASTOCYANIN-LIKE DOMAIN.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M30388; G141902; -.
DR   PIR; A00286; AZALCD.
DR   PIR; JQ0643; JQ0643.
DR   PDB; 2AZA; 15-JAN-90.
DR   PDB; 1AZB; 31-OCT-93.
DR   PDB; 1AZC; 31-OCT-93.
DR   PDB; 1AIZ; 31-JAN-94.
DR   PDB; 1URI; 01-APR-97.
DR   PDB; 1A4A; 29-APR-98.
DR   PDB; 1A4B; 29-APR-98.
DR   PDB; 1A4C; 29-APR-98.
DR   PROSITE; PS00196; COPPER_BLUE; 1.
DR   PFAM; PF00127; copper-bind; 1.
KW   ELECTRON TRANSPORT; COPPER; PERIPLASMIC; SIGNAL; 3D-STRUCTURE.
FT   SIGNAL        1     20
FT   CHAIN        21    149       AZURIN.
FT   DOMAIN       21    148       PLASTOCYANIN-LIKE.
FT   DISULFID     23     46
FT   METAL        66     66       COPPER.
FT   METAL       132    132       COPPER.
FT   METAL       137    137       COPPER.
FT   METAL       141    141       COPPER.
FT   CONFLICT     77     77       Q -> E (IN REF. 2).
FT   STRAND       24     29
FT   TURN         31     32
FT   STRAND       35     35
FT   STRAND       39     43
FT   TURN         44     45
FT   STRAND       48     55
FT   HELIX        61     64
FT   STRAND       66     66
FT   STRAND       69     72
FT   TURN         73     75
FT   HELIX        76     84
FT   TURN         85     86
FT   HELIX        88     90
FT   TURN         91     92
FT   TURN         95     96
FT   TURN         98     99
FT   STRAND      100    103
FT   STRAND      107    107
FT   TURN        109    110
FT   STRAND      112    118
FT   HELIX       119    121
FT   TURN        124    125
FT   STRAND      127    131
FT   TURN        135    136
FT   TURN        138    140
FT   STRAND      142    148
SQ   SEQUENCE   149 AA;  15924 MW;  081C6829 CRC32;
     MLAKATLAIV LSAASLPVLA AQCEATIESN DAMQYNLKEM VVDKSCKQFT VHLKHVGKMA
     KVAMGHNWVL TKEADKQGVA TDGMNAGLAQ DYVKAGDTRV IAHTKVIGGG ESDSVTFDVS
     KLTPGEAYAY FCSFPGHWAM MKGTLKLSN
//
ID   C551_PSEAE     STANDARD;      PRT;   104 AA.
AC   P00099;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-APR-1990 (REL. 14, LAST SEQUENCE UPDATE)
DT   01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE)
DE   CYTOCHROME C-551 PRECURSOR (C551) (CYTOCHROME C8).
GN   NIRM.
OS   PSEUDOMONAS AERUGINOSA.
OC   BACTERIA; PROTEOBACTERIA; GAMMA SUBDIVISION; PSEUDOMONAS GROUP;
OC   PSEUDOMONAS.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=ATCC 10145;
RX   MEDLINE; 90092552.
RA   NORDLING M., YOUNG S., KARLSSON B.G., LUNDBERG L.G.;
RT   "The structural gene for cytochrome c551 from Pseudomonas aeruginosa.
RT   The nucleotide sequence shows a location downstream of the nitrite
RT   reductase gene.";
RL   FEBS LETT. 259:230-232(1990).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 90169115.
RA   ARAI H., SANBONGI Y., IGARASHI Y., KODAMA T.;
RT   "Cloning and sequencing of the gene encoding cytochrome c-551 from
RT   Pseudomonas aeruginosa.";
RL   FEBS LETT. 261:196-198(1990).
RN   [3]
RP   SEQUENCE OF 23-104.
RC   STRAIN=P6009;
RA   AMBLER R.P.;
RT   "The amino acid sequence of Pseudomonas cytochrome c-551.";
RL   BIOCHEM. J. 89:349-378(1963).
RN   [4]
RP   SEQUENCE OF 23-104.
RC   STRAIN=9 DIFFERENT STRAINS;
RX   MEDLINE; 74140216.
RA   AMBLER R.P.;
RT   "The evolutionary stability of cytochrome c-551 in Pseudomonas
RT   aeruginosa and Pseudomonas fluorescens biotype C.";
RL   BIOCHEM. J. 137:3-14(1974).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   MEDLINE; 82216851.
RA   MATSUURA Y., TAKANO T., DICKERSON R.E.;
RT   "Structure of cytochrome c551 from Pseudomonas aeruginosa refined at
RT   1.6-A resolution and comparison of the two redox forms.";
RL   J. MOL. BIOL. 156:389-409(1982).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 78202033.
RA   ALMASSY R.J., DICKERSON R.E.;
RT   "Pseudomonas cytochrome c551 at 2.0-A resolution: enlargement of the
RT   cytochrome c family.";
RL   PROC. NATL. ACAD. SCI. U.S.A. 75:2674-2678(1978).
RN   [7]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 91064340.
RA   DETLEFSEN D.J., THANABAL V., PECORARO V.L., WAGNER G.;
RT   "Sequential 1H NMR assignments of iron(II) cytochrome c551 from
RT   Pseudomonas aeruginosa.";
RL   BIOCHEMISTRY 29:9377-9386(1990).
RN   [8]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 91369910.
RA   DETLEFSEN D.J., THANABAL V., PECORARO V.L., WAGNER G.;
RT   "Solution structure of Fe(II) cytochrome c551 from Pseudomonas
RT   aeruginosa as determined by two-dimensional 1H NMR.";
RL   BIOCHEMISTRY 30:9040-9046(1991).
RN   [9]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 94032272.
RA   TIMKOVICH R., CAI M.;
RT   "Investigation of the structure of oxidized Pseudomonas aeruginosa
RT   cytochrome c-551 by NMR: comparison of observed paramagnetic shifts
RT   and calculated pseudocontact shifts.";
RL   BIOCHEMISTRY 32:11516-11523(1993).
CC   -!- FUNCTION: ELECTRON DONOR FOR CYTOCHROME CD1 IN NITRITE AND NITRATE
CC       RESPIRATION. THIS CYTOCHROME HAS A REDOX POTENTIAL OF ABOUT +260
CC       MV.
CC   -!- SUBCELLULAR LOCATION: PERIPLASMIC.
CC   -!- PTM: BINDS ONE HEME GROUP PER MOLECULE.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; X51319; G45307; -.
DR   EMBL; X51631; G45318; -.
DR   PIR; A00091; CCPS5A.
DR   PIR; B34141; B34141.
DR   PIR; B34255; B34255.
DR   PDB; 351C; 30-SEP-83.
DR   PDB; 451C; 30-SEP-83.
DR   PDB; 2PAC; 31-OCT-93.
DR   PROSITE; PS00190; CYTOCHROME_C; 1.
DR   PFAM; PF00034; cytochrome_c; 1.
KW   ELECTRON TRANSPORT; HEME; PERIPLASMIC; 3D-STRUCTURE; SIGNAL.
FT   SIGNAL        1     22
FT   CHAIN        23    104       CYTOCHROME C-551.
FT   BINDING      34     34       HEME (COVALENT).
FT   BINDING      37     37       HEME (COVALENT).
FT   METAL        38     38       IRON (HEME AXIAL LIGAND).
FT   METAL        83     83       IRON (HEME AXIAL LIGAND).
FT   VARIANT      24     24       D -> A (IN STRAIN 129/1224).
FT   HELIX        25     28
FT   TURN         29     33
FT   HELIX        34     36
FT   TURN         37     37
FT   TURN         39     41
FT   HELIX        49     53
FT   TURN         54     56
FT   HELIX        64     67
FT   TURN         68     72
FT   HELIX        92    101
FT   TURN        102    102
SQ   SEQUENCE   104 AA;  10967 MW;  894AB12D CRC32;
     MKPYALLSLL ATGTLLAQGA WAEDPEVLFK NKGCVACHAI DTKMVGPAYK DVAAKFAGQA
     GAEAELAQRI KNGSQGVWGP IPMPPNAVSD DEAQTLAKWV LSQK
//
ID   CTRA_BOVIN     STANDARD;      PRT;   245 AA.
AC   P00766;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   CHYMOTRYPSINOGEN A (EC 3.4.21.1).
OS   BOS TAURUS (BOVINE).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   ARTIODACTYLA; RUMINANTIA; PECORA; BOVOIDEA; BOVIDAE; BOVINAE; BOS.
RN   [1]
RP   SEQUENCE, DISULFIDE BONDS, AND ACTIVE SITE.
RX   MEDLINE; 67181721.
RA   BROWN J.R., HARTLEY B.S.;
RT   "Location of disulphide bridges by diagonal paper electrophoresis.
RT   The disulphide bridges of bovine chymotrypsinogen A.";
RL   BIOCHEM. J. 101:214-228(1966).
RN   [2]
RP   REVISION TO 102.
RX   MEDLINE; 69106266.
RA   BLOW D.M., BIRKTOFT J.J., HARTLEY B.S.;
RT   "Role of a buried acid group in the mechanism of action of
RT   chymotrypsin.";
RL   NATURE 221:337-340(1969).
RN   [3]
RP   PRELIMINARY SEQUENCE.
RA   HARTLEY B.S.;
RT   "Amino-acid sequence of bovine chymotrypsinogen-A.";
RL   NATURE 201:1284-1287(1964).
RN   [4]
RP   SEQUENCE, AND DISULFIDE BONDS.
RX   MEDLINE; 67183948.
RA   MELOUN B., KLUH I., KOSTKA V., MORAVEK L., PRUSIK Z., VANACEK J.,
RA   KEIL B., SORM F.;
RT   "Covalent structure of bovine chymotrypsinogen A.";
RL   BIOCHIM. BIOPHYS. ACTA 130:543-546(1966).
RN   [5]
RP   ACTIVE SITE.
RX   MEDLINE; 67181723.
RA   SMILLIE L.B., HARTLEY B.S.;
RT   "Histidine sequences in the active centres of some 'serine'
RT   proteinases.";
RL   BIOCHEM. J. 101:232-241(1966).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY.
RX   MEDLINE; 72035052.
RA   BIRKTOFT J.J., BLOW D.M., HENDERSON R., STEITZ T.A.;
RT   "I. Serine proteinases. The structure of alpha-chymotrypsin.";
RL   PHILOS. TRANS. R. SOC. LOND., B, BIOL. SCI. 257:67-76(1970).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF CHYMOTRYPSINOGEN.
RX   MEDLINE; 70177557.
RA   FREER S.T., KRAUT J., ROBERTUS J.D., WRIGHT H.T., XUONG N.H.;
RT   "Chymotrypsinogen: 2.5-A crystal structure, comparison with alpha-
RT   chymotrypsin, and implications for zymogen activation.";
RL   BIOCHEMISTRY 9:1997-2009(1970).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF GAMMA-CHYMOTRYPSIN.
RX   MEDLINE; 82078042.
RA   COHEN G.H., SILVERTON E.W., DAVIES D.R.;
RT   "Refined crystal structure of gamma-chymotrypsin at 1.9-A resolution.
RT   Comparison with other pancreatic serine proteases.";
RL   J. MOL. BIOL. 148:449-479(1981).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.68 ANGSTROMS) OF ALPHA-CHYMOTRYPSIN.
RX   MEDLINE; 86011575.
RA   TSUKADA H., BLOW D.M.;
RT   "Structure of alpha-chymotrypsin refined at 1.68-A resolution.";
RL   J. MOL. BIOL. 184:703-711(1985).
CC   -!- CATALYTIC ACTIVITY: PREFERENTIAL CLEAVAGE: TYR-, TRP-, PHE-, LEU-.
CC   -!- SUBCELLULAR LOCATION: EXTRACELLULAR.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY S1; ALSO KNOWN AS THE
CC       TRYPSIN FAMILY.
DR   PIR; A00952; KYBOA.
DR   PDB; 2CGA; 15-APR-90.
DR   PDB; 2CHA; 31-MAY-84.
DR   PDB; 4CHA; 29-OCT-85.
DR   PDB; 5CHA; 16-OCT-87.
DR   PDB; 6CHA; 16-OCT-87.
DR   PDB; 1CHG; 27-JAN-84.
DR   PDB; 1CHO; 16-JUL-88.
DR   PDB; 2GCH; 31-MAY-84.
DR   PDB; 3GCH; 15-OCT-92.
DR   PDB; 4GCH; 15-OCT-90.
DR   PDB; 5GCH; 15-OCT-90.
DR   PDB; 6GCH; 15-OCT-90.
DR   PDB; 7GCH; 15-OCT-90.
DR   PDB; 8GCH; 15-JUL-93.
DR   PDB; 1GCT; 15-OCT-91.
DR   PDB; 2GCT; 15-OCT-91.
DR   PDB; 3GCT; 15-OCT-91.
DR   PDB; 1ACB; 31-OCT-93.
DR   PDB; 1GMC; 31-OCT-93.
DR   PDB; 1GMD; 31-OCT-93.
DR   PDB; 1CGI; 30-APR-94.
DR   PDB; 1CGJ; 30-APR-94.
DR   PDB; 1GCD; 22-JUN-94.
DR   PDB; 1GHA; 22-JUN-94.
DR   PDB; 1GHB; 22-JUN-94.
DR   PDB; 1GMH; 30-SEP-94.
DR   PDB; 2GMT; 01-NOV-94.
DR   PDB; 1MTN; 17-AUG-96.
DR   PDB; 1AB9; 20-AUG-97.
DR   PDB; 1AFQ; 17-SEP-97.
DR   PDB; 1CA0; 23-JUL-97.
DR   PDB; 1CBW; 23-JUL-97.
DR   PDB; 1VGC; 12-NOV-97.
DR   PDB; 2VGC; 12-NOV-97.
DR   PDB; 3VGC; 12-NOV-97.
DR   PDB; 4VGC; 12-NOV-97.
DR   PDB; 1HJA; 14-JAN-98.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
DR   PFAM; PF00089; trypsin; 1.
KW   HYDROLASE; SERINE PROTEASE; DIGESTION; PANCREAS; ZYMOGEN;
KW   3D-STRUCTURE.
FT   CHAIN         1     13       CHYMOTRYPSIN A, A CHAIN.
FT   CHAIN        16    146       CHYMOTRYPSIN A, B CHAIN.
FT   CHAIN       149    245       CHYMOTRYPSIN A, C CHAIN.
FT   ACT_SITE     57     57       CHARGE RELAY SYSTEM.
FT   ACT_SITE    102    102       CHARGE RELAY SYSTEM.
FT   ACT_SITE    195    195       CHARGE RELAY SYSTEM.
FT   DISULFID      1    122
FT   DISULFID     42     58
FT   DISULFID    136    201
FT   DISULFID    168    182
FT   DISULFID    191    220
FT   HELIX        12     15
FT   STRAND       20     21
FT   TURN         24     25
FT   TURN         28     29
FT   STRAND       30     34
FT   STRAND       40     46
FT   STRAND       51     54
FT   TURN         57     58
FT   TURN         62     63
FT   STRAND       65     68
FT   TURN         69     69
FT   STRAND       72     72
FT   TURN         73     74
FT   STRAND       81     90
FT   TURN         92     93
FT   STRAND       95     95
FT   TURN         96     99
FT   STRAND      100    100
FT   TURN        101    101
FT   STRAND      104    108
FT   STRAND      122    122
FT   TURN        126    127
FT   TURN        132    133
FT   STRAND      135    140
FT   TURN        146    148
FT   STRAND      154    154
FT   STRAND      156    163
FT   HELIX       165    168
FT   TURN        169    172
FT   HELIX       173    175
FT   STRAND      180    184
FT   TURN        192    193
FT   TURN        195    196
FT   STRAND      198    203
FT   TURN        204    205
FT   STRAND      206    216
FT   TURN        218    219
FT   TURN        222    223
FT   STRAND      225    230
FT   HELIX       231    233
FT   TURN        234    234
FT   HELIX       235    243
SQ   SEQUENCE   245 AA;  25666 MW;  05964B83 CRC32;
     CGVPAIQPVL SGLSRIVNGE EAVPGSWPWQ VSLQDKTGFH FCGGSLINEN WVVTAAHCGV
     TTSDVVVAGE FDQGSSSEKI QKLKIAKVFK NSKYNSLTIN NDITLLKLST AASFSQTVSA
     VCLPSASDDF AAGTTCVTTG WGLTRYTNAN TPDRLQQASL PLLSNTNCKK YWGTKIKDAM
     ICAGASGVSS CMGDSGGPLV CKKNGAWTLV GIVSWGSSTC STSTPGVYAR VTALVNWVQQ
     TLAAN
//
ID   CY2_RHORU      STANDARD;      PRT;   135 AA.
AC   P00092;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-APR-1990 (REL. 14, LAST SEQUENCE UPDATE)
DT   01-FEB-1994 (REL. 28, LAST ANNOTATION UPDATE)
DE   CYTOCHROME C2 PRECURSOR.
GN   CYCA.
OS   RHODOSPIRILLUM RUBRUM.
OC   BACTERIA; PROTEOBACTERIA; ALPHA SUBDIVISION; RHODOSPIRILLACEAE;
OC   RHODOSPIRILLUM.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=S1;
RX   MEDLINE; 90147629.
RA   SELF S.J., HUNTER C.N., LEATHERBARROW R.J.;
RT   "Molecular cloning, sequencing and expression of cytochrome c2 from
RT   Rhodospirillum rubrum.";
RL   BIOCHEM. J. 265:599-604(1990).
RN   [2]
RP   SEQUENCE OF 24-135.
RX   MEDLINE; 69080147.
RA   DUS K., SLETTEN K., KAMEN M.D.;
RT   "Cytochrome c2 of Rhodospirillum rubrum. II. Complete amino acid
RT   sequence and phylogenetic relationships.";
RL   J. BIOL. CHEM. 243:5507-5518(1968).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 73187380.
RA   SALEMME F.R., FREER S.T., XUONG N.H., ALDEN R.A., KRAUT J.;
RT   "The structure of oxidized cytochrome c2 of Rhodospirillum rubrum.";
RL   J. BIOL. CHEM. 248:3910-3921(1973).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY.
RX   MEDLINE; 74003179.
RA   SALEMME F.R., FREER S.T., ALDEN R.A., KRAUT J.;
RT   "Atomic coordinates for ferricytochrome c2 of Rhodospirillum rubrum.";
RL   BIOCHEM. BIOPHYS. RES. COMMUN. 54:47-52(1973).
CC   -!- FUNCTION: CYTOCHROME C2 IS FOUND MAINLY IN PURPLE, NONSULFUR,
CC       PHOTOSYNTHETIC BACTERIA WHERE IT FUNCTIONS AS THE ELECTRON DONOR
CC       TO THE OXIDIZED BACTERIOCHLOROPHYLL IN THE PHOTOPHOSPHORYLATION
CC       PATHWAY. HOWEVER, IT MAY ALSO HAVE A ROLE IN THE RESPIRATORY CHAIN
CC       AND IS FOUND IN SOME NONPHOTOSYNTHETIC BACTERIA.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; X17605; G46379; -.
DR   PIR; S08213; CCQF2R.
DR   PDB; 2C2C; 02-FEB-84.
DR   PDB; 3C2C; 02-FEB-84.
DR   PROSITE; PS00190; CYTOCHROME_C; 1.
DR   PFAM; PF00034; cytochrome_c; 1.
KW   ELECTRON TRANSPORT; PHOTOSYNTHESIS; HEME; 3D-STRUCTURE; SIGNAL.
FT   SIGNAL        1     23
FT   CHAIN        24    135       CYTOCHROME C2.
FT   BINDING      37     37       HEME (COVALENT).
FT   BINDING      40     40       HEME (COVALENT).
FT   METAL        41     41       IRON (HEME AXIAL LIGAND).
FT   METAL       114    114       IRON (HEME AXIAL LIGAND).
FT   CONFLICT     68     68       D -> N (IN REF. 2).
FT   CONFLICT     96     96       D -> N (IN REF. 2).
FT   HELIX        27     37
FT   TURN         38     40
FT   TURN         45     46
FT   TURN         56     57
FT   TURN         59     60
FT   STRAND       62     62
FT   TURN         67     68
FT   HELIX        73     80
FT   TURN         81     82
FT   STRAND       84     84
FT   HELIX        87     95
FT   HELIX        97    105
FT   TURN        108    109
FT   HELIX       121    131
FT   TURN        132    133
SQ   SEQUENCE   135 AA;  14395 MW;  4B38AD72 CRC32;
     MKKGFLAAGV FAAVAFASGA ALAEGDAAAG EKVSKKCLAC HTFDQGGANK VGPNLFGVFE
     NTAAHKDDYA YSESYTEMKA KGLTWTEANL AAYVKDPKAF VLEKSGDPKA KSKMTFKLTK
     DDEIENVIAY LKTLK
//
ID   CYC_KATPE      STANDARD;      PRT;   103 AA.
AC   P00025;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE)
DE   CYTOCHROME C.
OS   KATSUWONUS PELAMIS (SKIPJACK TUNA) (BONITO).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; ACTINOPTERYGII; NEOPTERYGII;
OC   TELEOSTEI; EUTELEOSTEI; ACANTHOPTERYGII; PERCOMORPHA; PERCIFORMES;
OC   SCOMBROIDEI; SCOMBRIDAE; EUTHYNNUS.
RN   [1]
RP   SEQUENCE.
RX   MEDLINE; 72003272.
RA   NAKAYAMA T., TITANI K., NARITA K.;
RT   "The amino acid sequence of cytochrome c from bonito (Katsuwonus
RT   pelamis, Linnaeus).";
RL   J. BIOCHEM. 70:311-326(1971).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF REDUCED FORM.
RX   MEDLINE; 75170243.
RA   TANAKA N., YAMANE T., TSUKIHARA T., ASHIDA T., KAKUDO M.;
RT   "The crystal structure of bonito (katsuo) ferrocytochrome c at 2.3-A
RT   resolution. II. Structure and function.";
RL   J. BIOCHEM. 77:147-162(1975).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF OXIDIZED FORM.
RX   MEDLINE; 79150869.
RA   MATSUURA Y., HATA Y., YAMAGUCHI T., TANAKA N., KAKUDO M.;
RT   "Structure of bonito heart ferricytochrome c and some remarks on
RT   molecular interaction in its crystalline state.";
RL   J. BIOCHEM. 85:729-737(1979).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF OXIDIZED AND REDUCED FORMS.
RX   MEDLINE; 77207068.
RA   MANDEL N., MANDEL G., TRUS B.L., ROSENBURG J., CARLSON G.,
RA   DICKERSON R.E.;
RT   "Tuna cytochrome c at 2.0-A resolution. III. Coordinate optimization
RT   and comparison of structures.";
RL   J. BIOL. CHEM. 252:4619-4636(1977).
CC   -!- SUBCELLULAR LOCATION: MITOCHONDRIAL MATRIX.
CC   -!- PTM: BINDS ONE HEME GROUP PER MOLECULE.
DR   PIR; A00022; CCBN.
DR   PDB; 1CYC; 27-JAN-84.
DR   PDB; 3CYT; 30-SEP-83.
DR   PDB; 5CYT; 12-JUL-89.
DR   PROSITE; PS00190; CYTOCHROME_C; 1.
DR   PFAM; PF00034; cytochrome_c; 1.
KW   MITOCHONDRION; ELECTRON TRANSPORT; RESPIRATORY CHAIN; HEME;
KW   ACETYLATION; 3D-STRUCTURE.
FT   MOD_RES       1      1       ACETYLATION.
FT   BINDING      14     14       HEME (COVALENT).
FT   BINDING      17     17       HEME (COVALENT).
FT   METAL        18     18       IRON (HEME AXIAL LIGAND).
FT   METAL        80     80       IRON (HEME AXIAL LIGAND).
FT   HELIX         3     13
FT   TURN         14     17
FT   TURN         22     23
FT   TURN         33     34
FT   TURN         36     37
FT   STRAND       39     39
FT   TURN         40     41
FT   TURN         44     45
FT   HELIX        50     53
FT   TURN         54     54
FT   STRAND       58     58
FT   HELIX        61     69
FT   HELIX        71     74
FT   TURN         76     77
FT   HELIX        88    101
SQ   SEQUENCE   103 AA;  11384 MW;  A9728CD4 CRC32;
     GDVAKGKKTF VQKCAQCHTV ENGGKHKVGP NLWGLFGRKT GQAEGYSYTD ANKSKGIVWN
     ENTLMEYLEN PKKYIPGTKM IFAGIKKKGE RQDLVAYLKS ATS
//
ID   CYC_ORYSA      STANDARD;      PRT;   111 AA.
AC   P00055;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE)
DE   CYTOCHROME C.
GN   CC-1.
OS   ORYZA SATIVA (RICE).
OC   EUKARYOTA; VIRIDIPLANTAE; STREPTOPHYTA; EMBRYOPHYTA; TRACHEOPHYTA;
OC   EUPHYLLOPHYTES; SPERMATOPHYTA; MAGNOLIOPHYTA; LILIOPSIDA; POALES;
OC   POACEAE; ORYZA.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 91260432.
RA   KEMMERER E.C., LEI M., WU R.;
RT   "Isolation and molecular evolutionary analysis of a cytochrome c gene
RT   from Oryza sativa (rice).";
RL   MOL. BIOL. EVOL. 8:212-226(1991).
RN   [2]
RP   SEQUENCE FROM N.A.
RC   STRAIN=CV. YAMAHOUSHI;
RA   NISHI R., UCHIMIYA H., KATO A.;
RL   SUBMITTED (JUL-1992) TO EMBL/GENBANK/DDBJ DATA BANKS.
RN   [3]
RP   SEQUENCE.
RX   MEDLINE; 80137364.
RA   MORI E., MORITA Y.;
RT   "Amino acid sequence of cytochrome c from rice.";
RL   J. BIOCHEM. 87:249-266(1980).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 83216146.
RA   OCHI H., HATA Y., TANAKA N., KAKUDO M., SAKURAI T., AIHARA S.,
RA   MORITA Y.;
RT   "Structure of rice ferricytochrome c at 2.0-A resolution.";
RL   J. MOL. BIOL. 166:407-418(1983).
CC   -!- SUBCELLULAR LOCATION: MITOCHONDRIAL MATRIX.
CC   -!- PTM: BINDS ONE HEME GROUP PER MOLECULE.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M63704; G169786; -.
DR   EMBL; D12634; G218249; -.
DR   PIR; A00048; CCRZ.
DR   PIR; JS0709; JS0709.
DR   PDB; 1CCR; 16-APR-87.
DR   PROSITE; PS00190; CYTOCHROME_C; 1.
DR   PFAM; PF00034; cytochrome_c; 1.
KW   MITOCHONDRION; ELECTRON TRANSPORT; RESPIRATORY CHAIN; 3D-STRUCTURE;
KW   HEME; METHYLATION; ACETYLATION.
FT   INIT_MET      0      0
FT   MOD_RES       1      1       ACETYLATION.
FT   BINDING      22     22       HEME (COVALENT).
FT   BINDING      25     25       HEME (COVALENT).
FT   METAL        26     26       IRON (HEME AXIAL LIGAND).
FT   MOD_RES      80     80       METHYLATION (TRI-).
FT   METAL        88     88       IRON (HEME AXIAL LIGAND).
FT   MOD_RES      94     94       METHYLATION (TRI-).
FT   HELIX         3      5
FT   HELIX        11     21
FT   TURN         22     25
FT   TURN         30     31
FT   TURN         41     42
FT   TURN         44     45
FT   STRAND       47     47
FT   TURN         48     49
FT   TURN         52     53
FT   HELIX        58     63
FT   STRAND       66     66
FT   HELIX        69     77
FT   HELIX        79     82
FT   TURN         84     85
FT   HELIX        96    109
FT   TURN        110    110
SQ   SEQUENCE   111 AA;  12140 MW;  A26D8090 CRC32;
     ASFSEAPPGN PKAGEKIFKT KCAQCHTVDK GAGHKQGPNL NGLFGRQSGT TPGYSYSTAN
     KNMAVIWEEN TLYDYLLNPK KYIPGTKMVF PGLKKPQERA DLISYLKEAT S
//
ID   DYR_ECOLI      STANDARD;      PRT;   159 AA.
AC   P00379;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE)
DE   DIHYDROFOLATE REDUCTASE (EC 1.5.1.3).
GN   FOLA OR TMRA.
OS   ESCHERICHIA COLI.
OC   BACTERIA; PROTEOBACTERIA; GAMMA SUBDIVISION; ENTEROBACTERIACEAE;
OC   ESCHERICHIA.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=K12;
RX   MEDLINE; 81053692.
RA   SMITH D.R., CALVO J.M.;
RT   "Nucleotide sequence of the E coli gene coding for dihydrofolate
RT   reductase.";
RL   NUCLEIC ACIDS RES. 8:2255-2274(1980).
RN   [2]
RP   SEQUENCE FROM N.A.
RC   STRAIN=K12;
RX   MEDLINE; 92334977.
RA   YURA T., MORI H., NAGAI H., NAGATA T., ISHIHAMA A., FUJITA N.,
RA   ISONO K., MIZOBUCHI K., NAKATA A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of
RT   the 0-2.4 min region.";
RL   NUCLEIC ACIDS RES. 20:3305-3308(1992).
RN   [3]
RP   SEQUENCE FROM N.A.
RC   STRAIN=K12 / MG1655;
RX   MEDLINE; 97426617.
RA   BLATTNER F.R., PLUNKETT G. III, BLOCH C.A., PERNA N.T., BURLAND V.,
RA   RILEY M., COLLADO-VIDES J., GLASNER F.D., RODE C.K., MAYHEW G.F.,
RA   GREGOR J., DAVIS N.W., KIRKPATRICK H.A., GOEDEN M.A., ROSE D.J.,
RA   MAU B., SHAO Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   SCIENCE 277:1453-1474(1997).
RN   [4]
RP   SEQUENCE (ISOZYME 1).
RC   STRAIN=B [RT500];
RX   MEDLINE; 77115802.
RA   STONE D., PHILLIPS A.W., BURCHALL J.J.;
RT   "The amino-acid sequence of the dihydrofolate reductase of a
RT   trimethoprim-resistant strain of Escherichia coli.";
RL   EUR. J. BIOCHEM. 72:613-624(1977).
RN   [5]
RP   SEQUENCE (ISOZYME 2).
RC   STRAIN=B [RT500];
RX   MEDLINE; 81117257.
RA   BACCANARI D.P., STONE D., KUYPER L.;
RT   "Effect of a single amino acid substitution on Escherichia coli
RT   dihydrofolate reductase catalysis and ligand binding.";
RL   J. BIOL. CHEM. 256:1738-1747(1981).
RN   [6]
RP   SEQUENCE.
RC   STRAIN=B [MB1428];
RX   MEDLINE; 78187252.
RA   BENNETT C.D., RODKEY J.A., SONDEY J.M., HIRSCHMANN R.;
RT   "Dihydrofolate reductase: the amino acid sequence of the enzyme from
RT   a methotrexate-resistant mutant of Escherichia coli.";
RL   BIOCHEMISTRY 17:1328-1337(1978).
RN   [7]
RP   SEQUENCE FROM N.A.
RC   STRAIN=1810;
RX   MEDLINE; 87161813.
RA   FLENSBURG J., SKOELD O.;
RT   "Massive overproduction of dihydrofolate reductase in bacteria as a
RT   response to the use of trimethoprim.";
RL   EUR. J. BIOCHEM. 162:473-476(1987).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   MEDLINE; 83056868.
RA   FILMAN D.J., BOLIN J.T., MATTHEWS D.A., KRAUT J.;
RT   "Crystal structures of Escherichia coli and Lactobacillus casei
RT   dihydrofolate reductase refined at 1.7-A resolution. II. Environment
RT   of bound NADPH and implications for catalysis.";
RL   J. BIOL. CHEM. 257:13663-13672(1982).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY.
RX   MEDLINE; 90241903.
RA   BYSTROFF C., OATLEY S.J., KRAUT J.;
RT   "Crystal structures of Escherichia coli dihydrofolate reductase: the
RT   NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate
RT   binding and a model for the transition state.";
RL   BIOCHEMISTRY 29:3263-3277(1990).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   MEDLINE; 91152037.
RA   BYSTROFF C., KRAUT J.;
RT   "Crystal structure of unliganded Escherichia coli dihydrofolate
RT   reductase. Ligand-induced conformational changes and cooperativity in
RT   binding.";
RL   BIOCHEMISTRY 30:2227-2239(1991).
CC   -!- CATALYTIC ACTIVITY: 5,6,7,8-TETRAHYDROFOLATE + NADP(+) =
CC       7,8-DIHYDROFOLATE + NADPH.
CC   -!- PATHWAY: ESSENTIAL STEP FOR DE NOVO GLYCINE AND PURINE SYNTHESIS,
CC       DNA PRECURSOR SYNTHESIS, AND FOR THE CONVERSION OF DUMP TO DTMP.
CC   -!- THE STRAIN K12 SEQUENCE IS SHOWN.
CC   -!- STRAIN B [RT500] IS RESISTANT TO 500 MICROGRAMS PER MILLILITER OF
CC       TRIMETHOPRIM.
CC   -!- STRAIN B [MB1428] IS METHOTREXATE-RESISTANT.
CC   -!- SIMILARITY: STRONG TO OTHER TYPE I DIHYDROFOLATE REDUCTASES.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; J01609; G146006; -.
DR   EMBL; X05108; G41265; -.
DR   EMBL; D10483; G216473; -.
DR   EMBL; AE000115; G1786233; -.
DR   PIR; A00391; RDECD.
DR   PDB; 4DFR; 15-JUL-92.
DR   PDB; 5DFR; 15-JUL-90.
DR   PDB; 6DFR; 15-JUL-90.
DR   PDB; 7DFR; 15-JUL-92.
DR   PDB; 1DRA; 31-JAN-94.
DR   PDB; 1DRB; 31-JAN-94.
DR   PDB; 2DRC; 31-JAN-94.
DR   PDB; 3DRC; 31-JAN-94.
DR   PDB; 1DHI; 31-JAN-94.
DR   PDB; 1DHJ; 31-JAN-94.
DR   PDB; 1DDR; 15-OCT-95.
DR   PDB; 1DDS; 15-OCT-95.
DR   PDB; 1DRE; 12-MAR-97.
DR   PDB; 1DRH; 07-FEB-95.
DR   PDB; 1DYH; 03-JUN-95.
DR   PDB; 1DYI; 03-JUN-95.
DR   PDB; 1DYJ; 03-JUN-95.
DR   PDB; 1JOL; 08-NOV-96.
DR   PDB; 1JOM; 08-NOV-96.
DR   PDB; 1RA1; 23-DEC-96.
DR   PDB; 1RA2; 23-DEC-96.
DR   PDB; 1RA3; 23-DEC-96.
DR   PDB; 1RA8; 12-MAR-97.
DR   PDB; 1RA9; 23-DEC-96.
DR   PDB; 1RB2; 12-MAR-97.
DR   PDB; 1RB3; 12-MAR-97.
DR   PDB; 1RC4; 12-MAR-97.
DR   PDB; 1RD7; 23-DEC-96.
DR   PDB; 1RE7; 23-DEC-96.
DR   PDB; 1RF7; 12-MAR-97.
DR   PDB; 1RG7; 12-MAR-97.
DR   PDB; 1RH3; 12-MAR-97.
DR   PDB; 1RX1; 11-JAN-97.
DR   PDB; 1RX2; 11-JAN-97.
DR   PDB; 1RX3; 11-JAN-97.
DR   PDB; 1RX4; 11-JAN-97.
DR   PDB; 1RX5; 11-JAN-97.
DR   PDB; 1RX6; 11-JAN-97.
DR   PDB; 1RX7; 12-MAR-97.
DR   PDB; 1RX8; 12-MAR-97.
DR   PDB; 1RX9; 01-APR-97.
DR   PDB; 1TDR; 10-JUL-95.
DR   SWISS-2DPAGE; P00379; COLI.
DR   ECO2DBASE; B020.0; 6TH EDITION.
DR   ECOGENE; EG10326; FOLA.
DR   PROSITE; PS00075; DHFR; 1.
DR   PFAM; PF00186; DiHfolate_red; 1.
KW   OXIDOREDUCTASE; NADP; TRIMETHOPRIM RESISTANCE;
KW   METHOTREXATE RESISTANCE; ONE-CARBON METABOLISM; 3D-STRUCTURE.
FT   VARIANT      28     28       L -> R (IN STRAIN B[RT500] ISOZYME 2).
FT   VARIANT      30     30       W -> G (IN STRAIN 1810).
FT   VARIANT     154    154       E -> Q (IN STRAIN 1810).
FT   VARIANT     154    154       E -> K (IN STRAIN B[MB1428]).
FT   STRAND        2      8
FT   HELIX        10     12
FT   STRAND       13     13
FT   HELIX        25     35
FT   TURN         36     37
FT   STRAND       39     43
FT   HELIX        44     50
FT   TURN         55     56
FT   STRAND       58     62
FT   STRAND       73     75
FT   HELIX        78     85
FT   STRAND       91     95
FT   HELIX        97    106
FT   STRAND      107    115
FT   STRAND      124    124
FT   TURN        130    131
FT   STRAND      133    141
FT   STRAND      151    158
SQ   SEQUENCE   159 AA;  17999 MW;  1F28DF10 CRC32;
     MISLIAALAV DRVIGMENAM PWNLPADLAW FKRNTLNKPV IMGRHTWESI GRPLPGRKNI
     ILSSQPGTDD RVTWVKSVDE AIAACGDVPE IMVIGGGRVY EQFLPKAQKL YLTHIDAEVE
     GDTHFPDYEP DDWESVFSEF HDADAQNSHS YCFEILERR
//
ID   DYR_LACCA      STANDARD;      PRT;   162 AA.
AC   P00381;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   13-AUG-1987 (REL. 05, LAST SEQUENCE UPDATE)
DT   15-JUL-1998 (REL. 36, LAST ANNOTATION UPDATE)
DE   DIHYDROFOLATE REDUCTASE (EC 1.5.1.3).
GN   DHFR.
OS   LACTOBACILLUS CASEI.
OC   BACTERIA; FIRMICUTES; BACILLUS/CLOSTRIDIUM GROUP; LACTOBACILLACEAE;
OC   LACTOBACILLUS.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 85286353.
RA   ANDREWS J., CLORE G.M., DAVIES R.W., GRONENBORN A.M., GRONENBORN B.,
RA   KALDERON D., PAPADOPOULOS P.C., SCHAEFER S., SIMS P.F.G.,
RA   STANCOMBE R.;
RT   "Nucleotide sequence of the dihydrofolate reductase gene of
RT   methotrexate-resistant Lactobacillus casei.";
RL   GENE 35:217-222(1985).
RN   [2]
RP   SEQUENCE.
RX   MEDLINE; 78242349.
RA   FREISHEIM J.H., BITAR K.G., REDDY A.V., BLANKENSHIP D.T.;
RT   "Dihydrofolate reductase from amethopterin-resistant Lactobacillus
RT   casei. Sequences of the cyanogen bromide peptides and complete
RT   sequences of the enzyme.";
RL   J. BIOL. CHEM. 253:6437-6444(1978).
RN   [3]
RP   SEQUENCE OF 1-51.
RX   MEDLINE; 77181453.
RA   BATLEY K.E., MORRIS H.R.;
RT   "Dihydrofolate reductase from Lactobacillus casei: N-terminal
RT   sequence and comparison with the substrate binding region of other
RT   reductases.";
RL   BIOCHEM. BIOPHYS. RES. COMMUN. 75:1010-1014(1977).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   MEDLINE; 83056868.
RA   FILMAN D.J., BOLIN J.T., MATTHEWS D.A., KRAUT J.;
RT   "Crystal structures of Escherichia coli and Lactobacillus casei
RT   dihydrofolate reductase refined at 1.7-A resolution. II. Environment
RT   of bound NADPH and implications for catalysis.";
RL   J. BIOL. CHEM. 257:13663-13672(1982).
RN   [5]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 91283478.
RA   CARR M.D., BIRDSALL B., FRENKIEL T.A., BAUER C.J., JIMENEZ-BARBERO J.,
RA   POLSHAKOV V.I., MCCORMICK J.E., ROBERTS G.C.K., FEENEY J.;
RT   "Dihydrofolate reductase: sequential resonance assignments using 2D
RT   and 3D NMR and secondary structure determination in solution.";
RL   BIOCHEMISTRY 30:6330-6341(1991).
RN   [6]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 96018856.
RA   MORGAN W.D., BIRDSALL B., POLSHAKOV V.I., SALI D., KOMPIS I.,
RA   FEENEY J.;
RT   "Solution structure of a brodimoprim analogue in its complex with
RT   Lactobacillus casei dihydrofolate reductase.";
RL   BIOCHEMISTRY 34:11690-11702(1995).
RN   [7]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 98181015.
RA   GARGARO A.R., SOTERIOU A., FRENKIEL T.A., BAUER C.J., BIRDSALL B.,
RA   POLSHAKOV V.I., BARSUKOV I.L., ROBERTS G.C.K., FEENEY J.;
RT   "The solution structure of the complex of Lactobacillus casei
RT   dihydrofolate reductase with methotrexate.";
RL   J. MOL. BIOL. 277:119-134(1998).
CC   -!- CATALYTIC ACTIVITY: 5,6,7,8-TETRAHYDROFOLATE + NADP(+) =
CC       7,8-DIHYDROFOLATE + NADPH.
CC   -!- PATHWAY: ESSENTIAL STEP FOR DE NOVO GLYCINE AND PURINE SYNTHESIS,
CC       DNA PRECURSOR SYNTHESIS, AND FOR THE CONVERSION OF DUMP TO DTMP.
CC   -!- SUBUNIT: MONOMER.
CC   -!- THIS BACTERIAL STRAIN IS RESISTANT TO THE FOLIC ACID ANALOG
CC       METHOTREXATE (AMETHOPTERIN).
CC   -!- SIMILARITY: STRONG TO OTHER TYPE I DIHYDROFOLATE REDUCTASES.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M10922; G149540; -.
DR   PIR; A00394; RDLBD.
DR   PIR; A12987; A12987.
DR   PIR; A24036; A24036.
DR   PDB; 3DFR; 31-JAN-84.
DR   PDB; 1DIS; 14-NOV-95.
DR   PDB; 1DIU; 14-NOV-95.
DR   PDB; 1AO8; 25-FEB-98.
DR   PROSITE; PS00075; DHFR; 1.
DR   PFAM; PF00186; DiHfolate_red; 1.
KW   OXIDOREDUCTASE; NADP; METHOTREXATE RESISTANCE; 3D-STRUCTURE;
KW   ONE-CARBON METABOLISM.
FT   INIT_MET      0      0
FT   ACT_SITE     21     21       CHEMICAL STUDIES SUGGEST THAT IT PARTI-
FT                                CIPATES IN ENZYME FUNCTION.
FT   ACT_SITE     26     26       INVOLVED IN BINDING METHOTREXATE.
FT   ACT_SITE     31     31       INVOLVED IN BINDING METHOTREXATE.
FT   ACT_SITE     43     43       MAY BE INVOLVED IN BINDING THE COENZYME
FT                                NADPH.
FT   ACT_SITE     57     57       INVOLVED IN BINDING METHOTREXATE.
FT   CONFLICT      8      8       D -> N (IN REF. 2).
FT   CONFLICT     90     90       L -> P (IN REF. 1).
FT   STRAND        2      7
FT   TURN          9     10
FT   STRAND       12     15
FT   TURN         16     17
FT   STRAND       18     18
FT   HELIX        24     32
FT   TURN         33     36
FT   STRAND       38     42
FT   HELIX        43     48
FT   TURN         55     56
FT   STRAND       58     62
FT   TURN         66     67
FT   TURN         71     72
FT   STRAND       74     76
FT   HELIX        79     88
FT   STRAND       94     96
FT   HELIX       100    105
FT   TURN        106    106
FT   HELIX       107    109
FT   STRAND      112    118
FT   STRAND      126    127
FT   HELIX       133    135
FT   STRAND      136    144
FT   HELIX       149    151
FT   STRAND      153    160
SQ   SEQUENCE   162 AA;  18324 MW;  871C8E34 CRC32;
     TAFLWAQDRD GLIGKDGHLP WHLPDDLHYF RAQTVGKIMV VGRRTYESFP KRPLPERTNV
     VLTHQEDYQA QGAVVVHDVA AVFAYAKQHL DQELVIAGGA QIFTAFKDDV DTLLVTRLAG
     SFEGDTKMIP LNWDDFTKVS SRTVEDTNPA LTHTYEVWQK KA
//
ID   EPC_HUMAN      STANDARD;      PRT;   428 AA.
AC   P01854;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   IG EPSILON CHAIN C REGION.
GN   IGHE.
OS   HOMO SAPIENS (HUMAN).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 83168897.
RA   SENO M., KUROKAWA T., ONO Y., ONDA H., SASADA R., IGARASHI K.,
RA   KIKUCHI M., SUGINO Y., NISHIDA Y., HONJO T.;
RT   "Molecular cloning and nucleotide sequencing of human immunoglobulin
RT   epsilon chain cDNA.";
RL   NUCLEIC ACIDS RES. 11:719-726(1983).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 83001945.
RA   MAX E.E., BATTEY J., NEY R., KIRSCH I.R., LEDER P.;
RT   "Duplication and deletion in the human immunoglobulin epsilon genes.";
RL   CELL 29:691-699(1982).
RN   [3]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 84236029.
RA   FLANAGAN J.G., RABBITTS T.H.;
RT   "The sequence of a human immunoglobulin epsilon heavy chain constant
RT   region gene, and evidence for three non-allelic genes.";
RL   EMBO J. 1:655-660(1982).
RN   [4]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 84207910.
RA   UEDA S., NAKAI S., NISHIDA Y., HISAJIMA H., HONJO T.;
RT   "Long terminal repeat-like elements flank a human immunoglobulin
RT   epsilon pseudogene that lacks introns.";
RL   EMBO J. 1:1539-1544(1982).
RN   [5]
RP   MYELOMA PROTEIN ND, PRELIMINARY SEQUENCE.
RA   BENNICH H.H., JOHANSSON S.G.O., VON BAHR-LINDSTROM H.;
RL   (IN) BACH M.K. (EDS.);
RL   IMMEDIATE HYPERSENSITIVITY: MODERN CONCEPTS AND DEVELOPMENTS, PP.1-36,
RL   MARCEL DEKKER, NEW YORK (1978).
RN   [6]
RP   SEQUENCE OF 1-40; 68-114 AND 427-428 FROM N.A.
RX   MEDLINE; 83065234.
RA   KENTEN J.H., MOLGAARD H.V., HOUGHTON M., DERBYSHIRE R.B., VINEY J.,
RA   BELL L.O., GOULD H.J.;
RT   "Cloning and sequence determination of the gene for the human
RT   immunoglobulin epsilon chain expressed in a myeloma cell line.";
RL   PROC. NATL. ACAD. SCI. U.S.A. 79:6661-6665(1982).
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; J00222; G184760; ALT_SEQ.
DR   EMBL; L00022; G386807; ALT_INIT.
DR   EMBL; V00555; -; NOT_ANNOTATED_CDS.
DR   PIR; A02142; EHHU.
DR   PIR; A22771; A22771.
DR   PIR; A23195; A23195.
DR   PDB; 1IGE; 15-JUL-92.
DR   MIM; 147180; -.
DR   PROSITE; PS00290; IG_MHC; 3.
DR   PFAM; PF00047; ig; 4.
KW   IMMUNOGLOBULIN C REGION; GLYCOPROTEIN; 3D-STRUCTURE.
FT   NON_TER       1      1
FT   DISULFID     14     14       INTERCHAIN (WITH A LIGHT CHAIN).
FT   DISULFID     15    105
FT   DISULFID     29     85
FT   DISULFID    121    121       INTERCHAIN (WITH A HEAVY CHAIN).
FT   DISULFID    135    193
FT   DISULFID    209    209       INTERCHAIN (WITH A HEAVY CHAIN).
FT   DISULFID    239    299
FT   DISULFID    345    405
FT   CARBOHYD     21     21
FT   CARBOHYD     49     49
FT   CARBOHYD     99     99
FT   CARBOHYD    146    146
FT   CARBOHYD    252    252
FT   CARBOHYD    275    275
FT   VARIANT     359    359       W -> L (IN REF. 2, POSSIBLY DUE TO
FT                                POLYMORPHISM).
SQ   SEQUENCE   428 AA;  47019 MW;  A48C00FB CRC32;
     ASTQSPSVFP LTRCCKNIPS NATSVTLGCL ATGYFPEPVM VTWDTGSLNG TTMTLPATTL
     TLSGHYATIS LLTVSGAWAK QMFTCRVAHT PSSTDWVDNK TFSVCSRDFT PPTVKILQSS
     CDGGGHFPPT IQLLCLVSGY TPGTINITWL EDGQVMDVDL STASTTQEGE LASTQSELTL
     SQKHWLSDRT YTCQVTYQGH TFEDSTKKCA DSNPRGVSAY LSRPSPFDLF IRKSPTITCL
     VVDLAPSKGT VNLTWSRASG KPVNHSTRKE EKQRNGTLTV TSTLPVGTRD WIEGETYQCR
     VTHPHLPRAL MRSTTKTSGP RAAPEVYAFA TPEWPGSRDK RTLACLIQNF MPEDISVQWL
     HNEVQLPDAR HSTTQPRKTK GSGFFVFSRL EVTRAEWEQK DEFICRAVHE AASPSQTVQR
     AVSVNPGK
//
ID   GC1_HUMAN      STANDARD;      PRT;   330 AA.
AC   P01857;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   01-MAR-1992 (REL. 21, LAST ANNOTATION UPDATE)
DE   IG GAMMA-1 CHAIN C REGION.
GN   IGHG1.
OS   HOMO SAPIENS (HUMAN).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 82274238.
RA   ELLISON J.W., BERSON B.J., HOOD L.E.;
RT   "The nucleotide sequence of a human immunoglobulin C gamma1 gene.";
RL   NUCLEIC ACIDS RES. 10:4071-4079(1982).
RN   [2]
RP   SEQUENCE OF 1-135 (MYELOMA PROTEIN EU).
RX   MEDLINE; 71064024.
RA   CUNNINGHAM B.A., RUTISHAUSER U., GALL W.E., GOTTLIEB P.D.,
RA   WAXDAL M.J., EDELMAN G.M.;
RT   "The covalent structure of a human gamma G-immunoglobulin. VII. Amino
RT   acid sequence of heavy-chain cyanogen bromide fragments H1-H4.";
RL   BIOCHEMISTRY 9:3161-3170(1970).
RN   [3]
RP   SEQUENCE OF 136-329 (EU).
RX   MEDLINE; 71064025.
RA   RUTISHAUSER U., CUNNINGHAM B.A., BENNETT C., KONIGSBERG W.H.,
RA   EDELMAN G.M.;
RT   "The covalent structure of a human gamma G-immunoglobulin. 8. Amino
RT   acid sequence of heavy-chain cyanogen bromide fragments H5-H7.";
RL   BIOCHEMISTRY 9:3171-3181(1970).
RN   [4]
RP   SEQUENCE (MYELOMA PROTEIN NIE).
RX   MEDLINE; 77070269.
RA   PONSTINGL H., HILSCHMANN N.;
RT   "The rule of antibody structure. The primary structure of a
RT   monoclonal IgG1 immunoglobulin (myeloma protein Nie). III. The
RT   chymotryptic peptides of the H-chain, alignment of the tryptic
RT   peptides and discussion of the complete structure.";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 357:1571-1604(1976).
RN   [5]
RP   SEQUENCE (MYELOMA PROTEIN KOL), AND DISULFIDE BONDS.
RX   MEDLINE; 83289131.
RA   SCHMIDT W.E., JUNG H.-D., PALM W., HILSCHMANN N.;
RT   "Three-dimensional structure determination of antibodies. Primary
RT   structure of crystallized monoclonal immunoglobulin IgG1 KOL, I.";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 364:713-747(1983).
RN   [6]
RP   DISULFIDE BONDS.
RX   MEDLINE; 71064027.
RA   GALL W.E., EDELMAN G.M.;
RT   "The covalent structure of a human gamma G-immunoglobulin. X.
RT   Intrachain disulfide bonds.";
RL   BIOCHEMISTRY 9:3188-3196(1970).
RN   [7]
RP   DISULFIDE BONDS.
RX   MEDLINE; 77070267.
RA   DREKER L., SCHWARZ J., REICHEL W., HILSCHMANN N.;
RT   "Rule of antibody structure. The primary structure of a monoclonal
RT   IgG1 immunoglobulin (myeloma protein Nie), I: Purification and
RT   characterization of the protein, the L- and H-chains, the
RT   cyanogen bromide cleavage products, and the disulfide bridges.";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 357:1515-1540(1976).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS).
RX   MEDLINE; 81208100.
RA   DEISENHOFER J.;
RT   "Crystallographic refinement and atomic models of a human Fc fragment
RT   and its complex with fragment B of protein A from Staphylococcus
RT   aureus at 2.9- and 2.8-A resolution.";
RL   BIOCHEMISTRY 20:2361-2370(1981).
CC   -!- NIE HAS THE G1M(17) ALLOTYPIC MARKER, 97-K, & THE G1M(1) MARKERS,
CC       239-D & 241-L. KOL & EU SEQUENCES HAVE THE G1M(3) MARKER & THE G1M
CC       (NON-1) MARKERS.
CC   -!- NIE ALSO DIFFERS IN THE AMIDATION STATES OF 35,116,198,269 & 272.
CC   -!- EU ALSO DIFFERS IN THE AMIDATION STATES OF RESIDUES 155, 166, 177,
CC       195, 198, 269, AND 272 AND IN THE ORDER OF RESIDUES 268-272.
CC   -!- KOL ALSO DIFFERS IN THE AMIDATION STATES OF RESIDUES 198,267&272.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; J00228; G184747; ALT_INIT.
DR   PIR; A02146; GHHU.
DR   PDB; 1FC1; 15-JUL-92.
DR   PDB; 1FC2; 15-JUL-92.
DR   MIM; 147100; -.
DR   PROSITE; PS00290; IG_MHC; 2.
DR   PFAM; PF00047; ig; 3.
KW   IMMUNOGLOBULIN C REGION; GLYCOPROTEIN; 3D-STRUCTURE.
FT   NON_TER       1      1
FT   DOMAIN        1     98       CH1.
FT   DOMAIN       99    110       HINGE.
FT   DOMAIN      111    223       CH2.
FT   DOMAIN      224    330       CH3.
FT   DISULFID     27     83
FT   DISULFID    103    103       INTERCHAIN (WITH LIGHT CHAIN).
FT   DISULFID    109    109       INTERCHAIN (WITH HEAVY CHAIN).
FT   DISULFID    112    112       INTERCHAIN (WITH HEAVY CHAIN).
FT   DISULFID    144    204
FT   DISULFID    250    308
FT   CARBOHYD    180    180
FT   VARIANT      97     97       K -> R (IN G1M(3) MARKER).
FT   VARIANT     239    239       D -> E (IN G1M(NON-1) MARKER).
FT   VARIANT     241    241       L -> M (IN G1M(NON-1) MARKER).
FT   MOD_RES     330    330       REMOVED POST-TRANSLATIONALLY.
FT   STRAND      123    126
FT   HELIX       130    134
FT   TURN        136    137
FT   STRAND      141    148
FT   STRAND      158    162
FT   TURN        163    164
FT   STRAND      165    166
FT   STRAND      175    178
FT   STRAND      183    190
FT   HELIX       193    197
FT   TURN        198    199
FT   STRAND      202    206
FT   STRAND      215    219
FT   STRAND      227    227
FT   STRAND      230    234
FT   HELIX       238    240
FT   TURN        241    242
FT   STRAND      245    256
FT   STRAND      260    266
FT   TURN        267    268
FT   STRAND      269    270
FT   STRAND      274    276
FT   STRAND      280    281
FT   TURN        283    284
FT   STRAND      287    296
FT   HELIX       297    301
FT   TURN        302    303
FT   STRAND      306    312
FT   TURN        313    314
FT   TURN        316    317
FT   STRAND      320    324
SQ   SEQUENCE   330 AA;  36106 MW;  D6E28609 CRC32;
     ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
     GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
     PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
     STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE
     LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
     QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
//
ID   GLB3_CHITH     STANDARD;      PRT;   151 AA.
AC   P02229;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-OCT-1989 (REL. 12, LAST SEQUENCE UPDATE)
DT   01-OCT-1996 (REL. 34, LAST ANNOTATION UPDATE)
DE   GLOBIN CTT-III PRECURSOR (ERYTHROCRUORIN III).
GN   A AND A' AND B AND B'.
OS   CHIRONOMUS THUMMI THUMMI (MIDGE).
OC   EUKARYOTA; METAZOA; ARTHROPODA; TRACHEATA; HEXAPODA; INSECTA;
OC   PTERYGOTA; DIPTERA; NEMATOCERA; CHIRONOMOIDEA; CHIRONOMIDAE;
OC   CHIRONOMINAE; CHIRONOMUS.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 88056313.
RA   ANTOINE M., ERBIL C., MUENCH E., SCHNELL S., NIESSING J.;
RT   "Genomic organization and primary structure of five homologous pairs
RT   of intron-less genes encoding secretory globins from the insect
RT   Chironomus thummi thummi.";
RL   GENE 56:41-51(1987).
RN   [2]
RP   SEQUENCE FROM N.A.
RA   HANKELN T., AMID C., WEICH B., SCHMIDT E.R.;
RL   SUBMITTED (JAN-1997) TO EMBL/GENBANK/DDBJ DATA BANKS.
RN   [3]
RP   SEQUENCE OF 16-151.
RX   MEDLINE; 79108397.
RA   BUSE G., STEFFENS G.J., BRAUNITZER G., STEER W.;
RT   "Hemoglobins, XXV. Hemoglobin (erythrocruorin) CTT III from
RT   Chironomus thummi thummi (Diptera). Primary structure and
RT   relationship to other heme proteins.";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 360:89-97(1979).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS).
RX   MEDLINE; 78153774.
RA   WEBER E., STEIGEMANN W., JONES T.A., HUBER R.;
RT   "The structure of oxy-erythrocruorin at 1.4-A resolution.";
RL   J. MOL. BIOL. 120:327-336(1978).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   MEDLINE; 71157305.
RA   HUBER R., EPP O., STEIGEMANN W., FORMANEK H.;
RT   "The atomic structure of erythrocruorin in the light of the chemical
RT   sequence and its comparison with myoglobin.";
RL   EUR. J. BIOCHEM. 19:42-50(1971).
RN   [6]
RP   HEME-BINDING.
RX   MEDLINE; 69266512.
RA   HUBER R., EPP O., FORMANEK H.;
RT   "The environment of the haem group in erythrocruorin (Chironomus
RT   thummi).";
RL   J. MOL. BIOL. 42:591-594(1969).
RN   [7]
RP   HEME-BINDING.
RX   MEDLINE; 70206790.
RA   GLOSSMANN H., HORST J., PLAGENS U., BRAUNITZER G.;
RT   "Hemoglobins, XVIII. Isoelectric focussing of hemoglobins
RT   (erythrocruorins) from insects (Chironomus thummi, thummi,
RT   Diptera).";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 351:342-348(1970).
CC   -!- THERE ARE AT LEAST 12 DIFFERENT COMPONENTS IN MIDGE GLOBIN.
CC   -!- THE SEQUENCE OF GENES B AND B' ARE SHOWN.
CC   -!- IN ALL OTHER GLOBINS STUDIED, THE HEME GROUP IS BOUND TO 2 HIS
CC       CORRESPONDING TO HIS-102 AND HIS-73 OF INSECT GLOBIN COMPONENT
CC       III.
CC   -!- SUBUNIT: MONOMER.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M17600; G156562; -.
DR   EMBL; M17601; G156563; -.
DR   EMBL; M17691; G156573; -.
DR   EMBL; M17692; G156574; -.
DR   EMBL; Y10622; E293346; -.
DR   PIR; A02551; GGICE3.
DR   PDB; 1ECA; 30-SEP-83.
DR   PDB; 1ECD; 30-SEP-83.
DR   PDB; 1ECN; 30-SEP-83.
DR   PDB; 1ECO; 30-SEP-83.
DR   PROSITE; PS01033; GLOBIN; 1.
DR   PFAM; PF00042; globin; 1.
KW   HEME; OXYGEN TRANSPORT; RESPIRATORY PROTEIN; 3D-STRUCTURE; SIGNAL.
FT   SIGNAL        1     15
FT   CHAIN        16    151       GLOBIN CTT-III.
FT   VARIANT      72     72       I -> T (IN GENES A AND A').
FT   VARIANT      92     93       EA -> DG (IN GENE A).
FT   METAL        77     77       IRON (HEME) (EXCEPTION, SEE COMMENTS).
FT   METAL       102    102       IRON (HEME).
FT   HELIX        18     29
FT   TURN         30     33
FT   HELIX        35     45
FT   HELIX        47     50
FT   TURN         51     52
FT   TURN         54     58
FT   HELIX        61     64
FT   TURN         65     66
FT   HELIX        68     86
FT   TURN         87     89
FT   HELIX        92    105
FT   TURN        106    106
FT   HELIX       109    126
FT   HELIX       129    148
FT   TURN        149    150
SQ   SEQUENCE   151 AA;  16348 MW;  95FB7EFE CRC32;
     MKFLILALCF AAASALSADQ ISTVQASFDK VKGDPVGILY AVFKADPSIM AKFTQFAGKD
     LESIKGTAPF EIHANRIVGF FSKIIGELPN IEADVNTFVA SHKPRGVTHD QLNNFRAGFV
     SYMKAHTDFA GAEAAWGATL DTFFGMIFSK M
//
ID   HBB_HUMAN      STANDARD;      PRT;   146 AA.
AC   P02023;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   HEMOGLOBIN BETA CHAIN.
GN   HBB.
OS   HOMO SAPIENS (HUMAN), PAN TROGLODYTES (CHIMPANZEE), AND
OS   PAN PANISCUS (PYGMY CHIMPANZEE) (BONOBO).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE.
RC   SPECIES=HUMAN;
RA   BRAUNITZER G., GEHRING-MULLER R., HILSCHMANN N., HILSE K., HOBOM G.,
RA   RUDLOFF V., WITTMANN-LIEBOLD B.;
RT   "The constitution of normal adult human haemoglobin.";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 325:283-286(1961).
RN   [2]
RP   SEQUENCE FROM N.A.
RC   SPECIES=HUMAN;
RX   MEDLINE; 81064667.
RA   LAWN R.M., EFSTRATIADIS A., O'CONNELL C., MANIATIS T.;
RT   "The nucleotide sequence of the human beta-globin gene.";
RL   CELL 21:647-651(1980).
RN   [3]
RP   SEQUENCE OF 121-146 FROM N.A.
RC   SPECIES=HUMAN;
RX   MEDLINE; 85205333.
RA   LANG K.M., SPRITZ R.A.;
RT   "Cloning specific complete polyadenylylated 3'-terminal cDNA
RT   segments.";
RL   GENE 33:191-196(1985).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF DEOXYHEMOGLOBIN.
RC   SPECIES=HUMAN;
RX   MEDLINE; 76027820.
RA   FERMI G.;
RT   "Three-dimensional fourier synthesis of human deoxyhaemoglobin at
RT   2.5-A resolution: refinement of the atomic model.";
RL   J. MOL. BIOL. 97:237-256(1975).
RN   [5]
RP   SEQUENCE.
RC   SPECIES=P.TROGLODYTES;
RX   MEDLINE; 66071496.
RA   RIFKIN D.B., KONIGSBERG W.;
RT   "The characterization of the tryptic peptides from the hemoglobin of
RT   the chimpanzee (Pan troglodytes).";
RL   BIOCHIM. BIOPHYS. ACTA 104:457-461(1965).
RN   [6]
RP   SEQUENCE.
RC   SPECIES=P.PANISCUS;
RX   MEDLINE; 83219265.
RA   GOODMAN M., BRAUNITZER G., STANGL A., SCHRANK B.;
RT   "Evidence on human origins from haemoglobins of African apes.";
RL   NATURE 303:546-548(1983).
RN   [7]
RP   HAPTOGLOBIN BINDING.
RX   MEDLINE; 86242088.
RA   YOSHIOKA N., ATASSI M.Z.;
RT   "Haemoglobin binding with haptoglobin. Localization of the
RT   haptoglobin-binding sites on the beta-chain of human haemoglobin by
RT   synthetic overlapping peptides encompassing the entire chain.";
RL   BIOCHEM. J. 234:453-456(1986).
RN   [8]
RP   GLYCATION IN N-TERMINAL.
RX   MEDLINE; 78138698.
RA   BUNN H.F., GABBAY K.H., GALLOP P.M.;
RT   "The glycosylation of hemoglobin: relevance to diabetes mellitus.";
RL   SCIENCE 200:21-27(1978).
RN   [9]
RP   VARIANT ALABAMA.
RX   MEDLINE; 75109326.
RA   BRIMHALL B., JONES R.T., SCHNEIDER R.G., HOSTY T.S., TOMLIN G.,
RA   ATKINS R.;
RT   "Two new hemoglobins. Hemoglobin Alabama (beta39(C5)Gln leads to Lys)
RT   and hemoglobin Montgomery (alpha 48(CD 6) Leu leads to Arg).";
RL   BIOCHIM. BIOPHYS. ACTA 379:28-32(1975).
RN   [10]
RP   VARIANT ALESHA.
RX   MEDLINE; 93322192.
RA   MOLCHANOVA T.P., POSTNIKOV Y.V., POBEDIMSKAYA D.D., SMETANINA N.S.,
RA   MOSCHAN A.A., KAZANETZ E.G., TOKAREV Y.N., HUISMAN T.H.J.;
RT   "Hb Alesha or alpha 2 beta (2)67(E11)Val-->Met: a new unstable
RT   hemoglobin variant identified through sequencing of amplified DNA.";
RL   HEMOGLOBIN 17:217-225(1993).
RN   [11]
RP   VARIANT J-ALTGELDS GARDENS.
RX   MEDLINE; 79067354.
RA   ADAMS J.G. III, PRZYWARA K.P., HELLER P., SHAMSUDDIN M.;
RT   "Hemoglobin J Altgeld Gardens. A hemoglobin variant with a
RT   substitution of the proximal histidine of the beta-chain.";
RL   HEMOGLOBIN 2:403-415(1978).
RN   [12]
RP   VARIANT ANKARAS.
RX   MEDLINE; 74297498.
RA   ARCASOY A., CASEY R., LEHMANN H., CAVDAR A.O., BERKI A.;
RT   "A new haemoglobin J from Turkey -- Hb Ankara (beta10 (A7) Ala-Asp).";
RL   FEBS LETT. 42:121-123(1974).
RN   [13]
RP   VARIANTS J-ANTAKYA AND COMPLUTENSE.
RX   MEDLINE; 86216227.
RA   HUISMAN T.H.J., WILSON J.B., KUTLAR A., YANG K.-G., CHEN S.-S.,
RA   WEBBER B.B., ALTAY C., MARTINEZ A.V.;
RT   "Hb J-Antakya or alpha 2 beta (2)65(E9)Lys-->Met in a Turkish family
RT   and Hb complutense or alpha 2 beta (2)127(H5)Gln-->Glu in a Spanish
RT   family; correction of a previously published identification.";
RL   BIOCHIM. BIOPHYS. ACTA 871:229-231(1986).
RN   [14]
RP   VARIANT J-AUCKLAND.
RX   MEDLINE; 88006903.
RA   WILLIAMSON D., WELLS R.M.G., ANDERSON R., MATTHEWS J.;
RT   "A new unstable and low oxygen affinity hemoglobin variant: Hb J-
RT   Auckland [beta 25(B7)Gly-->Asp].";
RL   HEMOGLOBIN 11:221-230(1987).
RN   [15]
RP   VARIANT AURORA.
RX   MEDLINE; 96352910.
RA   LAFFERTY J., ALI M., MATTHEW K., ENG B., PATTERSON M., WAYE J.S.;
RT   "Identification of a new high oxygen affinity hemoglobin variant: Hb
RT   Aurora [beta 139(H17) Asn-->Tyr].";
RL   HEMOGLOBIN 19:335-341(1995).
RN   [16]
RP   VARIANT BREST.
RX   MEDLINE; 88256755.
RA   BAUDIN-CHICH V., WAJCMAN H., GOMBAUD-SAINTONGE G., AROUS N., RIOU J.,
RA   BRIERE J., GALACTEROS F.;
RT   "Hemoglobin Brest [beta 127 (H5)Gln-->Lys] a new unstable human
RT   hemoglobin variant located at the alpha 1 beta 1 interface with
RT   specific electrophoretic behavior.";
RL   HEMOGLOBIN 12:179-188(1988).
RN   [17]
RP   VARIANT BRISBANE.
RX   MEDLINE; 81239159.
RA   BRENNAN S.O., WELLS R.M., SMITH H., CARRELL R.W.;
RT   "Hemoglobin Brisbane: beta68 Leu replaced by His. A new high oxygen
RT   affinity variant.";
RL   HEMOGLOBIN 5:325-335(1981).
RN   [18]
RP   VARIANT BUNBURY.
RX   MEDLINE; 84031649.
RA   COMO P.F., KENNETT D., WILKINSON T., KRONENBERG H.;
RT   "A new hemoglobin with high oxygen affinity -- hemoglobin Bunbury:
RT   alpha 2 beta 2 [94 (FG1) Asp replaced by Asn].";
RL   HEMOGLOBIN 7:413-421(1983).
RN   [19]
RP   VARIANT J-CAIRO.
RX   MEDLINE; 76114933.
RA   GAREL M.-C., HASSAN W., COQUELET M.T., GOOSSENS M., ROSA J., AROUS N.;
RT   "Hemoglobin J Cairo: beta 65 (E9) Lys leads to Gln, A new hemoglobin
RT   variant discovered in an Egyptian family.";
RL   BIOCHIM. BIOPHYS. ACTA 420:97-104(1976).
RN   [20]
RP   VARIANT CAMPERDOWN.
RX   MEDLINE; 75184109.
RA   WILKINSON T., CHUA C.G., CARRELL R.W., ROBIN H., EXNER T., LEE K.M.,
RA   KRONENBERG H.;
RT   "A new haemoglobin variant, haemoglobin Camperdown (beta 104 (G6)
RT   arginine->serine).";
RL   BIOCHIM. BIOPHYS. ACTA 393:195-200(1975).
RN   [21]
RP   VARIANT CARIBBEAN.
RX   MEDLINE; 77048866.
RA   AHERN E., AHERN V., HILTON T., SERJEANT G.R., SERJEANT B.E.,
RA   SEAKINS M., LANG A., MIDDLETON A., LEHMANN H.;
RT   "Haemoglobin caribbean beta91 (F7) Leu replaced by Arg: a mildly
RT   haemoglobin with a low oxygen affinity.";
RL   FEBS LETT. 69:99-102(1976).
RN   [22]
RP   VARIANT CITY OF HOPE.
RX   MEDLINE; 85006311.
RA   RAHBAR S., ASMEROM Y., BLUME K.G.;
RT   "A silent hemoglobin variant detected by HPLC: hemoglobin City of
RT   Hope beta 69 (E13) Gly-->Ser.";
RL   HEMOGLOBIN 8:333-342(1984).
RN   [23]
RP   VARIANT COIMBRA.
RX   MEDLINE; 92267852.
RA   TAMAGNINI G.P., RIBEIRO M.L., VALENTE V., RAMACHANDRAN M.,
RA   WILSON J.B., BAYSAL E., GU L.H., HUISMAN T.H.J.;
RT   "Hb Coimbra or alpha 2 beta (2)99(G1)Asp-->Glu, a newly discovered
RT   high oxygen affinity variant.";
RL   HEMOGLOBIN 15:487-496(1991).
RN   [24]
RP   VARIANT COSTA RICA.
RX   MEDLINE; 96235282.
RA   ROMERO W.E.R., CASTILLO M., CHAVES M.A., SAENZ G.F., GU L.-H.,
RA   WILSON J.B., BAYSAL E., SMETANINA N.S., LEONOVA J.Y., HUISMAN T.H.J.;
RT   "Hb Costa Rica or alpha 2 beta 2 77(EF1)His-->Arg: the first
RT   example of a somatic cell mutation in a globin gene.";
RL   HUM. GENET. 97:829-833(1996).
RN   [25]
RP   VARIANT DEBROUSSE.
RX   MEDLINE; 96180033.
RA   LACAN P., KISTER J., FRANCINA A., SOUILLET G., GALACTEROS F.,
RA   DELAUNAY J., WAJCMAN H.;
RT   "Hemoglobin Debrousse (beta 96[FG3]Leu-->Pro): a new unstable
RT   hemoglobin with twofold increased oxygen affinity.";
RL   AM. J. HEMATOL. 51:276-281(1996).
RN   [26]
RP   VARIANT DHONBURI.
RX   MEDLINE; 90379198.
RA   BARDAKDJIAN-MICHAU J., FUCHAROEN S., DELANOE-GARIN J., KISTER J.,
RA   LACOMBE C., WINICHAGOON P., BLOUQUIT Y., RIOU J., WASI P.,
RA   GALACTEROS F.;
RT   "Hemoglobin Dhonburi alpha 2 beta 2 126 (H4) Val-->Gly: a new
RT   unstable beta variant producing a beta-thalassemia intermedia
RT   phenotype in association with beta zero-thalassemia.";
RL   AM. J. HEMATOL. 35:96-99(1990).
RN   [27]
RP   VARIANT DUINO (HB NEWCASTLE AND HB CAMPERDOWN).
RX   MEDLINE; 92380658.
RA   WAJCMAN H., BLOUQUIT Y., VASSEUR C., LE QUERREC A., LANIECE M.,
RA   MELEVENDI C., RASORE A., GALACTEROS F.;
RT   "Two new human hemoglobin variants caused by unusual mutational
RT   events: Hb Zaire contains a five residue repetition within the
RT   alpha-chain and Hb Duino has two residues substituted in the
RT   beta-chain.";
RL   HUM. GENET. 89:676-680(1992).
RN   [28]
RP   VARIANT J-EUROPA.
RX   MEDLINE; 96407264.
RA   KIGER L., KISTER J., GROFF P., KALMES G., PROME D., GALACTEROS F.,
RA   WAJCMAN H.;
RT   "Hb J-Europa [beta 62(E6)Ala-->Asp]: normal oxygen binding properties
RT   in a new variant involving a residue located distal to the heme.";
RL   HEMOGLOBIN 20:135-140(1996).
RN   [29]
RP   VARIANT GEELONG.
RX   MEDLINE; 92010939.
RA   COMO P.F., HOCKING D.R., SWINTON G.W., TRENT R.J., HOLLAND R.A.,
RA   TIBBEN E.A., WILKINSON T., KRONENBERG H.;
RT   "Hb Geelong [beta 139(H17)Asn-->Asp].";
RL   HEMOGLOBIN 15:85-95(1991).
RN   [30]
RP   VARIANT GRANGE-BLANCHE.
RX   MEDLINE; 88030044.
RA   BAKLOUTI F., GIRAUD Y., FRANCINA A., RICHARD G., PERIER C.,
RA   GEYSSANT A., JAUBERT J., BRIZARD C., DELAUNAY J.;
RT   "Hemoglobin Grange-Blanche [beta 27(B9) Ala-->Val], a new variant
RT   with normal expression and increased affinity for oxygen.";
RL   FEBS LETT. 223:59-62(1987).
RN   [31]
RP   VARIANT GRAZ.
RX   MEDLINE; 93138927.
RA   LIU J.S., MOLCHANOVA T.P., GU L.H., WILSON J.B., HOPMEIER P.,
RA   SCHNEDL W., BALAUN E., KREJS G.J., HUISMAN T.H.J.;
RT   "Hb Graz or alpha 2 beta 2(2)(NA2)His-->Leu; a new beta chain variant
RT   observed in four families from southern Austria.";
RL   HEMOGLOBIN 16:493-501(1992).
RN   [32]
RP   VARIANT HELSINKI.
RX   MEDLINE; 77062201.
RA   IKKALA E., KOSKELA J., PIKKARAINEN P., RAHIALA E.-L., EL-HAZMI M.A.F.,
RA   NAGAI K., LANG A., LEHMANN H.;
RT   "Hb Helsinki: a variant with a high oxygen affinity and a
RT   substitution at a 2,3-DPG binding site (beta82[EF6] Lys replaced by
RT   Met).";
RL   ACTA HAEMATOL. 56:257-275(1976).
RN   [33]
RP   VARIANT HIMEJI.
RX   MEDLINE; 86167527.
RA   OHBA Y., MIYAJI T., MURAKAMI M., KADOWAKI S., FUJITA T., OIMOMI M.,
RA   HATANAKA H., ISHIKAWA K., BABA S., HITAKA K., IMAI K.;
RT   "Hb Himeji or beta 140 (H18) Ala-->Asp. A slightly unstable
RT   hemoglobin with increased beta N-terminal glycation.";
RL   HEMOGLOBIN 10:109-126(1986).
RN   [34]
RP   VARIANT HINSDALE.
RX   MEDLINE; 90093866.
RA   MOO-PENN W.F., JOHNSON M.H., JUE D.L., LONSER R.;
RT   "Hb Hinsdale [beta 139 (H17)Asn-->Lys]: a variant in the central
RT   cavity showing reduced affinity for oxygen and
RT   2,3-diphosphoglycerate.";
RL   HEMOGLOBIN 13:455-464(1989).
RN   [35]
RP   VARIANT HINWIL.
RX   MEDLINE; 96351651.
RA   FRISCHKNECHT H., VENTRUTO M., HESS D., HUNZIKER P., ROSATELLI M.C.,
RA   CAO A., BREITENSTEIN U., FEHR J., TUCHSCHMID P.;
RT   "HB Hinwil or beta 38(C4)Thr-->Asn: a new beta chain variant detected
RT   in a Swiss family.";
RL   HEMOGLOBIN 20:31-40(1996).
RN   [36]
RP   VARIANT HOWICK.
RX   MEDLINE; 94193408.
RA   OWEN M.C., OCKELFORD P.A., WELLS R.M.G.;
RT   "Hb Howick [beta 37(C3)Trp-->Gly]: a new high oxygen affinity variant
RT   of the alpha 1 beta 2 contact.";
RL   HEMOGLOBIN 17:513-521(1993).
RN   [37]
RP   VARIANT INDIANAPOLIS.
RX   MEDLINE; 79151109.
RA   ADAMS J.G. III, STEINBERG M.H., BOXER L.A., BAEHNER R.L., FORGET B.G.,
RA   TSISTRAKIS G.A.;
RT   "The structure of hemoglobin Indianapolis [beta112(G14) arginine]. An
RT   unstable variant detectable only by isotopic labeling.";
RL   J. BIOL. CHEM. 254:3479-3482(1979).
RN   [38]
RP   VARIANT ISEHARA.
RX   MEDLINE; 92155974.
RA   HARANO T., HARANO K., KUSHIDA Y., UEDA S., YOSHII A., NISHINARITA M.;
RT   "Hb Isehara (or Hb Redondo) [beta 92 (F8) His-->Asn]: an unstable
RT   variant with a proximal histidine substitution at the heme contact.";
RL   HEMOGLOBIN 15:279-290(1991).
RN   [39]
RP   VARIANT ISTAMBUL.
RX   MEDLINE; 73054825.
RA   AKSOY M., ERDEM S., EFREMOV G.D., WILSON J.B., HUISMAN T.H.J.,
RA   SCHROEDER W.A., SHELTON J.R., SHELTON J.B., ULITIN O.N.,
RA   MUFTUOGLU A.;
RT   "Hemoglobin Istanbul: substitution of glutamine for histidine in a
RT   proximal histidine (F8(92) ).";
RL   J. CLIN. INVEST. 51:2380-2387(1972).
RN   [40]
RP   VARIANT JACKSONVILLE.
RX   MEDLINE; 91331861.
RA   GAUDRY C.L. JR., PITEL P.A., JUE D.L., HINE T.K., JOHNSON M.H.,
RA   MOO-PENN W.F.;
RT   "Hb Jacksonville [alpha 2 beta 2(54)(D5)Val-->Asp]: a new unstable
RT   variant found in a patient with hemolytic anemia.";
RL   HEMOGLOBIN 14:653-659(1990).
RN   [41]
RP   VARIANT JIANGHUA.
RX   MEDLINE; 84007581.
RA   LU Y.Q., FAN J.L., LIU J.F., HU H.L., PENG X.H., HUANG C.H.,
RA   HUANG P.Y., CHEN S.S., JAI P.C., YANG K.G.;
RT   "Hemoglobin Jianghua [beta 120(GH3) LYS leads to ILE]: a new
RT   fast-moving variant found in China.";
RL   HEMOGLOBIN 7:321-326(1983).
RN   [42]
RP   VARIANT KARLSKOGA.
RX   MEDLINE; 93322190.
RA   LANDIN B.;
RT   "Hb Karlskoga or alpha 2 beta (2)21(B3) Asp-->His: a new slow-moving
RT   variant found in Sweden.";
RL   HEMOGLOBIN 17:201-208(1993).
RN   [43]
RP   VARIANT KNOSSOS.
RX   MEDLINE; 83079719.
RA   AROUS N., GALACTEROS F., FESSAS P., LOUKOPOULOS D., BLOUQUIT Y.,
RA   KOMIS G., SELLAYE M., BOUSSIOU M., ROSA J.;
RT   "Structural study of hemoglobin Knossos, beta 27 (B9) Ala leads to
RT   Ser. A new abnormal hemoglobin present as a silent
RT   beta-thalassemia.";
RL   FEBS LETT. 147:247-250(1982).
RN   [44]
RP   VARIANT KODAIRA.
RX   MEDLINE; 92340295.
RA   HARANO T., HARANO K., KUSHIDA Y., IMAI K., NISHINAKAMURA R.,
RA   MATSUNAGA T.;
RT   "Hb Kodaira [beta 146(HC3)His-->Gln]: a new beta chain variant with
RT   an amino acid substitution at the C-terminus.";
RL   HEMOGLOBIN 16:85-91(1992).
RN   [45]
RP   VARIANT KOFU.
RX   MEDLINE; 86303641.
RA   HARANO T., HARANO K., UEDA S., IMAI N., KITAZUMI T.;
RT   "A new electrophoretically-silent hemoglobin variant: hemoglobin Kofu
RT   or alpha 2 beta 2 84 (EF8) Thr-->Ile.";
RL   HEMOGLOBIN 10:417-420(1986).
RN   [46]
RP   VARIANT KRALOVE.
RX   MEDLINE; 94042221.
RA   DIVOKY V., SVOBODOVA M., INDRAK K., CHROBAK L., MOLCHANOVA T.P.,
RA   HUISMAN T.H.J.;
RT   "Hb Hradec Kralove (Hb HK) or alpha 2 beta 2 115(G17)Ala-->Asp, a
RT   severely unstable hemoglobin variant resulting in a dominant beta-
RT   thalassemia trait in a Czech family.";
RL   HEMOGLOBIN 17:319-328(1993).
RN   [47]
RP   VARIANT LA DESIRADE.
RX   MEDLINE; 87165149.
RA   MERAULT G., KECLARD L., GARIN J., POYART C., BLOUQUIT Y., AROUS N.,
RA   GALACTEROS F., FEINGOLD J., ROSA J.;
RT   "Hemoglobin La Desirade alpha A2 beta 2 129 (H7) Ala-->Val: a new
RT   unstable hemoglobin.";
RL   HEMOGLOBIN 10:593-605(1986).
RN   [48]
RP   VARIANT LAS PALMAS.
RX   MEDLINE; 88256753.
RA   MALCORRA-AZPIAZU J.J., BALDA-AGUIRRE M.I., DIAZ-CHICO J.C., HU H.,
RA   WILSON J.B., WEBBER B.B., KUTLAR F., KUTLAR A., HUISMAN T.H.J.;
RT   "Hb Las Palmas or alpha 2 beta 2(49)(CD8)Ser-->Phe, a mildly
RT   unstable hemoglobin variant.";
RL   HEMOGLOBIN 12:163-170(1988).
RN   [49]
RP   VARIANT LINKOEPING.
RX   MEDLINE; 88083482.
RA   BERLIN G., WRANNE B., JEPPSSON J.-O.;
RT   "Hb Linkoping (beta 36 Pro-->Thr): a new high oxygen affinity
RT   hemoglobin variant found in two families of Finnish origin.";
RL   EUR. J. HAEMATOL. 39:452-456(1987).
RN   [50]
RP   VARIANT MAPUTO.
RX   MEDLINE; 84031650.
RA   MARINUCCI M., BOISSEL J.P., MASSA A., WAJCMAN H., TENTORI L.,
RA   LABIE D.;
RT   "Hemoglobin Maputo: a new beta-chain variant (alpha 2 beta 2 47 (CD6)
RT   Asp replaced by Tyr) in combination with hemoglobin S, identified by
RT   high performance liquid chromatography (HPLC).";
RL   HEMOGLOBIN 7:423-433(1983).
RN   [51]
RP   VARIANT MATERA.
RX   MEDLINE; 90346586.
RA   SCIARRATTA G.V., IVALDI G.;
RT   "Hb Matera [beta 55(D6)Met-->Lys]: a new unstable hemoglobin variant
RT   in an Italian family.";
RL   HEMOGLOBIN 14:79-85(1990).
RN   [52]
RP   VARIANT MIYASHIRO.
RX   MEDLINE; 82166873.
RA   NAKATSUJI T., MIWA S., OHBA Y., HATTORI Y., MIYAJI T., MIYATA H.,
RA   SHINOHARA T., HORI T., TAKAYAMA J.;
RT   "Hemoglobin Miyashiro (beta 23[B5] val substituting for gly) an
RT   electrophoretically silent variant discovered by the isopropanol
RT   test.";
RL   HEMOGLOBIN 5:653-666(1981).
RN   [53]
RP   VARIANT MIZUHO.
RX   MEDLINE; 77248961.
RA   OHBA Y., MIYAJI T., MATSUOKA M., SUGIYAMA K., SUZUKI T., SUGIURA T.;
RT   "Hemoglobin Mizuho or beta 68 (E 12) leucine leads to proline, a new
RT   unstable variant associated with severe hemolytic anemia.";
RL   HEMOGLOBIN 1:467-477(1977).
RN   [54]
RP   VARIANT MUSCAT.
RX   MEDLINE; 92387956.
RA   RAMACHANDRAN M., GU L.H., WILSON J.B., KITUNDU M.N., ADEKILE A.D.,
RA   LIU J.C., MCKIE K.M., HUISMAN T.H.;
RT   "A new variant, HB Muscat [alpha 2 beta (2)32(B14)Leu-->Val]
RT   observed in association with HB S in an Arabian family.";
RL   HEMOGLOBIN 16:259-266(1992).
RN   [55]
RP   VARIANT N-TIMONE.
RX   MEDLINE; 90236754.
RA   LENA-RUSSO D., ORSINI A., VOVAN L., BARDAKDJIAN-MICHAU J., LACOMBE C.,
RA   BLOUQUIT Y., CRAESCU C.T., GALACTEROS F.;
RT   "Hb N-Timone [alpha 2 beta 2(8)(A5)Lys-->Glu]: a new fast-moving
RT   variant with normal stability and oxygen affinity.";
RL   HEMOGLOBIN 13:743-747(1989).
RN   [56]
RP   VARIANT NAGOYA.
RX   MEDLINE; 85206960.
RA   OHBA Y., IMANAKA M., MATSUOKA M., HATTORI Y., MIYAJI T., FUNAKI C.,
RA   SHIBATA K., SHIMOKATA H., KUZUYA F., MIWA S.;
RT   "A new unstable, high oxygen affinity hemoglobin: Hb Nagoya or beta
RT   97 (FG4) His-->Pro.";
RL   HEMOGLOBIN 9:11-24(1985).
RN   [57]
RP   VARIANT D-NEATH.
RX   MEDLINE; 93322197.
RA   WELCH S.G., BATEMAN C.;
RT   "Hb D-Neath or beta 121 (GH4) Glu-->Ala: a new member of the Hb D
RT   family.";
RL   HEMOGLOBIN 17:255-259(1993).
RN   [58]
RP   VARIANT NORTH CHICAGO.
RX   MEDLINE; 86139289.
RA   RAHBAR S., LOUIS J., LEE T., ASMEROM Y.;
RT   "Hemoglobin North Chicago (beta 36 [C2] proline-->serine): a new
RT   high affinity hemoglobin.";
RL   HEMOGLOBIN 9:559-576(1985).
RN   [59]
RP   VARIANT NORTH SHORE.
RX   MEDLINE; 77246803.
RA   ARENDS T., LEHMANN H., PLOWMAN D., STATHOPOULOU R.;
RT   "Haemoglobin North Shore-Caracas beta 134 (H12) valine replaced by
RT   glutamic acid.";
RL   FEBS LETT. 80:261-265(1977).
RN   [60]
RP   VARIANT OLOMOUC.
RX   MEDLINE; 87307470.
RA   INDRAK K., WIEDERMANN B.F., BATEK F., WILSON J.B., WEBBER B.B.,
RA   KUTLAR A., HUISMAN T.H.J.;
RT   "Hb Olomouc or alpha 2 beta 2(86)(F2)Ala-->Asp, a new high oxygen
RT   affinity variant.";
RL   HEMOGLOBIN 11:151-155(1987).
RN   [61]
RP   VARIANT PALMERSTON NORTH.
RX   MEDLINE; 83135041.
RA   BRENNAN S.O., WILLIAMSON D., WHISSON M.E., CARRELL R.W.;
RT   "Hemoglobin Palmerston North beta 23 (B5) Val replaced by Phe. A new
RT   variant identified in a patient with polycythemia.";
RL   HEMOGLOBIN 6:569-575(1982).
RN   [62]
RP   VARIANT PIERRE-BENITE.
RX   MEDLINE; 88256754.
RA   BAKLOUTI F., GIRAUD Y., FRANCINA A., RICHARD G., FAVRE-GILLY J.,
RA   DELAUNAY J.;
RT   "Hemoglobin Pierre-Benite [beta 90(F6)Glu-->Asp], a new high
RT   affinity variant found in a French family.";
RL   HEMOGLOBIN 12:171-177(1988).
RN   [63]
RP   VARIANT PRESBYTERIAN.
RX   MEDLINE; 78215075.
RA   MOO-PENN W.F., WOLFF J.A., SIMON G., VACEK M., JUE D.L., JOHNSON M.H.;
RT   "Hemoglobin Presbyterian: beta108 (G10) asparagine leads to lysine, A
RT   hemoglobin variant with low oxygen affinity.";
RL   FEBS LETT. 92:53-56(1978).
RN   [64]
RP   VARIANT PUTTELANGE.
RX   MEDLINE; 96101899.
RA   WAJCMAN H., GIRODON E., PROME D., NORTH M.L., PLASSA F., DUWIG I.,
RA   KISTER J., BERGERAT J.P., OBERLING F., LAMPERT E., LONSDORFER J.,
RA   GOOSSENS M., GALACTEROS F.;
RT   "Germline mosaicism for an alanine to valine substitution at residue
RT   beta 140 in hemoglobin Puttelange, a new variant with high oxygen
RT   affinity.";
RL   HUM. GENET. 96:711-716(1995).
RN   [65]
RP   VARIANT QUIN-HAI.
RX   MEDLINE; 84031648.
RA   JEN P.C., CHEN L.C., CHEN P.F., WONG Y., CHEN L.F., GUO Y.Y.,
RA   CHANG F.Q., CHOW Y.C., CHIU Y.;
RT   "Hemoglobin Quin-Hai, beta 78 (EF2) Leu replaced by Arg, a new
RT   abnormal hemoglobin found in Guangdong, China.";
RL   HEMOGLOBIN 7:407-412(1983).
RN   [66]
RP   VARIANT RAMBAM.
RX   MEDLINE; 98432396.
RA   BISSE E., ZORN N., EIGEL A., LIZAMA M., HUAMAM-GUILLEN P., MARZ W.,
RA   VAN DORSSELAER A., WIELAND H.;
RT   "Hemoglobin Rambam (beta69[E13]Gly-->Asp), a pitfall in the
RT   assessment of diabetic control: characterization by electrospray mass
RT   spectrometry and HPLC.";
RL   CLIN. CHEM. 44:2172-2177(1998).
RN   [67]
RP   VARIANT RANDWICK.
RX   MEDLINE; 88256752.
RA   GILBERT A.T., FLEMING P.J., SUMNER D.R., HUGHES W.G., IP F.,
RA   KWAN Y.L., HOLLAND R.A.;
RT   "Hemoglobin Randwick or beta 15 (A12)Trp-->Gly: a new unstable beta-
RT   chain hemoglobin variant.";
RL   HEMOGLOBIN 12:149-161(1988).
RN   [68]
RP   VARIANT RIO GRANDE.
RX   MEDLINE; 83185445.
RA   MOO-PENN W.F., JOHNSON M.H., MCGUFFEY J.E., JUE D.L.,
RA   THERRELL B.L. JR.;
RT   "Hemoglobin Rio Grande [beta 8 (A5) Lys leads to Thr] a new variant
RT   found in a Mexican-American family.";
RL   HEMOGLOBIN 7:91-95(1983).
RN   [69]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF VARIANT ROTSCHILD.
RX   MEDLINE; 92232710.
RA   KAVANAUGH J.S., ROGERS P.H., CASE D.A., ARNONE A.;
RT   "High-resolution X-ray study of deoxyhemoglobin Rothschild 37 beta
RT   Trp-->Arg: a mutation that creates an intersubunit chloride-binding
RT   site.";
RL   BIOCHEMISTRY 31:4111-4121(1992).
RN   [70]
RP   VARIANT RUSH.
RX   MEDLINE; 74080282.
RA   ADAMS J.G. III, WINTER W.P., TAUSK K., HELLER P.;
RT   "Hemoglobin Rush (beta 101 (g3) glutamine): a new unstable hemoglobin
RT   causing mild hemolytic anemia.";
RL   BLOOD 43:261-269(1974).
RN   [71]
RP   VARIANT SAITAMA.
RX   MEDLINE; 83185440.
RA   OHBA Y., HASEGAWA Y., AMINO H., MIWA S., NAKATSUJI T., HATTORI Y.,
RA   MIYAJI T.;
RT   "Hemoglobin Saitama or beta 117 (G19) His leads to Pro, a new variant
RT   causing hemolytic disease.";
RL   HEMOGLOBIN 7:47-56(1983).
RN   [72]
RP   VARIANT M-SASKATOON.
RA   GERALD P.S., EFRON M.L.;
RT   "Chemical studies of several varieties of Hb M.";
RL   PROC. NATL. ACAD. SCI. U.S.A. 47:1758-1767(1961).
RN   [73]
RP   VARIANT SHELBY.
RX   MEDLINE; 85130256.
RA   MOO-PENN W.F., JOHNSON M.H., MCGUFFEY J.E., JUE D.L.;
RT   "Hemoglobin Shelby [beta 131(H9) Gln-->Lys] a correction to the
RT   structure of hemoglobin Deaconess and hemoglobin Leslie.";
RL   HEMOGLOBIN 8:583-593(1984).
RN   [74]
RP   VARIANT J-SICILIA.
RX   MEDLINE; 74302182.
RA   RICCO G., PICH P.G., MAZZA U., ROSSI G., AJMAR P., ARESE P., GALLO E.;
RT   "Hb J Sicilia: beta 65 (E9) Lys-Asn, a beta homologue of Hb Zambia.";
RL   FEBS LETT. 39:200-204(1974).
RN   [75]
RP   VARIANT STANMORE.
RX   MEDLINE; 92010936.
RA   COMO P.F., WYLIE B.R., TRENT R.J., BRUCE D., VOLPATO F., WILKINSON T.,
RA   KRONENBERG H., HOLLAND R.A., TIBBEN E.A.;
RT   "A new unstable and low oxygen affinity hemoglobin variant: Hb
RT   Stanmore [beta 111(G13)Val-->Ala].";
RL   HEMOGLOBIN 15:53-65(1991).
RN   [76]
RP   VARIANT ST MANDE.
RX   MEDLINE; 81212764.
RA   AROUS N., BRACONNIER F., THILLET J., BLOUQUIT Y., GALACTEROS F.,
RA   CHEVRIER M., BORDAHANDY C., ROSA J.;
RT   "Hemoglobin Saint Mande beta 102 (G4) asn replaced by tyr: a new low
RT   oxygen affinity variant.";
RL   FEBS LETT. 126:114-116(1981).
RN   [77]
RP   VARIANT WINDSOR.
RX   MEDLINE; 90093865.
RA   GILBERT A.T., FLEMING P.J., SUMNER D.R., HUGHES W.G., HOLLAND R.A.,
RA   TIBBEN E.A.;
RT   "Hemoglobin Windsor or beta 11 (A8)Val-->Asp: a new unstable
RT   beta-chain hemoglobin variant producing a hemolytic anemia.";
RL   HEMOGLOBIN 13:437-453(1989).
RN   [78]
RP   VARIANT YAHATA.
RX   MEDLINE; 92010926.
RA   HARANO T., HARANO K., KUSHIDA Y., UEDA S.;
RT   "A new abnormal variant, Hb Yahata or beta 112(G14)Cys-->Tyr, found
RT   in a Japanese: structural confirmation by DNA sequencing of the beta-
RT   globin gene.";
RL   HEMOGLOBIN 15:109-113(1991).
RN   [79]
RP   VARIANT YOKOHAMA.
RX   MEDLINE; 82166874.
RA   NAKATSUJI T., MIWA S., OHBA Y., HATTORI Y., MIYAJI T., HINO S.,
RA   MATSUMOTO N.;
RT   "A new unstable hemoglobin, Hb Yokohama beta 31 (B13)Leu substituting
RT   for Pro, causing hemolytic anemia.";
RL   HEMOGLOBIN 5:667-678(1981).
CC   -!- PTM: GLUCOSE REACTS NONENZYMATICALLY WITH THE N-TERMINAL OF THE
CC       BETA CHAIN TO FORMS A STABLE KETOAMINE LINKAGE. THIS TAKES PLACE
CC       SLOWLY AND CONTINOUSLY THROUGHOUT THE 120-DAY LIFE-SPAN OF THE RED
CC       CELL. THE RATE OF GLYCATION IS INCREASED IN PATIENTS WITH DIABETES
CC       MELLITUS.
CC   -!- DISEASE: DEFICIENCY IN BETA-GLOBIN IS THE CAUSE OF SICKLE CELL
CC       ANEMIA AND POLYCYTHEMIA.
CC   -!- DATABASE: NAME=Hb variant; NOTE=Human hemoglobin variants;
CC       WWW="http://globin.cse.psu.edu/globin/html/huisman/variants/".
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U01317; G455997; -.
DR   EMBL; V00497; G29437; -.
DR   EMBL; V00499; G29441; -.
DR   EMBL; V00500; G29446; ALT_SEQ.
DR   EMBL; L26462; G532506; -.
DR   EMBL; L26463; G532507; -.
DR   EMBL; L26464; G532514; -.
DR   EMBL; L26465; G532508; -.
DR   EMBL; L26466; G532509; -.
DR   EMBL; L26467; G532510; -.
DR   EMBL; L26468; G532511; -.
DR   EMBL; L26469; G532512; -.
DR   EMBL; L26470; G532513; -.
DR   EMBL; L26471; G532515; -.
DR   EMBL; L26472; G532516; -.
DR   EMBL; L26473; G532517; -.
DR   EMBL; L26474; G532518; -.
DR   EMBL; L26475; G532519; -.
DR   EMBL; L26476; G532520; -.
DR   EMBL; L26477; G532521; -.
DR   EMBL; L26478; G532522; -.
DR   EMBL; L48213; G1066768; -.
DR   EMBL; L48214; G1066771; -.
DR   EMBL; L48215; G1066774; -.
DR   EMBL; L48216; G1066777; -.
DR   EMBL; L48217; G1066780; -.
DR   EMBL; M36640; G183830; -.
DR   EMBL; M11428; G386766; -.
DR   EMBL; A01592; G344422; -.
DR   PIR; A02352; HBHU.
DR   PIR; B93303; HBCZ.
DR   PIR; D93303; HBCZP.
DR   PDB; 1CBL; 31-JUL-94.
DR   PDB; 1CBM; 31-JUL-94.
DR   PDB; 1COH; 15-OCT-94.
DR   PDB; 1HBS; 29-OCT-85.
DR   PDB; 1HCO; 30-SEP-83.
DR   PDB; 2HCO; 30-SEP-83.
DR   PDB; 1HHO; 31-JAN-84.
DR   PDB; 2HHB; 18-JUL-84.
DR   PDB; 3HHB; 18-JUL-84.
DR   PDB; 4HHB; 17-JUL-84.
DR   PDB; 1THB; 15-JAN-91.
DR   PDB; 1NIH; 15-OCT-92.
DR   PDB; 1BAB; 31-JAN-94.
DR   PDB; 1BBB; 31-JAN-94.
DR   PDB; 1CMY; 31-OCT-93.
DR   PDB; 1DXT; 31-OCT-93.
DR   PDB; 1DXU; 31-OCT-93.
DR   PDB; 1DXV; 31-OCT-93.
DR   PDB; 1HBA; 31-JAN-94.
DR   PDB; 1HBB; 31-JAN-94.
DR   PDB; 2HBC; 07-FEB-95.
DR   PDB; 2HBD; 07-FEB-95.
DR   PDB; 2HBE; 07-FEB-95.
DR   PDB; 2HBF; 07-FEB-95.
DR   PDB; 2HBS; 23-JUL-97.
DR   PDB; 1HGA; 31-JAN-94.
DR   PDB; 1HGB; 31-JAN-94.
DR   PDB; 1HGC; 31-JAN-94.
DR   PDB; 2HHD; 26-JAN-95.
DR   PDB; 2HHE; 26-JAN-95.
DR   PDB; 1CLS; 14-OCT-96.
DR   PDB; 1GBU; 11-JAN-97.
DR   PDB; 1GBV; 11-JAN-97.
DR   PDB; 1GLI; 01-AUG-96.
DR   PDB; 1DSH; 31-MAR-95.
DR   PDB; 1HAB; 12-NOV-97.
DR   PDB; 1HAC; 12-NOV-97.
DR   PDB; 1HDB; 03-APR-96.
DR   PDB; 1SDK; 01-AUG-96.
DR   PDB; 1SDL; 01-AUG-96.
DR   PDB; 1AXF; 28-JAN-98.
DR   PDB; 1ABY; 25-FEB-98.
DR   PDB; 1A00; 18-MAR-98.
DR   PDB; 1A01; 18-MAR-98.
DR   PDB; 1A0U; 18-MAR-98.
DR   PDB; 1A0V; 18-MAR-98.
DR   PDB; 1A0W; 18-MAR-98.
DR   PDB; 1A0X; 18-MAR-98.
DR   PDB; 1A0Y; 18-MAR-98.
DR   PDB; 1A0Z; 18-MAR-98.
DR   PDB; 1RVW; 25-MAR-98.
DR   PDB; 1VWT; 25-MAR-98.
DR   PDB; 1A3N; 29-APR-98.
DR   PDB; 1A3O; 29-APR-98.
DR   PDB; 1AJ9; 20-MAY-98.
DR   PDB; 1ABW; 17-JUN-98.
DR   PDB; 1BZ0; 11-NOV-98.
DR   PDB; 1BZ1; 11-NOV-98.
DR   PDB; 1BZZ; 11-NOV-98.
DR   SWISS-2DPAGE; P02023; HUMAN.
DR   HSC-2DPAGE; P02023; HUMAN.
DR   MIM; 141900; -.
DR   PROSITE; PS01033; GLOBIN; 1.
DR   PFAM; PF00042; globin; 1.
KW   HEME; OXYGEN TRANSPORT; RESPIRATORY PROTEIN; ERYTHROCYTE;
KW   ACETYLATION; DISEASE MUTATION; POLYMORPHISM; 3D-STRUCTURE.
FT   INIT_MET      0      0
FT   METAL        63     63       IRON (HEME DISTAL LIGAND).
FT   METAL        92     92       IRON (HEME PROXIMAL LIGAND).
FT   MOD_RES       1      1       ACETYLATION (IN VARIANT RALEIGH).
FT   CARBOHYD      1      1       GLUCOSE (GLYCATION) (IN HB A1C).
FT   VARIANT       1      1       V -> A (IN RALEIGH; O2 AFFINITY DOWN).
FT   VARIANT       2      2       H -> L (IN GRAZ).
FT   VARIANT       2      2       H -> Q (IN OKAYAMA; O2 AFFINITY UP).
FT   VARIANT       2      2       H -> R (IN DEER LODGE; O2 AFFINITY UP).
FT   VARIANT       2      2       H -> Y (IN FUKUOKA).
FT   VARIANT       5      5       P -> R (IN WARWICKSHIRE).
FT   VARIANT       6      6       E -> A (IN G-MAKASSAR).
FT   VARIANT       6      6       E -> V (IN S; SICKLE CELL ANEMIA).
FT   VARIANT       6      6       E -> K (IN C).
FT   VARIANT       6      6       E -> Q (IN MACHIDA).
FT   VARIANT       7      7       E -> G (IN G-SAN JOSE; MILDLY UNSTABLE).
FT   VARIANT       7      7       E -> K (IN G-SIRIRAJ).
FT   VARIANT       8      8       K -> E (IN N-TIMONE).
FT   VARIANT       8      8       K -> Q (IN J-LUHE).
FT   VARIANT       8      8       K -> T (IN RIO GRANDE).
FT   VARIANT       9      9       S -> C (IN PORTO ALEGRE; O2 AFFINITY UP).
FT   VARIANT      10     10       A -> D (IN ANKARA).
FT   VARIANT      11     11       V -> D (IN WINDSOR; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      11     11       V -> I (IN HAMILTON).
FT   VARIANT      13     13       A -> D (IN J-LENS).
FT   VARIANT      14     14       L -> P (IN SAKI; UNSTABLE).
FT   VARIANT      14     14       L -> R (IN SOEGN; UNSTABLE).
FT   VARIANT      15     15       W -> G (IN RANDWICK; UNSTABLE).
FT   VARIANT      15     15       W -> R (IN BELFAST; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      16     16       G -> D (IN J-BALTIMORE/J-TRINIDAD/
FT                                J-IRELAND/J-GEORGIA/N-NEW HAVEN).
FT   VARIANT      16     16       G -> R (IN D-BUSHMAN).
FT   VARIANT      17     17       K -> E (IN NAGASAKI).
FT   VARIANT      17     17       K -> N (IN J-AMIENS).
FT   VARIANT      17     17       K -> Q (IN NIKOSIA).
FT   VARIANT      18     18       V -> M (IN BADEN; SLIGHTLY INSTABLE).
FT   VARIANT      19     19       N -> D (IN ALAMO).
FT   VARIANT      19     19       N -> K (IN D-OULEH RABAH).
FT   VARIANT      19     19       N -> S (IN MALAY).
FT   VARIANT      20     20       V -> M (IN OLYMPIA; O2 AFFINITY UP).
FT   VARIANT      21     21       D -> G (IN CONNECTICUT; O2 AFFINITY
FT                                DOWN).
FT   VARIANT      21     21       D -> N (IN COCODY).
FT   VARIANT      21     21       D -> H (IN KARLSKOGA).
FT   VARIANT      21     21       D -> Y (IN YUSA).
FT   VARIANT      22     22       E -> A (IN G-COUSHATTA/G-SASKATOON/
FT                                G-TAEGU/HSIN CHU).
FT   VARIANT      22     22       E -> G (IN G-TAIPEI).
FT   VARIANT      22     22       E -> K (IN E-SASKATOON; UNSTABLE).
FT   VARIANT      22     22       E -> Q (IN D-IRAN).
FT   VARIANT      22     22       E -> V (IN D-GRANADA).
FT   VARIANT      23     23       V -> D (IN STRASBOURG; O2 AFFINITY UP).
FT   VARIANT      23     23       V -> F (IN PALMERSTON NORTH; O2 AFFINITY
FT                                UP; UNSTABLE).
FT   VARIANT      23     23       V -> G (IN MIYASHIRO; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      24     24       G -> D (IN MOSCVA; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT      24     24       G -> R (IN RIVERDALE-BRONX; O2 AFFINITY
FT                                UP; UNSTABLE).
FT   VARIANT      24     24       G -> V (IN SAVANNAH; UNSTABLE).
FT   VARIANT      25     25       G -> D (IN J-AUCKLAND; UNSTABLE; O2
FT                                AFFINITY DOWN).
FT   VARIANT      25     25       G -> R (IN G-TAIWAN AMI).
FT   VARIANT      26     26       E -> K (IN E).
FT   VARIANT      26     26       E -> V (IN HENRI MONDOR; SLIGHTLY
FT                                UNSTABLE).
FT   VARIANT      27     27       A -> D (IN VOLGA/DRENTHE; UNSTABLE).
FT   VARIANT      27     27       A -> S (IN KNOSSOS).
FT   VARIANT      27     27       A -> V (IN GRANGE-BLANCHE; O2 AFFINITY
FT                                UP).
FT   VARIANT      28     28       L -> P (IN GENOVA/HYOGO; UNSTABLE).
FT   VARIANT      29     29       G -> D (IN LUFKIN; UNSTABLE).
FT   VARIANT      30     30       R -> S (IN TACOMA; UNSTABLE).
FT   VARIANT      31     31       L -> P (IN YOKOHAMA; UNSTABLE).
FT   VARIANT      32     32       L -> R (IN CASTILLA; UNSTABLE).
FT   VARIANT      32     32       L -> V (IN MUSCAT; SLIGHTLY UNSTABLE).
FT   VARIANT      34     34       V -> F (IN PITIE-SALPETRIERE; O2 AFFINITY
FT                                UP).
FT   VARIANT      35     35       Y -> F (IN PHILLY; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      36     36       P -> R (IN SUNNYBROOK).
FT   VARIANT      36     36       P -> S (IN NORTH CHICAGO; O2 AFFINITY
FT                                UP).
FT   VARIANT      36     36       P -> T (IN LINKOEPING/FINLANDIA; O2
FT                                AFFINITY UP).
FT   VARIANT      37     37       W -> G (IN HOWICK).
FT   VARIANT      37     37       W -> S (IN HIROSE; O2 AFFINITY UP).
FT   VARIANT      37     37       W -> R (IN ROTHSCHILD; O2 AFFINITY DOWN).
FT   VARIANT      38     38       T -> N (IN HINWIL; O2 AFFINITY UP).
FT   VARIANT      39     39       Q -> E (IN VAASA; UNSTABLE).
FT   VARIANT      39     39       Q -> K (IN ALABAMA).
FT   VARIANT      39     39       Q -> R (IN TIANSHUI).
FT   VARIANT      41     41       F -> Y (IN MEQUON).
FT   VARIANT      42     42       F -> L (IN LOUISVILLE; UNSTABLE).
FT   VARIANT      43     43       E -> Q (IN HOSHIDA/CHAYA).
FT   VARIANT      44     44       S -> C (IN MISSISSIPPI).
FT   VARIANT      45     45       F -> S (IN CHEVERLY; UNSTABLE).
FT   VARIANT      46     46       G -> E (IN K-IBADAN).
FT   VARIANT      47     47       D -> A (IN AVICENNA).
FT   VARIANT      47     47       D -> G (IN GAVELLO).
FT   VARIANT      47     47       D -> Y (IN MAPUTO).
FT   VARIANT      48     48       L -> P (IN BAB-SAADOUM; SLIGHLTY
FT                                UNSTABLE).
FT   VARIANT      49     49       S -> F (IN LAS PALMAS; SLIGHTLY
FT                                UNSTABLE).
FT   VARIANT      50     50       T -> K (IN EDMONTON).
FT   VARIANT      51     51       P -> R (IN WILLAMETTE; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      52     52       D -> A (IN OCHO RIOS).
FT   VARIANT      52     52       D -> H (IN SUMMER HILL).
FT   VARIANT      54     54       V -> D (IN JACKSONVILLE; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      55     55       M -> K (IN MATERA; UNSTABLE).
FT   VARIANT      56     56       G -> R (IN HAMADAN).
FT   VARIANT      57     57       N -> K (IN G-FERRARA; UNSTABLE).
FT   VARIANT      58     58       P -> R (IN DHOFAR/YUKUHASHI).
FT   VARIANT      59     59       K -> E (IN I-HIGH WYCOMBE).
FT   VARIANT      60     60       V -> A (IN COLLINGWOOD; UNSTABLE).
FT   VARIANT      61     61       K -> E (IN N-SEATLLE).
FT   VARIANT      61     61       K -> M (IN BOLOGNA; O2 AFFINITY DOWN).
FT   VARIANT      61     61       K -> N (IN HIKARI).
FT   VARIANT      62     62       A -> D (IN J-EUROPA).
FT   VARIANT      62     62       A -> P (IN DUARTE; UNSTABLE).
FT   VARIANT      63     63       H -> Y (IN M-SASKATOON; O2 AFFINITY UP).
FT   VARIANT      65     65       K -> M (IN J-ANTAKYA).
FT   VARIANT      65     65       K -> N (IN J-SICILIA).
FT   VARIANT      65     65       K -> Q (IN J-CAIRO).
FT   VARIANT      66     66       K -> T (IN CHICO; O2 AFFINITY DOWN).
FT   VARIANT      67     67       V -> A (IN SIDNEY; UNSTABLE).
FT   VARIANT      67     67       V -> M (IN ALESHA; UNSTABLE).
FT   VARIANT      68     68       L -> H (IN BRISBANE; O2 AFFINITY UP).
FT   VARIANT      68     68       L -> P (IN MIZUHO; UNSTABLE).
FT   VARIANT      69     69       G -> D (IN RAMBAM).
FT   VARIANT      69     69       G -> R (IN KENITRA).
FT   VARIANT      69     69       G -> S (IN CITY OF HOPE).
FT   VARIANT      70     70       A -> D (IN SEATTLE; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT      71     71       F -> S (IN CHRISTCHURCH; UNSTABLE).
FT   VARIANT      73     73       D -> G (IN TILBURG; O2 AFFINITY DOWN).
FT   VARIANT      73     73       D -> V (IN MOBILE; O2 AFFINITY DOWN).
FT   VARIANT      73     73       D -> Y (IN VANCOUVER; O2 AFFINITY DOWN).
FT   VARIANT      74     74       G -> R (IN AALBORG; UNSTABLE).
FT   VARIANT      74     74       G -> V (IN BUSHWICK; UNSTABLE).
FT   VARIANT      75     75       L -> P (IN ATLANTA; UNSTABLE).
FT   VARIANT      75     75       L -> R (IN PASADENA; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      76     76       A -> D (IN J-CHICAGO).
FT   VARIANT      77     77       H -> D (IN J-IRAN).
FT   VARIANT      77     77       H -> R (IN COSTA RICA).
FT   VARIANT      77     77       H -> Y (IN FUKUYAMA).
FT   VARIANT      78     78       L -> R (IN QUIN-HAI).
FT   VARIANT      79     79       D -> Y (IN TAMPA).
FT   VARIANT      80     80       N -> K (IN G-SZUHU/GIFU).
FT   VARIANT      81     81       L -> R (IN BAYLOR; UNSTABLE).
FT   VARIANT      82     82       K -> M (IN HELSINKI; O2 AFFINITY UP).
FT   VARIANT      83     83       G -> R (IN MUSKEGON).
FT   VARIANT      84     84       T -> I (IN KOFU).
FT   VARIANT      86     86       A -> D (IN OLOMOUC; O2 AFFINITY UP).
FT   VARIANT      87     87       T -> I (IN QUEBEC-CHORI).
FT   VARIANT      87     87       T -> K (IN D-IBADAN).
FT   VARIANT      87     87       T -> P (IN VALLETTA).
FT   VARIANT      88     88       L -> P (IN SANTA ANA; UNSTABLE).
FT   VARIANT      88     88       L -> R (IN BORAS; UNSTABLE).
FT   VARIANT      89     89       S -> N (IN CRETEIL; O2 AFFINITY UP).
FT   VARIANT      89     89       S -> R (IN VANDERBILT; O2 AFFINITY UP).
FT   VARIANT      90     90       E -> D (IN PIERRE-BENITE; O2 AFFINITY
FT                                UP).
FT   VARIANT      90     90       E -> K (IN AGENOGI; O2 AFFINITY DOWN).
FT   VARIANT      91     91       L -> P (IN SABINE; UNSTABLE).
FT   VARIANT      91     91       L -> R (IN CARIBBEAN; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT      92     92       H -> D (IN J-ALTGELDS GARDENS; UNSTABLE).
FT   VARIANT      92     92       H -> N (IN ISEHARA; UNSTABLE).
FT   VARIANT      92     92       H -> P (IN NEWCASTLE AND DUINO;
FT                                UNSTABLE).
FT   VARIANT      92     92       H -> Q (IN ISTAMBUL; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      93     93       C -> R (IN OKAZAKI; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      94     94       D -> G (IN CHANDIGARH).
FT   VARIANT      94     94       D -> H (IN BARCELONA; O2 AFFINITY UP).
FT   VARIANT      94     94       D -> N (IN BUNBURY; O2 AFFINITY UP).
FT   VARIANT      95     95       K -> M (IN J-CORDOBA).
FT   VARIANT      95     95       K -> N (IN DETROIT).
FT   VARIANT      96     96       L -> P (IN DEBROUSSE; UNSTABLE; O2
FT                                AFFINITY UP).
FT   VARIANT      96     96       L -> V (IN REGINA; O2 AFFINITY UP).
FT   VARIANT      97     97       H -> L (IN WOOD; O2 AFFINITY UP).
FT   VARIANT      97     97       H -> P (IN NAGOYA; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT      97     97       H -> Q (IN MALMOE; O2 AFFINITY UP).
FT   VARIANT      97     97       H -> Y (IN MORIGUCHI).
FT   VARIANT      98     98       V -> G (IN NOTTINGHAM; UNSTABLE).
FT   VARIANT      99     99       D -> E (IN COIMBRA; O2 AFFINITY UP).
FT   VARIANT     100    100       P -> L (IN BRIGHAM; O2 AFFINITY UP).
FT   VARIANT     100    100       P -> R (IN NEW MEXICO).
FT   VARIANT     101    101       E -> D (IN POTOMAC; O2 AFFINITY UP).
FT   VARIANT     101    101       E -> G (IN ALBERTA; O2 AFFINITY UP).
FT   VARIANT     101    101       E -> K (IN BRITISH COLUMBIA; O2 AFFINITY
FT                                UP).
FT   VARIANT     101    101       E -> Q (IN RUSH; UNSTABLE).
FT   VARIANT     102    102       N -> S (IN BETH ISRAEL; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT     102    102       N -> Y (IN ST MANDE; O2 AFFINITY DOWN).
FT   VARIANT     103    103       F -> L (IN HEATHROW; O2 AFFINITY UP).
FT   VARIANT     104    104       R -> S (IN CAMPERDOWN AND DUINO).
FT   VARIANT     104    104       R -> T (IN SHERWOOD FOREST).
FT   VARIANT     107    107       G -> R (IN BURKE; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT     108    108       N -> K (IN PRESBYTERIAN; O2 AFFINITY
FT                                DOWN; UNSTABLE).
FT   VARIANT     109    109       V -> M (IN SAN DIEGO; O2 AFFINITY UP).
FT   VARIANT     110    110       L -> P (IN SHOWA-YAKUSHIJI).
FT   VARIANT     111    111       V -> A (IN STANMORE; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT     112    112       C -> R (IN INDIANAPOLIS).
FT   VARIANT     112    112       C -> Y (IN YAHATA).
FT   VARIANT     115    115       A -> D (IN HRADEC KRALOVE; UNSTABLE;
FT                                CAUSES SEVERE BETA-THALASSEMIA).
FT   VARIANT     115    115       A -> P (IN MADRID; UNSTABLE).
FT   VARIANT     116    116       H -> Q (IN HAFNIA).
FT   VARIANT     117    117       H -> P (IN SAITAMA; UNSTABLE).
FT   VARIANT     117    117       H -> R (IN P-GALVESTON).
FT   VARIANT     119    119       G -> A (IN IOWA).
FT   VARIANT     120    120       K -> E (IN HIJIYAMA).
FT   VARIANT     120    120       K -> I (IN JIANGHUA).
FT   VARIANT     120    120       K -> Q (IN TAKAMATSU).
FT   VARIANT     121    121       E -> A (IN D-NEATH).
FT   VARIANT     121    121       E -> G (IN ST FRANCIS).
FT   VARIANT     121    121       E -> Q (IN D-LOS ANGELES/D-PUNJAB/
FT                                D-PORTUGAL/D-CHICAGO/D-OAK RIDGE).
FT   VARIANT     121    121       E -> K (IN O-ARAB).
FT   VARIANT     121    121       E -> V (IN D-CAMPERDOWN/BEOGRAD).
FT   VARIANT     123    123       T -> I (IN VILLEJUIF).
FT   VARIANT     124    124       P -> R (IN KHARTOUM; UNSTABLE).
FT   VARIANT     124    124       P -> Q (IN TY GARD; O2 AFFINITY UP).
FT   VARIANT     124    124       P -> S (IN TUNIS).
FT   VARIANT     126    126       V -> A (IN BEIRUT).
FT   VARIANT     126    126       V -> G (IN DHONBURI/NEAPOLIS; UNSTABLE;
FT                                BETA-THALASSEMIA).
FT   VARIANT     126    126       V -> E (IN HOFU; UNSTABLE).
FT   VARIANT     127    127       Q -> E (IN COMPLUTENSE).
FT   VARIANT     127    127       Q -> K (IN BREST; UNSTABLE).
FT   VARIANT     128    128       A -> D (IN J-GUANTANAMO; UNSTABLE).
FT   VARIANT     129    129       A -> P (IN CRETE; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT     129    129       A -> V (IN LA DESIRADE; O2 AFFINITY
FT                                DOWN; UNSTABLE).
FT   VARIANT     130    130       Y -> D (IN WIEN; UNSTABLE).
FT   VARIANT     130    130       Y -> S (IN NEVERS).
FT   VARIANT     131    131       Q -> E (IN CAMDEN/TOKUCHI/MOTOWN).
FT   VARIANT     131    131       Q -> K (IN SHELBY/LESLIE/DEACONESS;
FT                                UNSTABLE).
FT   VARIANT     131    131       Q -> P (IN SHANGAI; UNSTABLE).
FT   VARIANT     131    131       Q -> R (IN SARREBOURG; UNSTABLE).
FT   VARIANT     132    132       K -> N (IN YAMAGATA; O2 AFFINITY DOWN).
FT   VARIANT     132    132       K -> Q (IN K-WOOLWICH).
FT   VARIANT     133    133       V -> L (IN EXTREDEMURA).
FT   VARIANT     134    134       V -> E (IN NORTH SHORE; UNSTABLE).
FT   VARIANT     135    135       A -> E (IN BECKMAN; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT     135    135       A -> P (IN ALTDORF; O2 AFFINITY UP;
FT                                UNSTABLE).
FT   VARIANT     136    136       G -> D (IN HOPE; O2 AFFINITY DOWN;
FT                                UNSTABLE).
FT   VARIANT     138    138       A -> P (IN BROCKTON; UNSTABLE).
FT   VARIANT     139    139       N -> D (IN GEELONG; UNSTABLE).
FT   VARIANT     139    139       N -> K (IN HINSDALE; O2 AFFINITY DOWN).
FT   VARIANT     139    139       N -> Y (IN AURORA; O2 AFFINITY UP).
FT   VARIANT     140    140       A -> D (IN HIMEJI; UNSTABLE; O2 AFFINITY
FT                                DOWN).
FT   VARIANT     140    140       A -> T (IN ST JACQUES: O2 AFFINITY UP).
FT   VARIANT     140    140       A -> V (IN PUTTELANGE; POLYCYTHEMIA;
FT                                O2 AFFINITY UP).
FT   VARIANT     141    141       L -> R (IN OLMSTED; UNSTABLE).
FT   VARIANT     142    142       A -> D (IN OHIO; O2 AFFINITY UP).
FT   VARIANT     143    143       H -> D (IN RANCHO MIRAGE).
FT   VARIANT     143    143       H -> Q (IN LITTLE ROCK; O2 AFFINITY UP).
FT   VARIANT     143    143       H -> P (IN SYRACUSE; O2 AFFINITY UP).
FT   VARIANT     143    143       H -> R (IN ABRUZZO; O2 AFFINITY UP).
FT   VARIANT     144    144       K -> E (IN MITO; O2 AFFINITY UP).
FT   VARIANT     145    145       Y -> C (IN RAINIER; O2 AFFINITY UP).
FT   VARIANT     145    145       Y -> H (IN BETHESDA; O2 AFFINITY UP).
FT   VARIANT     146    146       H -> D (IN HIROSHIMA; O2 AFFINITY UP).
FT   VARIANT     146    146       H -> L (IN COWTOWN; O2 AFFINITY UP).
FT   VARIANT     146    146       H -> P (IN YORK; O2 AFFINITY UP).
FT   VARIANT     146    146       H -> Q (IN KODAIRA; O2 AFFINITY UP).
FT   HELIX         5     15
FT   TURN         16     17
FT   HELIX        20     34
FT   HELIX        36     41
FT   HELIX        43     45
FT   HELIX        51     55
FT   TURN         56     56
FT   HELIX        58     75
FT   TURN         76     77
FT   HELIX        78     94
FT   TURN         95     96
FT   TURN        100    100
FT   HELIX       101    121
FT   HELIX       124    142
FT   TURN        143    144
SQ   SEQUENCE   146 AA;  15867 MW;  EC9744C9 CRC32;
     VHLTPEEKSA VTALWGKVNV DEVGGEALGR LLVVYPWTQR FFESFGDLST PDAVMGNPKV
     KAHGKKVLGA FSDGLAHLDN LKGTFATLSE LHCDKLHVDP ENFRLLGNVL VCVLAHHFGK
     EFTPPVQAAY QKVVAGVANA LAHKYH
//
ID   HBG_HUMAN      STANDARD;      PRT;   146 AA.
AC   P02096;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   HEMOGLOBIN GAMMA-A AND GAMMA-G CHAINS.
GN   HBG1 AND HBG2.
OS   HOMO SAPIENS (HUMAN), AND PAN TROGLODYTES (CHIMPANZEE).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE FROM N.A. (GAMMA-A AND GAMMA-G).
RC   SPECIES=HUMAN;
RX   MEDLINE; 81064665.
RA   SLIGHTOM J.L., BLECHL A.E., SMITHIES O.;
RT   "Human fetal G gamma- and A gamma-globin genes: complete nucleotide
RT   sequences suggest that DNA can be exchanged between these duplicated
RT   genes.";
RL   CELL 21:627-638(1980).
RN   [2]
RP   SEQUENCE FROM N.A. (GAMMA-A).
RC   SPECIES=HUMAN;
RX   MEDLINE; 82137053.
RA   SHEN S., SLIGHTOM J.L., SMITHIES O.;
RT   "A history of the human fetal globin gene duplication.";
RL   CELL 26:191-203(1981).
RN   [3]
RP   SEQUENCE FROM N.A. (GAMMA-G).
RC   SPECIES=HUMAN;
RX   MEDLINE; 81237783.
RA   CAVALLESCO C., FORGET B.G., DERIEL J.K., WILSON L.B., WILSON J.T.,
RA   WEISSMAN S.M.;
RT   "Nucleotide sequence of human G gamma globin messenger RNA.";
RL   GENE 12:215-221(1980).
RN   [4]
RP   SEQUENCE OF 121-146 FROM N.A. (GAMMA-G).
RC   SPECIES=HUMAN;
RX   MEDLINE; 85205333.
RA   LANG K.M., SPRITZ R.A.;
RT   "Cloning specific complete polyadenylylated 3'-terminal cDNA
RT   segments.";
RL   GENE 33:191-196(1985).
RN   [5]
RP   SEQUENCE (GAMMA-G).
RC   SPECIES=HUMAN;
RA   SCHROEDER W.A., SHELTON J.R., SHELTON J.B., CORMICK J., JONES R.T.;
RT   "The amino acid sequence of the gamma chain of human fetal
RT   hemoglobin.";
RL   BIOCHEMISTRY 2:992-1008(1963).
RN   [6]
RP   SEQUENCE.
RC   SPECIES=P.TROGLODYTES;
RA   DE JONG W.W.W.;
RT   "Chimpanzee foetal haemoglobin: structure and heterogeneity of the
RT   gamma chain.";
RL   BIOCHIM. BIOPHYS. ACTA 251:217-226(1971).
RN   [7]
RP   SEQUENCE FROM N.A. (GAMMA-A AND GAMMA-G).
RC   SPECIES=P.TROGLODYTES;
RX   MEDLINE; 88216125.
RA   SLIGHTOM J.L., CHANG L.-Y.E., KOOP B.F., GOODMAN M.;
RT   "Chimpanzee fetal G gamma and A gamma globin gene nucleotide
RT   sequences provide further evidence of gene conversions in hominine
RT   evolution.";
RL   MOL. BIOL. EVOL. 2:370-389(1985).
RN   [8]
RP   SEQUENCE FROM N.A. (GAMMA-A AND GAMMA-G).
RC   SPECIES=P.TROGLODYTES;
RA   BAILEY W.J., HAYASAKA K., SKINNER C.G., KEHOE S.M., SUE L.,
RA   SLIGHTOM J.L., GOODMAN M.;
RL   SUBMITTED (XXX-1992) TO EMBL/GENBANK/DDBJ DATA BANKS.
RN   [9]
RP   ACETYLATION.
RX   MEDLINE; 71166470.
RA   STEGINK L.D., MEYER P.D., BRUMMEL M.C.;
RT   "Human fetal hemoglobin F 1. Acetylation status.";
RL   J. BIOL. CHEM. 246:3001-3007(1971).
RN   [10]
RP   VARIANT AUCKLAND.
RX   MEDLINE; 75036118.
RA   CARRELL R.W., OWEN M.C., ANDERSON R., BERRY E.;
RT   "Haemoglobin F auckland G gamma 7 Asp leads to Asn: further evidence
RT   for multiple genes for the gamma chain.";
RL   BIOCHIM. BIOPHYS. ACTA 365:323-327(1974).
RN   [11]
RP   VARIANT AUSTELL.
RX   MEDLINE; 89007589.
RA   KUTLAR A., KUTLAR F., WILSON J.B., WEBBER B.B., HU H., HUISMAN T.H.J.;
RT   "Hb F-Austell or alpha 2G gamma (2)40(C6)Arg-->Lys.";
RL   HEMOGLOBIN 12:409-411(1988).
RN   [12]
RP   VARIANT BASKENT.
RX   MEDLINE; 88256746.
RA   ALTAY C., GURGEY A., WILSON J.B., HU H., WEBBER B.B., KUTLAR F.,
RA   HUISMAN T.H.J.;
RT   "Hb F-Baskent or alpha 2A gamma 128(H6)Ala-->Thr.";
RL   HEMOGLOBIN 12:87-89(1988).
RN   [13]
RP   VARIANT BEECH ISLAND.
RX   MEDLINE; 86111142.
RA   CHEN S.S., WILSON J.B., WEBBER B.B., HUISMAN T.H.J.;
RT   "Hb F-Beech Island or alpha 2A gamma 2(53)(D4)Ala-->Asp.";
RL   HEMOGLOBIN 9:525-529(1985).
RN   [14]
RP   VARIANT BONAIRE.
RX   MEDLINE; 83135044.
RA   NAKATSUJI T., HEADLEE M., LAM H., WILSON J.B., HUISMAN T.H.J.;
RT   "Hb F-Bonaire-Ga or alpha 2 A gamma 2 39(C5) Gln replaced by Arg,
RT   characterized by high pressure liquid chromatographic and
RT   microsequencing procedures.";
RL   HEMOGLOBIN 6:599-606(1982).
RN   [15]
RP   VARIANT BROOKLYN.
RX   MEDLINE; 91107346.
RA   PLASESKA D., LI H.-J., WILSON J.B., KUTLAR F., KUTLAR A.,
RA   HUISMAN T.H.J., KULPA J.;
RT   "Hb F-Brooklyn or alpha 2G gamma 2(66)(E10)Lys-->Gln.";
RL   HEMOGLOBIN 14:213-216(1990).
RN   [16]
RP   VARIANT CALLUNA.
RX   MEDLINE; 84135126.
RA   NAKATSUJI T., LAM H., HUISMAN T.H.J.;
RT   "Hb F-Calluna or alpha 2 gamma 2(12 Thr replaced by Arg; 75Ile;
RT   136Ala) in a Caucasian baby.";
RL   HEMOGLOBIN 7:563-566(1983).
RN   [17]
RP   VARIANT CALTECH.
RX   MEDLINE; 83135042.
RA   SHELTON J.B., SHELTON J.R., ESPINUEVA Z., HUYNH V., SCHROEDER W.A.,
RA   POWARS D.;
RT   "Hemoglobin F-Caltech: alpha 2 G gamma 2 120Lys replaced by Gln.";
RL   HEMOGLOBIN 6:577-592(1982).
RN   [18]
RP   VARIANT CATALONIA.
RX   MEDLINE; 91177713.
RA   PLASESKA D., WILSON J.B., KUTLAR F., FONT L., BAIGET M.,
RA   HUISMAN T.H.J.;
RT   "Hb F-Catalonia or alpha 2G gamma(2)15(A12)Trp-->Arg.";
RL   HEMOGLOBIN 14:511-516(1990).
RN   [19]
RP   VARIANT CHARLOTTE.
RX   MEDLINE; 91331856.
RA   PLASESKA D., KUTLAR F., WILSON J.B., FEI Y.J., HUISMAN T.H.J.;
RT   "Hb F-Charlotte, an A gamma variant with a threonine residue in
RT   position gamma 75 and a glycine residue in position gamma 136.";
RL   HEMOGLOBIN 14:617-625(1990).
RN   [20]
RP   VARIANT COBB.
RX   MEDLINE; 86139294.
RA   CHEN S.S., WEBBER B.B., KUTLAR A., WILSON J.B., HUISMAN T.H.J.;
RT   "Hb F-Cobb or alpha(2)A gamma(2)37(C3)Trp-->Gly.";
RL   HEMOGLOBIN 9:617-619(1985).
RN   [21]
RP   VARIANT COLUMBUS-GA.
RX   MEDLINE; 83135043.
RA   NAKATSUJI T., LAM H., WILSON J.B., WEBBER B.B., HUISMAN T.H.J.;
RT   "Hb F-Columbus-Ga or alpha 2 G gamma 2 94(FGl) Asp replaced by Asn.";
RL   HEMOGLOBIN 6:593-598(1982).
RN   [22]
RP   VARIANT COSENZA.
RX   MEDLINE; 92267854.
RA   QUALTIERI A., CRESCIBENE L., BAGALA A., DE MARCO E.V., BRIA M.,
RA   BRANCATI C.;
RT   "Hb F-Cosenza or G gamma 25(B7)Gly-->Glu: a new fast-moving fetal
RT   hemoglobin variant.";
RL   HEMOGLOBIN 15:509-515(1991).
RN   [23]
RP   VARIANT DAMMAM.
RX   MEDLINE; 85288321.
RA   AL-AWAMY B.H., NIAZI G.A., AL-MOUZAN M.I., WILSON J.B., CHEN S.S.,
RA   WEBBER B.B., HUISMAN T.H.J.;
RT   "Hb F-Dammam or alpha 2A gamma 2(79) (EF3) Asp-->Asn.";
RL   HEMOGLOBIN 9:171-173(1985).
RN   [24]
RP   VARIANT DICKINSON.
RX   MEDLINE; 75127839.
RA   SCHNEIDER R.G., HAGGARD M.E., GUSTAVSON L.P., BRIMHALL B., JONES R.T.;
RT   "Genetic haemoglobin abnormalities in about 9000 Black and 7000 White
RT   newborns; haemoglobin F Dickinson (Agamma97His-Arg), a new variant.";
RL   BR. J. HAEMATOL. 28:515-524(1974).
RN   [25]
RP   VARIANT FORT RIPLEY.
RX   MEDLINE; 89239847.
RA   PRIEST J.R., WATTERSON J., JONES R.T., FAASSEN A.E., HEDLUND B.E.;
RT   "Mutant fetal hemoglobin causing cyanosis in a newborn.";
RL   PEDIATRICS 83:734-736(1989).
RN   [26]
RP   VARIANT FUKUYAMA.
RX   MEDLINE; 89197553.
RA   HIDAKA K., IUCHI I., NAKAHARA H., IWAKAWA G.;
RT   "Hb F-Fukuyama or A gamma T43(CD2)Asp-->Asn.";
RL   HEMOGLOBIN 13:93-96(1989).
RN   [27]
RP   VARIANT GRANADA.
RX   MEDLINE; 89007588.
RA   DE PABLOS J.M., CLEGG J.B.;
RT   "Hb F-Granada or alpha 2G gamma (2)22(B4)Asp-->Val: a new human fetal
RT   hemoglobin variant.";
RL   HEMOGLOBIN 12:405-407(1988).
RN   [28]
RP   VARIANT IZUMI.
RX   MEDLINE; 84104888.
RA   WADA Y., HAYASHI A., MASANORI F., KATAKUSE I., ICHIHARA T.,
RA   NAKABUSHI H., MATSUO T., SAKURAI T., MATSUDA H.;
RT   "Characterization of a new fetal hemoglobin variant, Hb F Izumi A
RT   gamma 6Glu replaced by Gly, by molecular secondary ion mass
RT   spectrometry.";
RL   BIOCHIM. BIOPHYS. ACTA 749:244-248(1983).
RN   [29]
RP   VARIANT JAMAICA.
RX   MEDLINE; 71076040.
RA   AHERN E.J., JONES R.T., BRIMHALL B., GRAY R.H.;
RT   "Haemoglobin F Jamaica (alpha-2 gamma-2 61 Lys leads to Glu; 136
RT   Ala).";
RL   BR. J. HAEMATOL. 18:369-375(1970).
RN   [30]
RP   VARIANT JIANGSU.
RX   MEDLINE; 91331856.
RA   PLASESKA D., KUTLAR F., WILSON J.B., WEBBER B.B., ZENG Y.-T.,
RA   HUISMAN T.H.J.;
RT   "Hb F-Charlotte, an A gamma variant with a threonine residue in
RT   position gamma 75 and a glycine residue in position gamma 136.";
RL   HEMOGLOBIN 14:177-183(1990).
RN   [31]
RP   VARIANT KENNESTONE.
RX   MEDLINE; 83265056.
RA   NAKATSUJI T., LAM H., HUISMAN T.H.J.;
RT   "Hb F-Kennestone or alpha 2G gamma 2 (EF1)77 His leads to Arg
RT   observed in a Caucasian baby.";
RL   HEMOGLOBIN 7:267-270(1983).
RN   [32]
RP   VARIANT KINGSTON.
RX   MEDLINE; 83132267.
RA   SERJEANT G.R., SERJEANT B.E., LEHMANN H., DUKES M., ROBB L.;
RT   "Hb F Kingston (G gamma 55 [D6] Met leads to Arg).";
RL   FEBS LETT. 150:77-80(1982).
RN   [33]
RP   VARIANT KOTOBUKI.
RX   MEDLINE; 82166887.
RA   YOSHINAKA H., OHBA Y., HATTORI Y., MATSUOKA M., MIYAJI T., FUYUNO K.;
RT   "A new gamma chain variant, HB F Kotobuki or AI gamma 6 (A3) Glu
RT   leads to Gly.";
RL   HEMOGLOBIN 6:37-42(1982).
RN   [34]
RP   VARIANT KUALA LUMPUR.
RX   MEDLINE; 74062194.
RA   LIE-INJO L.E., WILTSHIRE B.B., LEHMANN H.;
RT   "Structural identification of haemoglobin F Kuala Lumpur: alpha2
RT   gamma2 22(B4)Asp leads to Gly; 136 Ala.";
RL   BIOCHIM. BIOPHYS. ACTA 322:224-230(1973).
RN   [35]
RP   VARIANT LA GRANGE.
RX   MEDLINE; 85000557.
RA   NAKATSUJI T., SHIMIZU K., HUISMAN T.H.J.;
RT   "Hb F-La Grange or alpha 2 gamma 2 101(G3)Glu-->Lys; 75Ile; 136Gly:
RT   a high oxygen affinity fetal hemoglobin variant observed in a
RT   Caucasian newborn.";
RL   BIOCHIM. BIOPHYS. ACTA 789:224-228(1984).
RN   [36]
RP   VARIANT LESVOS.
RX   MEDLINE; 96163507.
RA   PAPADAKIS M.N., PATRINOS G.P., DRAKOULAKOU O.,
RA   LOUTRADI-ANAGNOSTOU A.;
RT   "HbF-Lesvos: an HbF variant due to a novel G gamma mutation (G gamma
RT   75 ATA-->ACA) detected in a Greek family.";
RL   HUM. GENET. 97:260-262(1996).
RN   [37]
RP   VARIANT LODZ.
RX   MEDLINE; 83049121.
RA   HONIG G.R., KOSHY M., SCHROEDER W.A., SHELTON J.B., SHELTON J.R.;
RT   "Hemoglobin F Lodz (G gamma I 44 Ser replaced by Arg). A newly
RT   identified variant from an American infant of Polish descent.";
RL   BIOCHIM. BIOPHYS. ACTA 707:213-216(1982).
RN   [38]
RP   VARIANT MALAYSIA.
RX   MEDLINE; 74258593.
RA   LIE-INJO L.E., KAMUZORA H., LEHMANN H.;
RT   "Haemoglobin F Malaysia: alpha 2, gamma 2 1(NA1) glycine-->cysteine;
RT   136 glycine.";
RL   J. MED. GENET. 11:25-30(1974).
RN   [39]
RP   VARIANT MEINOHAMA.
RX   MEDLINE; 82097665.
RA   OHTA Y., SAITO S., FUJITA S., WILSON J.B., LAM H., HUISMAN T.H.J.;
RT   "Hb F-Meinohama or alpha 2 gamma 2 (5 Glu replaced by Gly; 75 Ile;
RT   136 Gly).";
RL   HEMOGLOBIN 5:565-570(1981).
RN   [40]
RP   VARIANT OAKLAND.
RX   MEDLINE; 87307476.
RA   KLEMAN K., LUBIN B., WILSON J.B., KUTLAR A., WEBBER B.B.,
RA   HUISMAN T.H.J.;
RT   "Hb F-Oakland or alpha 2G gamma I2(26)(B8)Glu-->Lys.";
RL   HEMOGLOBIN 11:181-183(1987).
RN   [41]
RP   VARIANT ONODA.
RX   MEDLINE; 91107347.
RA   HARANO T., HARANO K., DOI K., UEDA S., IMAI K., OHBA Y., KUTLAR F.,
RA   HUISMAN T.H.J.;
RT   "Hb F-Onoda or alpha 2G gamma 2(146)(HC3)His-->Tyr, a newly discovered
RT   fetal hemoglobin variant in a Japanese newborn.";
RL   HEMOGLOBIN 14:217-222(1990).
RN   [42]
RP   VARIANT OSAKA.
RX   MEDLINE; 90236758.
RA   GLADER B.E., ZWERDLING D., KUTLAR F., KUTLAR A., WILSON J.B.,
RA   HUISMAN T.H.J.;
RT   "Hb F-M-Osaka or alpha 2G gamma 2(63)(E7)His-->Tyr in a Caucasian
RT   male infant.";
RL   HEMOGLOBIN 13:769-773(1989).
RN   [43]
RP   VARIANT PENDERGRASS.
RX   MEDLINE; 85206967.
RA   CHEN S.S., WILSON J.B., HUISMAN T.H.J.;
RT   "Hb F-Pendergrass, an A gamma I variant with a Pro-->Arg
RT   substitution at position gamma 36(C2).";
RL   HEMOGLOBIN 9:73-77(1985).
RN   [44]
RP   VARIANT POOLE.
RX   MEDLINE; 75151976.
RA   LEE-POTTER J.P., DEACON-SMITH R.A., SIMPKISS M.J., KAMUZORA H.,
RA   LEHMANN H.;
RT   "A new cause of haemolytic anaemia in the newborn. A description of
RT   an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130 trptophan
RT   yeilds glycine.";
RL   J. CLIN. PATHOL. 28:317-320(1975).
RN   [45]
RP   VARIANT PORDENONE.
RX   MEDLINE; 83056271.
RA   NAKATSUJI T., WEBBER B., LAM H., WILSON J.B., HUISMAN T.H.J.,
RA   SCIARRATTA G.V., SANSONE G., MOLARO G.L.;
RT   "A new gamma chain variant: Hb F-Pordenone [gamma 6(A3) Glu replaced
RT   by Gln: 75ILE: 136ALA].";
RL   HEMOGLOBIN 6:397-401(1982).
RN   [46]
RP   VARIANT PORT-ROYAL.
RX   MEDLINE; 74287006.
RA   BRIMHALL B., VEDVICK T.S., JONES R.T., AHERN E., PALOMINO E.,
RA   AHERN V.;
RT   "Haemoglobin F Port Royal (alpha2G gamma2 125 Glu leads to Ala).";
RL   BR. J. HAEMATOL. 27:313-318(1974).
RN   [47]
RP   VARIANT SARDINIA.
RX   MEDLINE; 76015698.
RA   GRIFONE V., KAMUZORA H., LEHMANN H., CHARLESWORTH D.;
RT   "A new Hb variant: Hb F Sardinia gamma75(E19) isoleucine leads to
RT   threonine found in a family with Hb G Philadelphia, beta-chain
RT   deficiency and a Lepore-like haemoglobin indistinguishable from Hb
RT   A2.";
RL   ACTA HAEMATOL. 53:347-355(1975).
RN   [48]
RP   VARIANT SIENNA.
RX   MEDLINE; 83185443.
RA   CARE A., MARINUCCI M., MASSA A., MAFFI D., SPOSI N.M., IMPROTA T.,
RA   TENTORI L.;
RT   "Hb F-Siena (alpha 2 a gamma t2 121 (GH4) Glu leads to Lys). A new
RT   fetal hemoglobin variant.";
RL   HEMOGLOBIN 7:79-83(1983).
RN   [49]
RP   VARIANT TEXAS-1.
RX   MEDLINE; 67095305.
RA   JENKINS G.C., BEALE D., BLACK A.J., HUNTSMAN R.G., LEHMANN H.;
RT   "Haemoglobin F Texas I(alpha-2,gamma-2-5glu-lys): a variant of
RT   haemoglobin F.";
RL   BR. J. HAEMATOL. 13:252-255(1967).
RN   [50]
RP   VARIANT TOKYO.
RX   MEDLINE; 85206961.
RA   CHEN S.S., WILSON J.B., WEBBER B.B., HUISMAN T.H.J., MIWA S.,
RA   AMENOMORI Y.;
RT   "Hb F-Tokyo or alpha 2G gamma 2 34(B16)Val-->Ile, a silent gamma chain
RT   variant detected by reverse phase high performance liquid
RT   chromatography.";
RL   HEMOGLOBIN 9:25-32(1985).
RN   [51]
RP   VARIANT VICTORIA JUBILEE.
RX   MEDLINE; 75184108.
RA   AHERN E., HOLDER W., AHERN V., SERJEANT G.R., SERJEANT B., FORBES M.,
RA   BRIMHALL B., JONES R.T.;
RT   "Haemoglobin F Victoria Jubilee (alpha 2 A gamma 2 80 Asp-Try).";
RL   BIOCHIM. BIOPHYS. ACTA 393:188-194(1975).
RN   [52]
RP   VARIANT XIN-SU.
RX   MEDLINE; 88114686.
RA   MA M., HU H., KUTLAR F., WILSON J.B., HUISMAN T.H.J.;
RT   "Hb F-Xin-Su or A gamma I73(E17)Asp-->His: a new slow-moving fetal
RT   hemoglobin variant.";
RL   HEMOGLOBIN 11:473-479(1987).
RN   [53]
RP   VARIANT XINJIANG.
RX   MEDLINE; 88114685.
RA   HU H., MA M.;
RT   "Hb F-Xinjiang or A gamma T25(B7)Gly-->Arg: a new slow-moving unstable
RT   fetal hemoglobin variant.";
RL   HEMOGLOBIN 11:465-472(1987).
CC   -!- FUNCTION: GAMMA CHAINS MAKE UP THE FETAL HEMOGLOBIN F, IN
CC       COMBINATION WITH ALPHA CHAINS.
CC   -!- SUBUNIT: TETRAMER OF TWO GAMMA AND TWO ALPHA CHAINS.
CC   -!- HUMAN AND CHIMPANZEE HAVE TWO NONALLELIC GAMMA CHAINS; GAMMA-A
CC       AND GAMMA-B. THE SEQUENCE SHOWN IS THAT OF GAMMA-A.
CC   -!- DEVELOPMENTAL STAGE: EXPRESSED UNTIL FOUR OR FIVE WEEKS AFTER
CC       BIRTH.
CC   -!- DISEASE: SOME GAMMA VARIANTS CAN CAUSE SEVERE JAUNDICE AND
CC       CYANOSIS IN PREMATURE AND NEW BORN BABIES.
CC   -!- DATABASE: NAME=Hb variant; NOTE=Human hemoglobin variants;
CC       WWW="http://globin.cse.psu.edu/globin/html/huisman/variants/".
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M91036; G182963; -.
DR   EMBL; M91037; G182965; -.
DR   EMBL; M91037; G182966; -.
DR   EMBL; U01317; G455994; -.
DR   EMBL; U01317; G455995; -.
DR   EMBL; V00513; G31729; -.
DR   EMBL; V00514; G31731; -.
DR   EMBL; V00515; G31733; -.
DR   EMBL; M11427; G386767; -.
DR   EMBL; V00517; G31761; -.
DR   EMBL; V00517; G31760; -.
DR   EMBL; J00176; G183872; -.
DR   EMBL; X03110; G38163; -.
DR   EMBL; X03109; G38220; -.
DR   EMBL; M92294; G176779; -.
DR   EMBL; M92294; G176780; -.
DR   PIR; A90803; HGHUA.
DR   PIR; B90803; HGHUG.
DR   PIR; A90581; HGCZA.
DR   PDB; 1FDH; 30-SEP-83.
DR   MIM; 142200; -.
DR   MIM; 142250; -.
DR   PROSITE; PS01033; GLOBIN; 1.
DR   PFAM; PF00042; globin; 1.
KW   HEME; OXYGEN TRANSPORT; RESPIRATORY PROTEIN; ERYTHROCYTE;
KW   ACETYLATION; POLYMORPHISM; DISEASE MUTATION; 3D-STRUCTURE.
FT   INIT_MET      0      0
FT   MOD_RES       1      1       ACETYLATION (IN MINOR HG F1 TETRAMER).
FT   VARIANT       1      1       G -> C (IN MALAYSIA).
FT   VARIANT       2      2       H -> Q (IN MACEDONIA-I).
FT   VARIANT       5      5       E -> K (IN TEXAS-1).
FT   VARIANT       5      5       E -> G (IN MEINOHAMA).
FT   VARIANT       6      6       E -> G (IN IZUMI/KOTOKUBI).
FT   VARIANT       6      6       E -> Q (IN PORDENONE).
FT   VARIANT       7      7       D -> N (IN AUCKLAND).
FT   VARIANT      12     12       T -> R (IN CALLUNA/HEATHER).
FT   VARIANT      15     15       W -> R (IN CATALONIA).
FT   VARIANT      16     16       G -> R (IN MELBOURNE).
FT   VARIANT      21     21       E -> K (IN SASKATOON).
FT   VARIANT      21     21       E -> Q (IN FUCHU).
FT   VARIANT      22     22       D -> G (IN KUALA LUMPUR/URUMQI).
FT   VARIANT      22     22       D -> V (IN GRANADA).
FT   VARIANT      25     25       G -> E (IN COSENZA).
FT   VARIANT      25     25       G -> R (IN XINJIANG; UNSTABLE).
FT   VARIANT      26     26       E -> K (IN OAKLAND).
FT   VARIANT      34     34       V -> I (IN TOKYO).
FT   VARIANT      36     36       P -> R (IN PENDERGRASS).
FT   VARIANT      37     37       W -> G (IN COBB).
FT   VARIANT      39     39       Q -> R (IN BONAIRE).
FT   VARIANT      40     40       R -> G (IN VELETA).
FT   VARIANT      40     40       R -> K (IN WOODSTOCK/AUSTELL).
FT   VARIANT      41     41       F -> S (IN CINCINNATI).
FT   VARIANT      43     43       D -> N (IN FUKUYAMA).
FT   VARIANT      44     44       S -> R (IN LODZ).
FT   VARIANT      53     53       A -> D (IN BEECH ISLAND).
FT   VARIANT      55     55       M -> R (IN KINGSTON).
FT   VARIANT      59     59       K -> E (IN EMIRATES).
FT   VARIANT      59     59       K -> Q (IN SACROMONTE).
FT   VARIANT      61     61       K -> E (IN JAMAICA).
FT   VARIANT      63     63       H -> Y (IN OSAKA; CYANOSIS).
FT   VARIANT      65     65       K -> N (IN CLARKE).
FT   VARIANT      66     66       K -> R (IN SHANGAI).
FT   VARIANT      66     66       K -> Q (IN BROOKLYN).
FT   VARIANT      72     72       G -> R (IN IWATA/MINOO).
FT   VARIANT      73     73       D -> N (IN FOREST PARK).
FT   VARIANT      73     73       D -> H (IN XIN-SU).
FT   VARIANT      75     75       I -> T (IN SARDINIA/CHARLOTTE/LESVOS).
FT   VARIANT      77     77       H -> R (IN KENNESTONE).
FT   VARIANT      79     79       D -> N (IN DAMMAM).
FT   VARIANT      80     80       D -> Y (IN VICTORIA JUBILEE).
FT   VARIANT      80     80       D -> N (IN YAMAGUCHI/MARIETTA).
FT   VARIANT      92     92       H -> Y (IN FORT RIPLEY; CYANOSIS).
FT   VARIANT      94     94       D -> N (IN COLUMBUS-GA).
FT   VARIANT      97     97       H -> R (IN DICKINSON).
FT   VARIANT     101    101       E -> K (IN LA GRANGE).
FT   VARIANT     104    104       K -> N (IN MACEDONIA-II).
FT   VARIANT     117    117       H -> R (IN MALTA-1).
FT   VARIANT     120    120       K -> Q (IN CALTECH).
FT   VARIANT     121    121       E -> K (IN SIENNA/CARLTON/HULL).
FT   VARIANT     125    125       E -> A (IN PORT-ROYAL).
FT   VARIANT     128    128       A -> T (IN BASKENT).
FT   VARIANT     130    130       W -> G (IN POOLE; UNSTABLE).
FT   VARIANT     134    134       V -> M (IN JIANGSU).
FT   VARIANT     136    136       A -> G (IN GAMMA-G).
FT   VARIANT     146    146       H -> Y (IN ONODA; O2 AFFINITY UP).
FT   HELIX         5     17
FT   HELIX        20     34
FT   TURN         36     37
FT   HELIX        39     41
FT   TURN         43     44
FT   HELIX        51     55
FT   HELIX        58     75
FT   TURN         76     79
FT   HELIX        81     94
FT   TURN         95     96
FT   TURN        100    100
FT   HELIX       101    121
FT   HELIX       124    142
FT   TURN        143    144
SQ   SEQUENCE   146 AA;  16009 MW;  9956D97D CRC32;
     GHFTEEDKAT ITSLWGKVNV EDAGGETLGR LLVVYPWTQR FFDSFGNLSS ASAIMGNPKV
     KAHGKKVLTS LGDAIKHLDD LKGTFAQLSE LHCDKLHVDP ENFKLLGNVL VTVLAIHFGK
     EFTPEVQASW QKMVTAVASA LSSRYH
//
ID   HV3K_HUMAN     STANDARD;      PRT;   126 AA.
AC   P01772;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   01-MAR-1992 (REL. 21, LAST ANNOTATION UPDATE)
DE   IG HEAVY CHAIN V-III REGION (KOL).
OS   HOMO SAPIENS (HUMAN).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE, AND DISULFIDE BONDS.
RX   MEDLINE; 83289131.
RA   SCHMIDT W.E., JUNG H.-D., PALM W., HILSCHMANN N.;
RT   "Three-dimensional structure determination of antibodies. Primary
RT   structure of crystallized monoclonal immunoglobulin IgG1 KOL, I.";
RL   HOPPE-SEYLER'S Z. PHYSIOL. CHEM. 364:713-747(1983).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   MEDLINE; 81072295.
RA   MARQUART M., DEISENHOFER J., HUBER R., PALM W.;
RT   "Crystallographic refinement and atomic models of the intact
RT   immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A
RT   and 1.0-A resolution.";
RL   J. MOL. BIOL. 141:369-391(1980).
DR   PIR; A02055; G1HUKL.
DR   PDB; 2FB4; 12-JUL-89.
DR   PDB; 2IG2; 12-JUL-89.
DR   PFAM; PF00047; ig; 1.
KW   IMMUNOGLOBULIN V REGION; 3D-STRUCTURE.
FT   MOD_RES       1      1       PYRROLIDONE CARBOXYLIC ACID.
FT   DISULFID     22     96
FT   DISULFID    105    110
FT   NON_TER     126    126
FT   STRAND        3      7
FT   STRAND       11     12
FT   TURN         14     15
FT   STRAND       18     25
FT   HELIX        29     31
FT   STRAND       34     39
FT   TURN         41     42
FT   STRAND       46     51
FT   TURN         53     54
FT   STRAND       58     60
FT   TURN         62     67
FT   STRAND       68     73
FT   TURN         74     77
FT   STRAND       78     83
FT   HELIX        88     90
FT   STRAND       92     99
FT   STRAND      106    106
FT   TURN        107    108
FT   STRAND      109    109
FT   STRAND      113    113
FT   STRAND      120    124
SQ   SEQUENCE   126 AA;  13718 MW;  14F328CF CRC32;
     QVQLVESGGG VVQPGRSLRL SCSSSGFIFS SYAMYWVRQA PGKGLEWVAI IWDDGSDQHY
     ADSVKGRFTI SRDNSKNTLF LQMDSLRPED TGVYFCARDG GHGFCSSASC FGPDYWGQGT
     PVTVSS
//
ID   LYC_CHICK      STANDARD;      PRT;   147 AA.
AC   P00698; Q90884;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   LYSOZYME C PRECURSOR (EC 3.2.1.17) (1,4-BETA-N-ACETYLMURAMIDASE C)
DE   (ALLERGEN GAL D 4) (GAL D IV).
OS   GALLUS GALLUS (CHICKEN).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; ARCHOSAURIA; AVES;
OC   NEOGNATHAE; GALLIFORMES; PHASIANIDAE; PHASIANINAE; GALLUS.
RN   [1]
RP   SEQUENCE FROM N.A., REVISION TO 121.
RX   MEDLINE; 81077254.
RA   JUNG A., SIPPEL A.E., GREZ M., SCHUTZ G.;
RT   "Exons encode functional and structural units of chicken lysozyme.";
RL   PROC. NATL. ACAD. SCI. U.S.A. 77:5759-5763(1980).
RN   [2]
RP   SEQUENCE OF 1-20.
RX   MEDLINE; 77249586.
RA   PALMITER R.D., GAGNON J., ERICSSON L.H., WALSH K.A.;
RT   "Precursor of egg white lysozyme. Amino acid sequence of an
RT   NH2-terminal extension.";
RL   J. BIOL. CHEM. 252:6386-6393(1977).
RN   [3]
RP   SEQUENCE OF 19-147.
RA   CANFIELD R.E.;
RT   "The amino acid sequence of egg white lysozyme.";
RL   J. BIOL. CHEM. 238:2698-2707(1963).
RN   [4]
RP   SEQUENCE OF 123-146 FROM N.A.
RX   MEDLINE; 80006645.
RA   BUELL G.N., WICKENS M.P., CARBON J., SCHIMKE R.T.;
RT   "Isolation of recombinant plasmids bearing cDNA to hen ovomucoid and
RT   lysozyme mRNAs.";
RL   J. BIOL. CHEM. 254:9277-9283(1979).
RN   [5]
RP   DISULFIDE BONDS.
RA   CANFIELD R.E., LIU A.K.;
RT   "The disulfide bonds of egg white lysozyme (muramidase).";
RL   J. BIOL. CHEM. 240:1997-2002(1965).
RN   [6]
RP   DISULFIDE BONDS.
RX   MEDLINE; 66076966.
RA   JAUREGUI-ADELL J., JOLLES J., JOLLES P.;
RT   "The disulfide bridges of hen's egg-white lysozyme.";
RL   BIOCHIM. BIOPHYS. ACTA 107:97-111(1965).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), REVIEW, ATOMIC COORDINATES.
RA   IMOTO T., JOHNSON L.N., NORTH A.C.T., PHILLIPS D.C., RUPLEY J.A.;
RT   "Vertebrate lysozymes.";
RL   (IN) BOYER P.D. (EDS.);
RL   THE ENZYMES (3RD ED.), PP.7:665-868, ACADEMIC PRESS, NEW YORK (1972).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 66035996.
RA   BLAKE C.C.F., KOENIG D.F., MAIR G.A., NORTH A.C.T., PHILLIPS D.C.,
RA   SARMA V.R.;
RT   "Structure of hen egg-white lysozyme. A three-dimensional Fourier
RT   synthesis at 2-A resolution.";
RL   NATURE 206:757-761(1965).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF TRICLINIC LYSOZYME.
RX   MEDLINE; 76146521.
RA   MOULT J., YONATH A., TRAUB W., SMILANSKY A., PODJARNY A.,
RA   RABINOVICH D., SAYA A.;
RT   "The structure of triclinic lysozyme at 2.5-A resolution.";
RL   J. MOL. BIOL. 100:179-195(1976).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF TRICLINIC LYSOZYME.
RX   MEDLINE; 76146540.
RA   KURACHI K., SIEKER L.C., JENSEN L.H.;
RT   "Structures of triclinic mono- and di-N-acetylglucosamine: lysozyme
RT   complexes -- a crystallographic study.";
RL   J. MOL. BIOL. 101:11-24(1976).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF COMPLEX WITH ANTIBODY.
RX   MEDLINE; 91302305.
RA   FISCHMANN T.O., BENTLEY G.A., BHAT T.N., BOULOT G., MARIUZZA R.A.,
RA   PHILLIPS S.E., TELLO D., POLJAK R.J.;
RT   "Crystallographic refinement of the three-dimensional structure of
RT   the FabD1.3-lysozyme complex at 2.5-A resolution.";
RL   J. BIOL. CHEM. 266:12915-12920(1991).
RN   [12]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 88163558.
RA   REDFIELD C., DOBSON C.M.;
RT   "Sequential 1H NMR assignments and secondary structure of hen egg
RT   white lysozyme in solution.";
RL   BIOCHEMISTRY 27:122-136(1988).
RN   [13]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 97365184.
RA   SCHWALBE H., FIEBIG K.M., BUCK M., JONES J.A., GRIMSHAW S.B.,
RA   SPENCER A., GLASER S.J., SMITH L.J., DOBSON C.M.;
RT   "Structural and dynamical properties of a denatured protein.
RT   Heteronuclear 3D NMR experiments and theoretical simulations of
RT   lysozyme in 8 M urea.";
RL   BIOCHEMISTRY 36:8977-8991(1997).
RN   [14]
RP   MUTAGENESIS.
RX   MEDLINE; 88139224.
RA   KUMAGAI I., KOJIMA S., TAMAKI E., MIURA K.;
RT   "Conversion of Trp 62 of hen egg-white lysozyme to Tyr by
RT   site-directed mutagenesis.";
RL   J. BIOCHEM. 102:733-740(1987).
CC   -!- FUNCTION: LYSOZYMES HAVE PRIMARILY BACTERIOLYTIC FUNCTION; THOSE
CC       IN TISSUES AND BODY FLUIDS ARE ASSOCIATED WITH THE MONOCYTE-
CC       MACROPHAGE SYSTEM AND ENHANCE THE ACTIVITY OF IMMUNOAGENTS.
CC   -!- CATALYTIC ACTIVITY: HYDROLYSIS OF THE 1,4-BETA-LINKAGES BETWEEN
CC       N-ACETYL-D-GLUCOSAMINE AND N-ACETYLMURAMIC ACID IN PEPTIDOGLYCAN
CC       HETEROPOLYMERS OF THE PROKARYOTES CELL WALLS.
CC   -!- SUBUNIT: MONOMER.
CC   -!- TISSUE SPECIFICITY: IN THE EGG WHITE AND POLYMORPHONUCLEAR
CC       LEUKOCYTES.
CC   -!- LYSOZYME C IS CAPABLE OF BOTH HYDROLYSIS AND TRANSGLYCOSYLATION;
CC       IT SHOWS ALSO A SLIGHT ESTERASE ACTIVITY. IT ACTS RAPIDLY ON BOTH
CC       PEPTIDE-SUBSTITUTED AND UNSUBSTITUTED PEPTIDOGLYCAN &, SLOWLY, ON
CC       CHITIN OLIGOSACCHARIDES.
CC   -!- SIMILARITY: BELONGS TO FAMILY 22 OF GLYCOSYL HYDROLASES.
CC   -!- CAUTION: THE GENE-DERIVED SEQUENCE AGREES WITH THAT SHOWN, BUT THE
CC       MRNA-DERIVED SEQUENCE DIFFERS IN HAVING 49-VAL AND 124-SER.
CC       THESE DIFFERENCES MAY HAVE ARISEN DURING CONSTRUCTION OF THE
CC       CDNA PLASMID.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M10640; G212279; -.
DR   EMBL; J00885; G212276; -.
DR   EMBL; V00428; G63581; -.
DR   PIR; A00853; LZCH.
DR   PIR; A41423; A41423.
DR   PDB; 2LYM; 16-JUL-88.
DR   PDB; 3LYM; 16-OCT-87.
DR   PDB; 4LYM; 15-OCT-91.
DR   PDB; 5LYM; 15-OCT-95.
DR   PDB; 1LYS; 30-APR-94.
DR   PDB; 3LYT; 31-OCT-93.
DR   PDB; 4LYT; 31-OCT-93.
DR   PDB; 5LYT; 31-OCT-93.
DR   PDB; 6LYT; 31-OCT-93.
DR   PDB; 1LYZ; 16-OCT-87.
DR   PDB; 2LYZ; 16-OCT-87.
DR   PDB; 3LYZ; 16-OCT-87.
DR   PDB; 4LYZ; 16-OCT-87.
DR   PDB; 5LYZ; 16-OCT-87.
DR   PDB; 6LYZ; 16-OCT-87.
DR   PDB; 7LYZ; 25-APR-86.
DR   PDB; 8LYZ; 14-JUL-86.
DR   PDB; 1LZH; 16-JUL-88.
DR   PDB; 2LZH; 16-JUL-88.
DR   PDB; 1LZT; 15-JAN-90.
DR   PDB; 2LZT; 15-JAN-90.
DR   PDB; 3LZT; 25-MAR-98.
DR   PDB; 4LZT; 01-APR-98.
DR   PDB; 3HFL; 31-JUL-95.
DR   PDB; 3HFM; 15-JAN-90.
DR   PDB; 1HEL; 31-OCT-93.
DR   PDB; 1HEM; 31-OCT-93.
DR   PDB; 1HEN; 31-OCT-93.
DR   PDB; 1HEO; 31-OCT-93.
DR   PDB; 1HEP; 31-OCT-93.
DR   PDB; 1HEQ; 31-OCT-93.
DR   PDB; 1HER; 31-OCT-93.
DR   PDB; 1HEW; 31-OCT-93.
DR   PDB; 1HWA; 31-OCT-93.
DR   PDB; 1LMA; 31-JAN-94.
DR   PDB; 1RCM; 31-OCT-93.
DR   PDB; 1LSA; 30-SEP-94.
DR   PDB; 1LSB; 30-SEP-94.
DR   PDB; 1LSC; 30-SEP-94.
DR   PDB; 1LSD; 30-SEP-94.
DR   PDB; 1LSE; 30-SEP-94.
DR   PDB; 1LSF; 30-SEP-94.
DR   PDB; 1LSM; 30-NOV-94.
DR   PDB; 1LSN; 30-NOV-94.
DR   PDB; 1LZA; 08-MAY-95.
DR   PDB; 1LZB; 08-MAY-95.
DR   PDB; 1LZC; 08-MAY-95.
DR   PDB; 1LZD; 08-MAY-95.
DR   PDB; 1LZE; 08-MAY-95.
DR   PDB; 1LZG; 08-MAY-95.
DR   PDB; 1FDL; 15-OCT-91.
DR   PDB; 1JPO; 12-NOV-97.
DR   PDB; 1KIP; 23-DEC-96.
DR   PDB; 1KIQ; 23-DEC-96.
DR   PDB; 1KIR; 23-DEC-96.
DR   PDB; 1LSG; 15-SEP-95.
DR   PDB; 1MEL; 16-JUN-97.
DR   PDB; 1RFP; 15-MAY-97.
DR   PDB; 1UCO; 11-JUL-96.
DR   PDB; 1AKI; 19-NOV-97.
DR   PDB; 1KXW; 26-NOV-97.
DR   PDB; 1KXX; 26-NOV-97.
DR   PDB; 1KXY; 26-NOV-97.
DR   PDB; 1LSY; 26-JAN-95.
DR   PDB; 1LSZ; 26-JAN-95.
DR   PDB; 1MLC; 03-JUN-95.
DR   PDB; 1UIA; 26-NOV-97.
DR   PDB; 1UIB; 26-NOV-97.
DR   PDB; 1UIC; 26-NOV-97.
DR   PDB; 1UID; 26-NOV-97.
DR   PDB; 1UIE; 26-NOV-97.
DR   PDB; 1UIF; 26-NOV-97.
DR   PDB; 1UIG; 26-NOV-97.
DR   PDB; 1UIH; 26-NOV-97.
DR   PDB; 1VFB; 31-MAY-94.
DR   PDB; 2IFF; 15-MAY-95.
DR   PDB; 1AT5; 25-FEB-98.
DR   PDB; 1AT6; 25-FEB-98.
DR   PDB; 1AZF; 25-FEB-98.
DR   PDB; 1XEI; 29-APR-98.
DR   PDB; 1XEJ; 29-APR-98.
DR   PDB; 1XEK; 29-APR-98.
DR   PDB; 1A2Y; 29-APR-98.
DR   PDB; 1LKR; 29-APR-98.
DR   PDB; 1LKS; 29-APR-98.
DR   PDB; 1LYO; 27-MAY-98.
DR   PDB; 2LYO; 27-MAY-98.
DR   PDB; 3LYO; 27-MAY-98.
DR   PDB; 4LYO; 27-MAY-98.
DR   PDB; 1LPI; 17-JUN-98.
DR   PDB; 1HSW; 12-AUG-98.
DR   PDB; 1HSX; 12-AUG-98.
DR   PDB; 1LCN; 04-NOV-98.
DR   PDB; 1BWH; 04-NOV-98.
DR   PDB; 1BWI; 04-NOV-98.
DR   PDB; 1BWJ; 04-NOV-98.
DR   PDB; 1BVX; 04-NOV-98.
DR   PDB; 1B0D; 11-NOV-98.
DR   PDB; 1BGI; 18-NOV-98.
DR   PDB; 1BHZ; 18-NOV-98.
DR   PDB; 1B2K; 02-DEC-98.
DR   PROSITE; PS00128; LACTALBUMIN_LYSOZYME; 1.
DR   PFAM; PF00062; lys; 1.
DR   HSSP; P00695; 1OUF.
KW   HYDROLASE; GLYCOSIDASE; BACTERIOLYTIC ENZYME; EGG WHITE; SIGNAL;
KW   3D-STRUCTURE; ALLERGEN.
FT   SIGNAL        1     18
FT   CHAIN        19    147       LYSOZYME C.
FT   DISULFID     24    145
FT   DISULFID     48    133
FT   DISULFID     82     98
FT   DISULFID     94    112
FT   ACT_SITE     53     53
FT   ACT_SITE     70     70
FT   BINDING     119    119       SUBSTRATE.
FT   CONFLICT     49     49       A -> V (IN G63581).
FT   CONFLICT    121    121       N -> D (IN REF. 3).
FT   CONFLICT    124    124       N -> S (IN G63581).
FT   CONFLICT    132    132       R -> S (IN REF. 4).
FT   STRAND       20     20
FT   HELIX        23     32
FT   TURN         33     34
FT   TURN         36     37
FT   STRAND       38     38
FT   TURN         39     40
FT   STRAND       41     41
FT   HELIX        43     54
FT   TURN         55     56
FT   STRAND       57     57
FT   TURN         58     59
FT   STRAND       61     63
FT   TURN         65     66
FT   STRAND       69     71
FT   TURN         72     75
FT   STRAND       76     77
FT   TURN         78     81
FT   STRAND       83     83
FT   TURN         88     89
FT   TURN         93     94
FT   STRAND       97     97
FT   HELIX        98    102
FT   HELIX       107    117
FT   TURN        118    121
FT   HELIX       122    125
FT   HELIX       127    132
FT   TURN        133    135
FT   HELIX       138    142
FT   TURN        143    144
SQ   SEQUENCE   147 AA;  16238 MW;  5B1A9D9E CRC32;
     MRSLLILVLC FLPLAALGKV FGRCELAAAM KRHGLDNYRG YSLGNWVCAA KFESNFNTQA
     TNRNTDGSTD YGILQINSRW WCNDGRTPGS RNLCNIPCSA LLSSDITASV NCAKKIVSDG
     NGMNAWVAWR NRCKGTDVQA WIRGCRL
//
ID   LYC_HUMAN      STANDARD;      PRT;   148 AA.
AC   P00695; Q13170;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-OCT-1989 (REL. 12, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   LYSOZYME C PRECURSOR (EC 3.2.1.17) (1,4-BETA-N-ACETYLMURAMIDASE C).
GN   LYZ OR LZM.
OS   HOMO SAPIENS (HUMAN), PAN TROGLODYTES (CHIMPANZEE), AND
OS   PAN PANISCUS (PYGMY CHIMPANZEE) (BONOBO).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   SPECIES=HUMAN;
RX   MEDLINE; 89325294.
RA   PETERS C.W.B., KRUSE U., POLLWEIN R., GRZESCHIK K.H., SIPPEL A.E.;
RT   "The human lysozyme gene. Sequence organization and chromosomal
RT   localization.";
RL   EUR. J. BIOCHEM. 182:507-516(1989).
RN   [2]
RP   SEQUENCE FROM N.A.
RC   SPECIES=HUMAN;
RX   MEDLINE; 89006264.
RA   CASTANON M.J., SPEVAK W., ADOLF G.R., CHLEBOWICZ-SLEDZIEWSKA E.,
RA   SLEDZIEWSKI A.;
RT   "Cloning of human lysozyme gene and expression in the yeast
RT   Saccharomyces cerevisiae.";
RL   GENE 66:223-234(1988).
RN   [3]
RP   SEQUENCE FROM N.A.
RC   SPECIES=HUMAN;
RX   MEDLINE; 88320415.
RA   CHUNG L.P., KESHAV S., GORDON S.;
RT   "Cloning the human lysozyme cDNA: inverted Alu repeat in the mRNA and
RT   in situ hybridization for macrophages and Paneth cells.";
RL   PROC. NATL. ACAD. SCI. U.S.A. 85:6227-6231(1988).
RN   [4]
RP   SEQUENCE FROM N.A.
RC   SPECIES=HUMAN;
RX   MEDLINE; 88134189.
RA   YOSHIMURA K., TOIBANA A., NAKAHAMA K.;
RT   "Human lysozyme: sequencing of a cDNA, and expression and secretion
RT   by Saccharomyces cerevisiae.";
RL   BIOCHEM. BIOPHYS. RES. COMMUN. 150:794-801(1988).
RN   [5]
RP   SEQUENCE FROM N.A.
RC   SPECIES=HUMAN;
RA   HUANG B., ZHAO C., LEI X., CAI L.;
RT   "The cloning, sequencing and analysis of Chinese human lysozyme gene
RT   cDNA amplified with RT-PCR from human placental total RNA.";
RL   CHIN. BIOCHEM. J. 9:269-273(1993).
RN   [6]
RP   SEQUENCE OF 19-148.
RC   SPECIES=HUMAN; TISSUE=URINE;
RX   MEDLINE; 71276655.
RA   CANFIELD R.E., KAMMERMAN S., SOBEL H.H., MORGAN F.J.;
RT   "Primary structure of lysozymes from man and goose.";
RL   NATURE NEW BIOL. 232:16-17(1971).
RN   [7]
RP   REVISION TO 118.
RC   SPECIES=HUMAN; TISSUE=URINE;
RA   THOMSEN J., LUND E.H., KRISTIANSEN K., BRUNFELDT K., MALMQUIST J.;
RT   "A Val-Val sequence found in a human monocytic leukemia lysozyme.";
RL   FEBS LETT. 22:34-36(1972).
RN   [8]
RP   SEQUENCE OF 19-148.
RC   SPECIES=HUMAN; TISSUE=MILK;
RX   MEDLINE; 72131416.
RA   JOLLES J., JOLLES P.;
RT   "Human milk lysozyme: unpublished data concerning the establishment
RT   of the complete primary structure; comparison with lysozymes of
RT   various origins.";
RL   HELV. CHIM. ACTA 54:2668-2675(1971).
RN   [9]
RP   REVISION TO 118.
RC   SPECIES=HUMAN; TISSUE=MILK;
RA   JOLLES J., JOLLES P.;
RT   "Comparison between human and bird lysozymes: note concerning the
RT   previously observed deletion.";
RL   FEBS LETT. 22:31-33(1972).
RN   [10]
RP   SEQUENCE FROM N.A.
RC   SPECIES=P.TROGLODYTES, AND P.PANISCUS; TISSUE=BLOOD;
RX   MEDLINE; 97144349.
RA   MESSIER W., STEWART C.B.;
RT   "Episodic adaptive evolution of primate lysozymes.";
RL   NATURE 385:151-154(1997).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RA   BANYARD S.H., BLAKE C.C.F., SWAN I.D.A.;
RL   (IN) OSSERMAN E.F., CANFIELD R.E., BEYCHOK S. (EDS.);
RL   LYSOZYME, PP.71-79, ACADEMIC PRESS, NEW YORK (1974).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS).
RX   MEDLINE; 82145543.
RA   ARTYMIUK P.J., BLAKE C.C.F.;
RT   "Refinement of human lysozyme at 1.5-A resolution analysis of non-
RT   bonded and hydrogen-bond interactions.";
RL   J. MOL. BIOL. 152:737-762(1981).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS).
RX   MEDLINE; 83268684.
RA   BLAKE C.C.F., PULFORD W.C.A., ARTYMIUK P.J.;
RT   "X-ray studies of water in crystals of lysozyme.";
RL   J. MOL. BIOL. 167:693-723(1983).
RN   [14]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 91002558.
RA   REDFIELD C., DOBSON C.M.;
RT   "1H NMR studies of human lysozyme: spectral assignment and comparison
RT   with hen lysozyme.";
RL   BIOCHEMISTRY 29:7201-7214(1990).
RN   [15]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 92176149.
RA   OHKUBO T., TANIYAMA Y., KIKUCHI M.;
RT   "1H and 15N NMR study of human lysozyme.";
RL   J. BIOCHEM. 110:1022-1029(1991).
RN   [16]
RP   VARIANTS THR-74 AND HIS-85.
RC   SPECIES=HUMAN;
RX   MEDLINE; 93218745.
RA   PEPY M.B., HAWKINS P.N., BOOTH D.R., VIGUSHIN D.M., TENNENT G.A.,
RA   SOUTAR A.K., TOTTY N., NGUYEN O., BLAKE C.C.F., TERRY C.J.,
RA   FEEST T.G., ZALIN A.M., HSUAN J.J.;
RT   "Human lysozyme gene mutations cause hereditary systemic
RT   amyloidosis.";
RL   NATURE 362:553-557(1993).
CC   -!- FUNCTION: LYSOZYMES HAVE PRIMARILY BACTERIOLYTIC FUNCTION; THOSE
CC       IN TISSUES AND BODY FLUIDS ARE ASSOCIATED WITH THE MONOCYTE-
CC       MACROPHAGE SYSTEM AND ENHANCE THE ACTIVITY OF IMMUNOAGENTS.
CC   -!- CATALYTIC ACTIVITY: HYDROLYSIS OF THE 1,4-BETA-LINKAGES BETWEEN
CC       N-ACETYL-D-GLUCOSAMINE AND N-ACETYLMURAMIC ACID IN PEPTIDOGLYCAN
CC       HETEROPOLYMERS OF THE PROKARYOTES CELL WALLS.
CC   -!- SUBUNIT: MONOMER.
CC   -!- DISEASE: DEFECTS IN LYSOZYME CAN BE THE CAUSE OF HEREDITARY
CC       NON-NEUROPATHIC SYSTEMIC AMYLOIDOSIS (OSTERTAG-TYPE) (AMYLOIDOSIS
CC       VIII).
CC   -!- LYSOZYME C IS CAPABLE OF BOTH HYDROLYSIS AND TRANSGLYCOSYLATION;
CC       IT SHOWS ALSO A SLIGHT ESTERASE ACTIVITY. IT ACTS RAPIDLY ON BOTH
CC       PEPTIDE-SUBSTITUTED AND UNSUBSTITUTED PEPTIDOGLYCAN &, SLOWLY, ON
CC       CHITIN OLIGOSACCHARIDES.
CC   -!- THE LYSOZYMES ISOLATED FROM HUMAN MILK AND FROM THE URINE OF
CC       PATIENTS WITH CHRONIC LEUKEMIA ARE IDENTICAL.
CC   -!- SIMILARITY: BELONGS TO FAMILY 22 OF GLYCOSYL HYDROLASES.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; J03801; G307140; -.
DR   EMBL; X14008; E74526; ALT_INIT.
DR   EMBL; M21119; G307141; -.
DR   EMBL; M19045; G307142; -.
DR   EMBL; A10156; E85124; -.
DR   EMBL; U25677; G847820; -.
DR   EMBL; U76912; G1790941; -.
DR   EMBL; U76933; G1790961; -.
DR   EMBL; U76930; G1790961; JOINED.
DR   EMBL; U76931; G1790961; JOINED.
DR   EMBL; U76932; G1790961; JOINED.
DR   PIR; A00849; LZHU.
DR   PIR; S04938; S04938.
DR   PIR; A31240; A31240.
DR   PIR; JS0063; JS0063.
DR   PIR; S32375; S32375.
DR   PDB; 1LAA; 15-JAN-93.
DR   PDB; 1LHM; 15-APR-92.
DR   PDB; 2LHM; 15-APR-92.
DR   PDB; 3LHM; 15-OCT-94.
DR   PDB; 1LZ1; 02-JAN-85.
DR   PDB; 1TAY; 15-JAN-93.
DR   PDB; 1TBY; 15-JAN-93.
DR   PDB; 1TCY; 15-JAN-93.
DR   PDB; 1TDY; 15-JAN-93.
DR   PDB; 1LHH; 31-JAN-94.
DR   PDB; 1LHI; 31-JAN-94.
DR   PDB; 1LHJ; 31-JAN-94.
DR   PDB; 1LHK; 31-JAN-94.
DR   PDB; 1LHL; 31-JAN-94.
DR   PDB; 1LMT; 31-MAR-95.
DR   PDB; 1LOZ; 01-APR-97.
DR   PDB; 1LYY; 01-APR-97.
DR   PDB; 1LZ4; 31-OCT-93.
DR   PDB; 1LZ5; 31-OCT-93.
DR   PDB; 1LZ6; 31-OCT-93.
DR   PDB; 1LZR; 20-APR-95.
DR   PDB; 1LZS; 20-APR-95.
DR   PDB; 1HNL; 14-FEB-95.
DR   PDB; 1JKA; 15-MAY-97.
DR   PDB; 1JKB; 15-MAY-97.
DR   PDB; 1JKC; 15-MAY-97.
DR   PDB; 1JKD; 15-MAY-97.
DR   PDB; 1REX; 12-FEB-97.
DR   PDB; 1REY; 12-FEB-97.
DR   PDB; 1REZ; 12-FEB-97.
DR   PDB; 1YAM; 03-APR-96.
DR   PDB; 1YAN; 03-APR-96.
DR   PDB; 1YAO; 03-APR-96.
DR   PDB; 1YAP; 03-APR-96.
DR   PDB; 1YAQ; 03-APR-96.
DR   PDB; 133L; 31-OCT-93.
DR   PDB; 207L; 14-OCT-96.
DR   PDB; 208L; 14-OCT-96.
DR   PDB; 1OUA; 12-FEB-97.
DR   PDB; 1OUB; 12-FEB-97.
DR   PDB; 1OUC; 12-FEB-97.
DR   PDB; 1OUD; 12-FEB-97.
DR   PDB; 1OUE; 12-FEB-97.
DR   PDB; 1OUF; 12-FEB-97.
DR   PDB; 1OUG; 12-FEB-97.
DR   PDB; 1OUH; 12-FEB-97.
DR   PDB; 1OUI; 12-FEB-97.
DR   PDB; 1OUJ; 12-FEB-97.
DR   PDB; 2HEA; 14-JAN-98.
DR   PDB; 2HEB; 28-JAN-98.
DR   PDB; 2HEC; 14-JAN-98.
DR   PDB; 2HED; 14-JAN-98.
DR   PDB; 2HEE; 14-JAN-98.
DR   PDB; 2HEF; 14-JAN-98.
DR   PDB; 1JSF; 29-APR-98.
DR   PDB; 1WQM; 01-JUL-98.
DR   PDB; 1WQN; 01-JUL-98.
DR   PDB; 1WQO; 01-JUL-98.
DR   PDB; 1WQP; 01-JUL-98.
DR   PDB; 1WQQ; 01-JUL-98.
DR   PDB; 1WQR; 01-JUL-98.
DR   PDB; 1REM; 15-JUL-98.
DR   PDB; 2MEA; 15-JUL-98.
DR   PDB; 2MEB; 15-JUL-98.
DR   PDB; 2MEC; 15-JUL-98.
DR   PDB; 2MED; 15-JUL-98.
DR   PDB; 2MEE; 15-JUL-98.
DR   PDB; 2MEF; 15-JUL-98.
DR   PDB; 2MEG; 15-JUL-98.
DR   PDB; 2MEH; 15-JUL-98.
DR   PDB; 2MEI; 15-JUL-98.
DR   PDB; 1BB3; 12-AUG-98.
DR   PDB; 1BB4; 12-AUG-98.
DR   PDB; 1BB5; 12-AUG-98.
DR   PDB; 2BQA; 12-AUG-98.
DR   PDB; 2BQB; 12-AUG-98.
DR   PDB; 2BQC; 12-AUG-98.
DR   PDB; 2BQD; 12-AUG-98.
DR   PDB; 2BQE; 12-AUG-98.
DR   PDB; 2BQF; 12-AUG-98.
DR   PDB; 2BQG; 12-AUG-98.
DR   PDB; 2BQH; 12-AUG-98.
DR   PDB; 2BQI; 12-AUG-98.
DR   PDB; 2BQJ; 12-AUG-98.
DR   PDB; 2BQK; 12-AUG-98.
DR   PDB; 2BQL; 12-AUG-98.
DR   PDB; 2BQM; 12-AUG-98.
DR   PDB; 2BQN; 12-AUG-98.
DR   PDB; 2BQO; 12-AUG-98.
DR   MIM; 153450; -.
DR   MIM; 105200; -.
DR   PROSITE; PS00128; LACTALBUMIN_LYSOZYME; 1.
DR   PFAM; PF00062; lys; 1.
KW   HYDROLASE; GLYCOSIDASE; BACTERIOLYTIC ENZYME; SIGNAL; AMYLOID;
KW   3D-STRUCTURE; DISEASE MUTATION.
FT   SIGNAL        1     18
FT   CHAIN        19    148       LYSOZYME C.
FT   DISULFID     24    146
FT   DISULFID     48    134
FT   DISULFID     83     99
FT   DISULFID     95    113
FT   ACT_SITE     53     53
FT   ACT_SITE     71     71
FT   VARIANT      74     74       I -> T (IN AMYLOIDOSIS VIII).
FT   VARIANT      85     85       D -> H (IN AMYLOIDOSIS VIII).
FT   CONFLICT     10     10       V -> A (IN REF. 5).
FT   CONFLICT     41     41       I -> M (IN REF. 2).
FT   CONFLICT    111    111       V -> A (IN REF. 5).
FT   CONFLICT    124    124       I -> V (IN REF. 5).
FT   CONFLICT    128    128       V -> A (IN REF. 5).
FT   CONFLICT    136    136       N -> D (IN REF. 5).
FT   STRAND       20     20
FT   HELIX        23     32
FT   TURN         33     34
FT   TURN         36     37
FT   STRAND       38     38
FT   TURN         39     40
FT   STRAND       41     41
FT   HELIX        43     54
FT   TURN         55     56
FT   STRAND       57     57
FT   TURN         58     59
FT   STRAND       61     64
FT   TURN         65     68
FT   STRAND       69     72
FT   TURN         73     76
FT   STRAND       77     78
FT   TURN         79     82
FT   STRAND       84     84
FT   TURN         89     90
FT   TURN         94     95
FT   STRAND       98     98
FT   HELIX        99    103
FT   HELIX       108    118
FT   TURN        119    119
FT   TURN        121    122
FT   HELIX       123    126
FT   HELIX       128    133
FT   TURN        134    136
FT   HELIX       140    142
FT   TURN        143    145
SQ   SEQUENCE   148 AA;  16537 MW;  9D619438 CRC32;
     MKALIVLGLV LLSVTVQGKV FERCELARTL KRLGMDGYRG ISLANWMCLA KWESGYNTRA
     TNYNAGDRST DYGIFQINSR YWCNDGKTPG AVNACHLSCS ALLQDNIADA VACAKRVVRD
     PQGIRAWVAW RNRCQNRDVR QYVQGCGV
//
ID   MYG_PHYCA      STANDARD;      PRT;   153 AA.
AC   P02185;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   21-JUL-1986 (REL. 01, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   MYOGLOBIN.
OS   PHYSETER CATODON (SPERM WHALE) (PHYSETER MACROCEPHALUS).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA; CETACEA;
OC   ODONTOCETI; PHYSETERIDAE; PHYSETER.
RN   [1]
RP   SEQUENCE.
RC   TISSUE=HEART MUSCLE;
RA   EDMUNDSON A.B.;
RT   "Amino-acid sequence of sperm whale myoglobin.";
RL   NATURE 205:883-887(1965).
RN   [2]
RP   REVISION TO 122.
RC   TISSUE=SKELETAL MUSCLE;
RA   ROMERO-HERRERA A.E., LEHMANN H.;
RT   "Residue 122 of sperm whale and horse myoglobin.";
RL   BIOCHIM. BIOPHYS. ACTA 336:318-323(1974).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF METMYOGLOBIN.
RX   MEDLINE; 77144097.
RA   TAKANO T.;
RT   "Structure of myoglobin refined at 2.0-A resolution. I.
RT   Crystallographic refinement of metmyoglobin from sperm whale.";
RL   J. MOL. BIOL. 110:537-568(1977).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF DEOXYMYOGLOBIN.
RX   MEDLINE; 77144098.
RA   TAKANO T.;
RT   "Structure of myoglobin refined at 2.0-A resolution. II. Structure of
RT   deoxymyoglobin from sperm whale.";
RL   J. MOL. BIOL. 110:569-584(1977).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF OXYMYOGLOBIN.
RX   MEDLINE; 81119812.
RA   PHILLIPS S.E.V.;
RT   "Structure and refinement of oxymyoglobin at 1.6-A resolution.";
RL   J. MOL. BIOL. 142:531-554(1980).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 91132649.
RA   LIONETTI C., GUANZIROLI M.G., FRIGERIO F., ASCENZI P., BOLOGNESI M.;
RT   "X-ray crystal structure of the ferric sperm whale myoglobin:
RT   imidazole complex at 2.0-A resolution.";
RL   J. MOL. BIOL. 217:409-412(1991).
CC   -!- FUNCTION: SERVES AS A RESERVE SUPPLY OF OXYGEN AND FACILITATES
CC       THE MOVEMENT OF OXYGEN WITHIN MUSCLES.
DR   PIR; A02506; MYWHP.
DR   PDB; 2MB5; 15-APR-91.
DR   PDB; 1MBC; 09-JAN-89.
DR   PDB; 1MBD; 27-OCT-83.
DR   PDB; 1MBI; 15-OCT-91.
DR   PDB; 1MBN; 27-OCT-83.
DR   PDB; 4MBN; 12-JUL-89.
DR   PDB; 5MBN; 12-JUL-89.
DR   PDB; 1MBO; 30-SEP-83.
DR   PDB; 2MBW; 23-DEC-96.
DR   PDB; 1FCS; 31-OCT-93.
DR   PDB; 1SWM; 31-JAN-94.
DR   PDB; 2CMM; 31-JAN-94.
DR   PDB; 1MGN; 31-JAN-94.
DR   PDB; 2MGA; 31-JAN-94.
DR   PDB; 2MGB; 31-JAN-94.
DR   PDB; 2MGC; 31-JUL-94.
DR   PDB; 2MGD; 31-JUL-94.
DR   PDB; 2MGE; 31-JUL-94.
DR   PDB; 2MGF; 31-JUL-94.
DR   PDB; 2MGG; 31-JUL-94.
DR   PDB; 2MGH; 31-JUL-94.
DR   PDB; 2MGI; 31-JUL-94.
DR   PDB; 2MGJ; 31-JUL-94.
DR   PDB; 2MGK; 31-JUL-94.
DR   PDB; 2MGL; 31-JUL-94.
DR   PDB; 2MGM; 31-JUL-94.
DR   PDB; 2MYA; 31-JAN-94.
DR   PDB; 2MYB; 31-JAN-94.
DR   PDB; 2MYC; 31-JAN-94.
DR   PDB; 2MYD; 31-JAN-94.
DR   PDB; 2MYE; 31-JAN-94.
DR   PDB; 1MYF; 27-FEB-95.
DR   PDB; 1MYM; 31-JAN-94.
DR   PDB; 2SPL; 31-JAN-94.
DR   PDB; 2SPM; 31-JAN-94.
DR   PDB; 2SPN; 31-JAN-94.
DR   PDB; 2SPO; 31-JAN-94.
DR   PDB; 1MLF; 31-AUG-94.
DR   PDB; 1MLG; 31-AUG-94.
DR   PDB; 1MLH; 31-AUG-94.
DR   PDB; 1MLJ; 31-AUG-94.
DR   PDB; 1MLK; 31-AUG-94.
DR   PDB; 1MLL; 31-AUG-94.
DR   PDB; 1MLM; 31-AUG-94.
DR   PDB; 1MLN; 31-AUG-94.
DR   PDB; 1MLO; 31-AUG-94.
DR   PDB; 1MLQ; 07-FEB-95.
DR   PDB; 1MLR; 31-AUG-94.
DR   PDB; 1MLS; 31-AUG-94.
DR   PDB; 1MLU; 31-AUG-94.
DR   PDB; 1BVC; 31-JUL-95.
DR   PDB; 1BVD; 31-JUL-95.
DR   PDB; 1ABS; 01-APR-97.
DR   PDB; 1AJG; 12-NOV-97.
DR   PDB; 1AJH; 12-NOV-97.
DR   PDB; 1HJT; 12-NOV-97.
DR   PDB; 1IRC; 11-JUL-96.
DR   PDB; 1SPE; 08-MAR-96.
DR   PDB; 1YOG; 07-DEC-96.
DR   PDB; 1YOH; 07-DEC-96.
DR   PDB; 1YOI; 07-DEC-96.
DR   PDB; 1LTW; 23-DEC-96.
DR   PDB; 1MCY; 07-DEC-95.
DR   PDB; 1MOA; 07-FEB-95.
DR   PDB; 1MOB; 07-FEB-95.
DR   PDB; 1MOC; 07-FEB-95.
DR   PDB; 1MOD; 07-FEB-95.
DR   PDB; 1MTI; 15-SEP-95.
DR   PDB; 1MTJ; 15-SEP-95.
DR   PDB; 1MTK; 15-SEP-95.
DR   PDB; 1TES; 08-NOV-96.
DR   PDB; 1VXA; 01-AUG-96.
DR   PDB; 1VXB; 01-AUG-96.
DR   PDB; 1VXC; 01-AUG-96.
DR   PDB; 1VXD; 01-AUG-96.
DR   PDB; 1VXE; 01-AUG-96.
DR   PDB; 1VXF; 01-AUG-96.
DR   PDB; 1VXG; 01-AUG-96.
DR   PDB; 1VXH; 01-AUG-96.
DR   PDB; 101M; 08-APR-98.
DR   PDB; 102M; 08-APR-98.
DR   PDB; 103M; 08-APR-98.
DR   PDB; 104M; 08-APR-98.
DR   PDB; 105M; 08-APR-98.
DR   PDB; 106M; 08-APR-98.
DR   PDB; 107M; 08-APR-98.
DR   PDB; 109M; 08-APR-98.
DR   PDB; 110M; 08-APR-98.
DR   PDB; 111M; 08-APR-98.
DR   PDB; 112M; 08-APR-98.
DR   PDB; 1IOP; 08-APR-98.
DR   PDB; 1OBM; 08-APR-98.
DR   PDB; 108M; 20-MAY-98.
DR   PDB; 1JDO; 27-MAY-98.
DR   PDB; 1OFJ; 27-MAY-98.
DR   PDB; 1A6G; 21-OCT-98.
DR   PDB; 1BZ6; 11-NOV-98.
DR   PDB; 1OFK; 11-NOV-98.
DR   PROSITE; PS01033; GLOBIN; 1.
DR   PFAM; PF00042; globin; 1.
KW   HEME; OXYGEN TRANSPORT; RESPIRATORY PROTEIN; MUSCLE; 3D-STRUCTURE.
FT   METAL        64     64       IRON (HEME DISTAL LIGAND).
FT   METAL        93     93       IRON (HEME PROXIMAL LIGAND).
FT   VARIANT     121    121       G -> A (IN METMYOGLOBIN).
FT   CONFLICT    122    122       D -> N (IN REF. 2).
FT   HELIX         4     35
FT   HELIX        37     42
FT   TURN         44     48
FT   HELIX        52     57
FT   HELIX        59     77
FT   TURN         78     80
FT   HELIX        83     95
FT   TURN         96     96
FT   HELIX       101    118
FT   HELIX       120    122
FT   HELIX       125    149
FT   TURN        150    150
SQ   SEQUENCE   153 AA;  17200 MW;  E3C9BA11 CRC32;
     VLSEGEWQLV LHVWAKVEAD VAGHGQDILI RLFKSHPETL EKFDRFKHLK TEAEMKASED
     LKKHGVTVLT ALGAILKKKG HHEAELKPLA QSHATKHKIP IKYLEFISEA IIHVLHSRHP
     GDFGADAQGA MNKALELFRK DIAAKYKELG YQG
//
ID   PAPA_CARPA     STANDARD;      PRT;   345 AA.
AC   P00784;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-JAN-1988 (REL. 06, LAST SEQUENCE UPDATE)
DT   01-OCT-1996 (REL. 34, LAST ANNOTATION UPDATE)
DE   PAPAIN PRECURSOR (EC 3.4.22.2) (PAPAYA PROTEINASE I) (PPI).
OS   CARICA PAPAYA (PAPAYA).
OC   EUKARYOTA; VIRIDIPLANTAE; STREPTOPHYTA; EMBRYOPHYTA; TRACHEOPHYTA;
OC   EUPHYLLOPHYTES; SPERMATOPHYTA; MAGNOLIOPHYTA; EUDICOTYLEDONS; ROSIDAE;
OC   VIOLALES; CARICACEAE; CARICA.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 87163525.
RA   COHEN L.W., COGHLAN V.M., DIHEL L.C.;
RT   "Cloning and sequencing of papain-encoding cDNA.";
RL   GENE 48:219-227(1986).
RN   [2]
RP   SEQUENCE OF 134-345.
RX   MEDLINE; 71007899.
RA   MITCHEL R.E.J., CHAIKEN I.M., SMITH E.L.;
RT   "The complete amino acid sequence of papain. Additions and
RT   corrections.";
RL   J. BIOL. CHEM. 245:3485-3492(1970).
RN   [3]
RP   REVISION TO 197.
RX   MEDLINE; 70141125.
RA   HUSAIN S.S., LOWE G.;
RT   "A reinvestigation of residues 64-68 and 175 in papain. Evidence that
RT   residues 64 and 175 are asparagine.";
RL   BIOCHEM. J. 116:689-692(1970).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   MEDLINE; 69006973.
RA   DRENTH J., JANSONIUS J.N., KOEKOEK R., SWEN H.M., WOLTHERS B.G.;
RT   "Structure of papain.";
RL   NATURE 218:929-932(1968).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS).
RX   MEDLINE; 85058190.
RA   KAMPHUIS I.G., KALK K.H., SWARTE M.B.A., DRENTH J.;
RT   "Structure of papain refined at 1.65-A resolution.";
RL   J. MOL. BIOL. 179:233-256(1984).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   MEDLINE; 90269230.
RA   STUBBS M.T., LABER B., BODE W., HUBER R., JERALA R., LENARCIC B.,
RA   TURK V.;
RT   "The refined 2.4 A X-ray crystal structure of recombinant human
RT   stefin B in complex with the cysteine proteinase papain: a novel type
RT   of proteinase inhibitor interaction.";
RL   EMBO J. 9:1939-1947(1990).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   MEDLINE; 93075728.
RA   YAMAMOTO A., TOMOO K., DOI M., OHISHI H., INOUE M., ISHIDA T.,
RA   YAMAMOTO D., TSUBOI S., OKAMOTO H., OKADA Y.;
RT   "Crystal structure of
RT   papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A
RT   resolution: noncovalent binding mode of a common sequence of
RT   endogenous thiol protease inhibitors.";
RL   BIOCHEMISTRY 31:11305-11309(1992).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RA   PICKERSGILL R.W., HARRIS G.W., GARMAN E.;
RT   "Structure of monoclinic papain at 1.60-A resolution.";
RL   ACTA CRYSTALLOGR. B 48:59-67(1992).
CC   -!- CATALYTIC ACTIVITY: PREFERENTIAL CLEAVAGE: ARG-. LYS-, PHE-XAA-.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY C1; ALSO KNOWN AS THE
CC       PAPAIN FAMILY OF THIOL PROTEASES.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M15203; G167391; -.
DR   PIR; A26466; PPPA.
DR   PDB; 1PAD; 17-FEB-84.
DR   PDB; 2PAD; 17-FEB-84.
DR   PDB; 4PAD; 04-MAR-85.
DR   PDB; 5PAD; 17-FEB-84.
DR   PDB; 6PAD; 17-FEB-84.
DR   PDB; 9PAP; 15-JAN-95.
DR   PDB; 1PE6; 15-APR-93.
DR   PDB; 1PIP; 31-OCT-93.
DR   PDB; 1POP; 31-OCT-93.
DR   PDB; 1PPD; 02-JAN-85.
DR   PDB; 1PPN; 31-JAN-94.
DR   PDB; 1PPP; 31-JAN-94.
DR   PDB; 1STF; 31-JAN-94.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
KW   HYDROLASE; THIOL PROTEASE; ZYMOGEN; SIGNAL; 3D-STRUCTURE.
FT   SIGNAL        1     18       POTENTIAL.
FT   PROPEP       19    133       ACTIVATION PEPTIDE.
FT   CHAIN       134    345       PAPAIN.
FT   ACT_SITE    158    158
FT   ACT_SITE    292    292
FT   ACT_SITE    308    308
FT   DISULFID    155    196
FT   DISULFID    189    228
FT   DISULFID    286    333
FT   CONFLICT    180    180       E -> Q (IN REF. 2).
FT   CONFLICT    219    220       YP -> PY (IN REF. 2).
FT   CONFLICT    251    251       E -> Q (IN REF. 2).
FT   CONFLICT    268    268       E -> Q (IN REF. 2).
FT   STRAND      138    139
FT   TURN        140    144
FT   STRAND      151    151
FT   TURN        153    154
FT   STRAND      156    156
FT   HELIX       158    175
FT   STRAND      181    181
FT   HELIX       183    189
FT   TURN        191    192
FT   TURN        195    196
FT   STRAND      197    197
FT   STRAND      199    199
FT   HELIX       201    210
FT   TURN        211    211
FT   STRAND      213    213
FT   STRAND      215    215
FT   TURN        216    218
FT   HELIX       231    233
FT   STRAND      238    238
FT   STRAND      242    245
FT   HELIX       251    260
FT   STRAND      263    267
FT   HELIX       272    276
FT   STRAND      281    282
FT   STRAND      292    299
FT   STRAND      303    307
FT   STRAND      310    310
FT   TURN        312    313
FT   TURN        315    315
FT   STRAND      316    316
FT   TURN        317    318
FT   STRAND      319    323
FT   HELIX       332    334
FT   TURN        335    336
FT   STRAND      340    343
SQ   SEQUENCE   345 AA;  38922 MW;  B329F58F CRC32;
     MAMIPSISKL LFVAICLFVY MGLSFGDFSI VGYSQNDLTS TERLIQLFES WMLKHNKIYK
     NIDEKIYRFE IFKDNLKYID ETNKKNNSYW LGLNVFADMS NDEFKEKYTG SIAGNYTTTE
     LSYEEVLNDG DVNIPEYVDW RQKGAVTPVK NQGSCGSCWA FSAVVTIEGI IKIRTGNLNE
     YSEQELLDCD RRSYGCNGGY PWSALQLVAQ YGIHYRNTYP YEGVQRYCRS REKGPYAAKT
     DGVRQVQPYN EGALLYSIAN QPVSVVLEAA GKDFQLYRGG IFVGPCGNKV DHAVAAVGYG
     PNYILIKNSW GTGWGENGYI RIKRGTGNSY GVCGLYTSSF YPVKN
//
ID   PLAS_POPNI     STANDARD;      PRT;   168 AA.
AC   P00299;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-OCT-1996 (REL. 34, LAST SEQUENCE UPDATE)
DT   01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE)
DE   PLASTOCYANIN A PRECURSOR.
GN   PETE.
OS   POPULUS NIGRA (LOMBARDY POPLAR).
OC   EUKARYOTA; VIRIDIPLANTAE; STREPTOPHYTA; EMBRYOPHYTA; TRACHEOPHYTA;
OC   EUPHYLLOPHYTES; SPERMATOPHYTA; MAGNOLIOPHYTA; EUDICOTYLEDONS; ROSIDAE;
OC   VIOLALES; SALICACEAE; POPULUS.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=CV. ITALICA; TISSUE=LEAF;
RA   REICHERT J., JENZELEWSKI V., HAEHNEL W.;
RL   SUBMITTED (AUG-1995) TO EMBL/GENBANK/DDBJ DATA BANKS.
RN   [2]
RP   SEQUENCE OF 70-168.
RC   STRAIN=CV. ITALICA;
RA   AMBLER R.P.;
RT   "Elegance in molecular design: the copper site of photosynthetic
RT   electron-transfer protein.";
RL   UNPUBLISHED RESULTS, CITED BY:
RL   FREEMAN H.C.;
RL   J. PROC. ROYAL SOC. N.S. WALES 112:45-62(1979).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   MEDLINE; 84135769.
RA   GARRETT T.P.J., CLINGELEFFER D.J., GUSS J.M., ROGERS S.J.,
RA   FREEMAN H.C.;
RT   "The crystal structure of poplar apoplastocyanin at 1.8-A resolution.
RT   The geometry of the copper-binding site is created by the
RT   polypeptide.";
RL   J. BIOL. CHEM. 259:2822-2825(1984).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   MEDLINE; 84010876.
RA   GUSS J.M., FREEMAN H.C.;
RT   "Structure of oxidized poplar plastocyanin at 1.6-A resolution.";
RL   J. MOL. BIOL. 169:521-563(1983).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RA   COLMAN P.M., FREEMAN H.C., GUSS J.M., MURATA M., NORRIS V.A.,
RA   RAMSHAW J.A.M., VENKATAPPA M.P.;
RT   "X-ray crystal structure analysis of plastocyanin at 2.7-A
RT   resolution.";
RL   NATURE 272:319-324(1978).
CC   -!- FUNCTION: PLASTOCYANIN PARTICIPATES IN ELECTRON TRANSFER BETWEEN
CC       P700 AND THE CYTOCHROME B/F COMPLEX IN PHOTOSYSTEM I.
CC   -!- SUBCELLULAR LOCATION: LOOSELY BOUND TO THE INNER THYLAKOID
CC       MEMBRANE SURFACE IN CHLOROPLASTS.
CC   -!- SIMILARITY: THERE ARE 12 DIFFERENCES BETWEEN THE SEQUENCE OF
CC       POPLAR PLASTOCYANINS A AND B.
CC   -!- SIMILARITY: CONTAINS ONE PLASTOCYANIN-LIKE DOMAIN.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; Z50185; G929813; -.
DR   PIR; A00309; CUPX.
DR   PDB; 2PCY; 15-JAN-86.
DR   PDB; 3PCY; 25-APR-86.
DR   PDB; 4PCY; 15-JAN-91.
DR   PDB; 5PCY; 15-JAN-91.
DR   PDB; 6PCY; 15-JAN-91.
DR   PDB; 1PLC; 31-OCT-93.
DR   PDB; 1PNC; 31-JAN-94.
DR   PDB; 1PND; 31-JAN-94.
DR   PROSITE; PS00196; COPPER_BLUE; 1.
DR   PFAM; PF00127; copper-bind; 1.
DR   MENDEL; 12195; POPni;PetE;1.
KW   CHLOROPLAST; ELECTRON TRANSPORT; COPPER; THYLAKOID MEMBRANE;
KW   TRANSIT PEPTIDE; MULTIGENE FAMILY; 3D-STRUCTURE.
FT   TRANSIT       1     69       CHLOROPLAST.
FT   CHAIN        70    168       PLASTOCYANIN A.
FT   DOMAIN       70    168       PLASTOCYANIN-LIKE.
FT   METAL       106    106       COPPER.
FT   METAL       153    153       COPPER.
FT   METAL       156    156       COPPER.
FT   METAL       161    161       COPPER.
FT   STRAND       71     74
FT   TURN         77     78
FT   STRAND       83     84
FT   STRAND       87     90
FT   TURN         92     93
FT   STRAND       95    100
FT   STRAND      106    106
FT   STRAND      109    110
FT   TURN        112    113
FT   TURN        117    118
FT   HELIX       121    123
FT   TURN        124    124
FT   STRAND      132    132
FT   TURN        135    136
FT   STRAND      138    142
FT   STRAND      147    152
FT   HELIX       154    156
FT   TURN        157    160
FT   STRAND      162    167
SQ   SEQUENCE   168 AA;  17020 MW;  917D9BA6 CRC32;
     MATVTSAAVS IPSFTGLKAG SASNAKVSAS AKVSASPLPR LSIKASMKDV GAAVVATAAS
     AMIASNAMAI DVLLGADDGS LAFVPSEFSI SPGEKIVFKN NAGFPHNIVF DEDSIPSGVD
     ASKISMSEED LLNAKGETFE VALSNKGEYS FYCSPHQGAG MVGKVTVN
//
ID   PRTA_STRGR     STANDARD;      PRT;   297 AA.
AC   P00776;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-FEB-1991 (REL. 17, LAST SEQUENCE UPDATE)
DT   01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE)
DE   STREPTOGRISIN A PRECURSOR (EC 3.4.21.80) (PROTEASE A) (SGPA) (PRONASE
DE   ENZYME A).
GN   SPRA.
OS   STREPTOMYCES GRISEUS.
OC   BACTERIA; FIRMICUTES; ACTINOBACTERIA; ACTINOBACTERIDAE;
OC   ACTINOMYCETALES; STREPTOMYCINEAE; STREPTOMYCETACEAE; STREPTOMYCES.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 87279934.
RA   HENDERSON G., KRYGSMAN P., LIU C.J., DAVEY C.C., MALEK L.T.;
RT   "Characterization and structure of genes for proteases A and B from
RT   Streptomyces griseus.";
RL   J. BACTERIOL. 169:3778-3784(1987).
RN   [2]
RP   SEQUENCE OF 116-297.
RX   MEDLINE; 75039088.
RA   JOHNSON P., SMILLIE L.B.;
RT   "The amino acid sequence and predicted structure of Streptomyces
RT   griseus protease A.";
RL   FEBS LETT. 47:1-6(1974).
RN   [3]
RP   REVISION TO 249.
RA   APOSTOL I., SMILLIE L.B., LASKOWSKI M. JR.;
RL   SUBMITTED (JUL-1996) TO THE SWISS-PROT DATA BANK.
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   MEDLINE; 80140489.
RA   SIELECKI A.R., HENDRICKSON W.A., BROUGHTON C.G., DELBAERE L.T.J.,
RA   BRAYER G.D., JAMES M.N.G.;
RT   "Protein structure refinement: Streptomyces griseus serine protease A
RT   at 1.8-A resolution.";
RL   J. MOL. BIOL. 134:781-804(1979).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   MEDLINE; 79050558.
RA   BRAYER G.D., DELBAERE L.T.J., JAMES M.N.G.;
RT   "Molecular structure of crystalline Streptomyces griseus protease A
RT   at 2.8-A resolution. II. Molecular conformation, comparison with
RT   alpha-chymotrypsin and active-site geometry.";
RL   J. MOL. BIOL. 124:261-283(1978).
CC   -!- FUNCTION: HAS A PRIMARY SPECIFICITY FOR LARGE ALIPHATIC OR
CC       AROMATIC AMINO ACIDS.
CC   -!- CATALYTIC ACTIVITY: HYDROLYSIS OF PROTEINS WITH SPECIFICITY
CC       SIMILAR TO CHYMOTRYPSIN.
CC   -!- SUBUNIT: MONOMER.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY S2A; ALSO KNOWN AS THE
CC       ALPHA-LYTIC PROTEASE FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M17103; G153467; -.
DR   EMBL; A24972; G904566; -.
DR   PIR; A00963; PRSMAG.
DR   PIR; A26974; A26974.
DR   PDB; 2SGA; 09-JAN-89.
DR   PDB; 3SGA; 15-OCT-91.
DR   PDB; 4SGA; 15-OCT-91.
DR   PDB; 5SGA; 15-OCT-91.
DR   PDB; 1SGC; 14-JUL-86.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
DR   PFAM; PF00089; trypsin; 1.
KW   HYDROLASE; SERINE PROTEASE; ZYMOGEN; SIGNAL; 3D-STRUCTURE.
FT   SIGNAL        1     38
FT   PROPEP       39    115
FT   CHAIN       116    297       STREPTOGRISIN A.
FT   DISULFID    130    150
FT   DISULFID    247    274
FT   ACT_SITE    149    149       CHARGE RELAY SYSTEM (BY SIMILARITY).
FT   ACT_SITE    171    171       CHARGE RELAY SYSTEM (BY SIMILARITY).
FT   ACT_SITE    253    253       CHARGE RELAY SYSTEM (BY SIMILARITY).
FT   CONFLICT    151    151       T -> TS (IN REF. 2).
FT   CONFLICT    184    184       D -> N (IN REF. 2).
FT   STRAND      119    119
FT   TURN        120    120
FT   STRAND      122    125
FT   TURN        126    127
FT   STRAND      128    131
FT   STRAND      134    138
FT   TURN        139    140
FT   STRAND      141    146
FT   HELIX       148    151
FT   TURN        152    153
FT   STRAND      156    157
FT   TURN        158    159
FT   STRAND      160    166
FT   STRAND      169    169
FT   STRAND      172    177
FT   HELIX       180    182
FT   STRAND      186    188
FT   STRAND      194    196
FT   STRAND      199    200
FT   TURN        205    206
FT   STRAND      208    213
FT   TURN        214    216
FT   STRAND      217    231
FT   HELIX       233    235
FT   STRAND      237    244
FT   TURN        250    251
FT   TURN        253    254
FT   STRAND      256    259
FT   TURN        260    261
FT   STRAND      262    273
FT   TURN        274    276
FT   STRAND      277    284
FT   HELIX       285    292
FT   TURN        293    293
FT   STRAND      294    296
SQ   SEQUENCE   297 AA;  29663 MW;  7BD4D6C6 CRC32;
     MTFKRFSPLS STSRYARLLA VASGLVAAAA LATPSAVAAP EAESKATVSQ LADASSAILA
     ADVAGTAWYT EASTGKIVLT ADSTVSKAEL AKVSNALAGS KAKLTVKRAE GKFTPLIAGG
     EAITTGGSRC SLGFNVSVNG VAHALTAGHC TNISASWSIG TRTGTSFPNN DYGIIRHSNP
     AAADGRVYLY NGSYQDITTA GNAFVGQAVQ RSGSTTGLRS GSVTGLNATV NYGSSGIVYG
     MIQTNVCAEP GDSGGSLFAG STALGLTSGG SGNCRTGGTT FYQPVTEALS AYGATVL
//
ID   THYG_HUMAN     STANDARD;      PRT;  2768 AA.
AC   P01266; Q15593; O43899; O15274;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   15-DEC-1998 (REL. 37, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   THYROGLOBULIN PRECURSOR.
GN   TG.
OS   HOMO SAPIENS (HUMAN).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   PRIMATES; CATARRHINI; HOMINIDAE; HOMO.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 87246630.
RA   MALTHIERY Y., LISSITZKY S.;
RT   "Primary structure of human thyroglobulin deduced from the sequence
RT   of its 8448-base complementary DNA.";
RL   EUR. J. BIOCHEM. 165:491-498(1987).
RN   [2]
RP   SEQUENCE FROM N.A.
RC   TISSUE=THYROID;
RX   MEDLINE; 97329813.
RA   VAN DE GRAAF S.A.R., PAUWS E., DE VIJLDER J.J.M., RIS-STALPERS C.;
RT   "The revised 8307 base pair coding sequence of human thyroglobulin
RT   transiently expressed in eukaryotic cells.";
RL   EUR. J. ENDOCRINOL. 136:508-515(1997).
RN   [3]
RP   SEQUENCE OF 1-730 FROM N.A.
RX   MEDLINE; 85127024.
RA   MALTHIERY Y., LISSITZKY S.;
RT   "Sequence of the 5'-end quarter of the human-thyroglobulin messenger
RT   ribonucleic acid and of its deduced amino-acid sequence.";
RL   EUR. J. BIOCHEM. 147:53-58(1985).
RN   [4]
RP   SEQUENCE OF 1-415; 640-737 AND 880-1000 FROM N.A.
RX   MEDLINE; 88062712.
RA   PARMA J., CHRISTOPHE D., POHL V., VASSART G.;
RT   "Structural organization of the 5' region of the thyroglobulin gene.
RT   Evidence for intron loss and 'exonization' during evolution.";
RL   J. MOL. BIOL. 196:769-779(1987).
RN   [5]
RP   SEQUENCE OF 1-25 FROM N.A.
RX   MEDLINE; 85269632.
RA   CHRISTOPHE D., CABRER B., BACOLLA A., TARGOVNIK H., POHL V.,
RA   VASSERT G.;
RT   "An unusually long poly(purine)-poly(pyrimidine) sequence is located
RT   upstream from the human thyroglobulin gene.";
RL   NUCLEIC ACIDS RES. 13:5127-5144(1985).
RN   [6]
RP   PRESENCE OF A 11TH TYROGLOBULIN TYPE-I REPEAT.
RX   MEDLINE; 96390872.
RA   MOLINA F., BOUANANI M., PAU B., GRANIER C.;
RT   "Characterization of the type-1 repeat from thyroglobulin, a
RT   cysteine-rich module found in proteins from different families.";
RL   EUR. J. BIOCHEM. 240:125-133(1996).
RN   [7]
RP   VARIANT HIS-870.
RX   MEDLINE; 93164775.
RA   CORRAL J., MARTIN C., PEREZ R., SANCHEZ I., MORIES M.T.,
RA   SAN MILLAN J.L., MIRALLES J.M., GONZALEZ-SARMIENTO R.;
RT   "Thyroglobulin gene point mutation associated with non-endemic simple
RT   goitre.";
RL   LANCET 341:462-464(1993).
CC   -!- FUNCTION: PRECURSOR OF THE IODINATED THYROID HORMONES THYROXINE
CC       (T4) AND TRIIODOTHYRONINE (T3).
CC   -!- SUBUNIT: HOMODIMER.
CC   -!- TISSUE SPECIFICITY: THYROID GLAND SPECIFIC.
CC   -!- DISEASE: SOME FORMS OF GOITER, AN ENLARGEMENT OF THE THYROID
CC       GLAND, ARE PRODUCED BY DEFECTS IN TG.
CC   -!- SIMILARITY: BELONGS TO THE TYPE-B CARBOXYLESTERASE/LIPASE FAMILY.
CC   -!- SIMILARITY: CONTAINS 11 THYROGLOBULIN TYPE-I DOMAINS.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; X05615; G37174; -.
DR   EMBL; U93033; G2707181; -.
DR   EMBL; X02154; G37177; -.
DR   EMBL; X06059; E245851; -.
DR   EMBL; X06060; E245851; JOINED.
DR   EMBL; X06061; E245851; JOINED.
DR   EMBL; X06062; E245851; JOINED.
DR   EMBL; X06063; E245851; JOINED.
DR   EMBL; X06064; E245851; JOINED.
DR   EMBL; X06065; E245851; JOINED.
DR   EMBL; X06066; E245851; JOINED.
DR   EMBL; X06067; E321981; -.
DR   EMBL; X06068; E321981; JOINED.
DR   EMBL; X06069; E322102; -.
DR   EMBL; X06070; E322102; JOINED.
DR   EMBL; X02749; G758106; -.
DR   PIR; A01532; UIHU.
DR   PIR; S00014; S00014.
DR   PIR; S03422; S03422.
DR   MIM; 188450; -.
DR   MIM; 138800; -.
DR   MIM; 274900; -.
DR   PROSITE; PS00484; THYROGLOBULIN_1; 9.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
DR   PFAM; PF00086; thyroglobulin_1; 10.
DR   PFAM; PF00135; COesterase; 2.
DR   HSSP; P21836; 1MAH.
KW   GLYCOPROTEIN; REPEAT; THYROID HORMONE; IODINATION; SIGNAL;
KW   DISEASE MUTATION.
FT   SIGNAL        1     19
FT   CHAIN        20   2768       THYROGLOBULIN.
FT   DOMAIN       32     92       THYROGLOBULIN TYPE IA.
FT   DOMAIN       93    160       THYROGLOBULIN TYPE IA.
FT   DOMAIN      161    297       THYROGLOBULIN TYPE IA.
FT   DOMAIN      298    358       THYROGLOBULIN TYPE IA.
FT   DOMAIN      605    658       THYROGLOBULIN TYPE IA.
FT   DOMAIN      659    726       THYROGLOBULIN TYPE IA.
FT   DOMAIN      727    921       THYROGLOBULIN TYPE IA.
FT   DOMAIN      922   1073       THYROGLOBULIN TYPE IA.
FT   DOMAIN     1074   1145       THYROGLOBULIN TYPE IB.
FT   DOMAIN     1146   1210       THYROGLOBULIN TYPE IA.
FT   REPEAT     1456   1469       TYPE II.
FT   REPEAT     1470   1486       TYPE II.
FT   REPEAT     1487   1503       TYPE II.
FT   DOMAIN     1511   1565       THYROGLOBULIN TYPE IB.
FT   REPEAT     1603   1723       TYPE IIIA.
FT   REPEAT     1724   1892       TYPE IIIB.
FT   REPEAT     1893   1995       TYPE IIIA.
FT   REPEAT     1996   2129       TYPE IIIB.
FT   REPEAT     2130   2187       TYPE IIIA.
FT   MOD_RES      24     24       IODINATION (IN T4).
FT   MOD_RES    2573   2573       IODINATION (IN T4).
FT   MOD_RES    2611   2611       IODINATION (IN T4).
FT   MOD_RES    2766   2766       IODINATION (IN T3).
FT   CARBOHYD     76     76       POTENTIAL.
FT   CARBOHYD    110    110       POTENTIAL.
FT   CARBOHYD    198    198       POTENTIAL.
FT   CARBOHYD    484    484       POTENTIAL.
FT   CARBOHYD    496    496       POTENTIAL.
FT   CARBOHYD    529    529       POTENTIAL.
FT   CARBOHYD    748    748       POTENTIAL.
FT   CARBOHYD    816    816       POTENTIAL.
FT   CARBOHYD    947    947       POTENTIAL.
FT   CARBOHYD   1220   1220       POTENTIAL.
FT   CARBOHYD   1348   1348       POTENTIAL.
FT   CARBOHYD   1349   1349       POTENTIAL.
FT   CARBOHYD   1365   1365       POTENTIAL.
FT   CARBOHYD   1716   1716       POTENTIAL.
FT   CARBOHYD   1774   1774       POTENTIAL.
FT   CARBOHYD   1869   1869       POTENTIAL.
FT   CARBOHYD   2013   2013       POTENTIAL.
FT   CARBOHYD   2122   2122       POTENTIAL.
FT   CARBOHYD   2250   2250       POTENTIAL.
FT   CARBOHYD   2295   2295       POTENTIAL.
FT   CARBOHYD   2582   2582       POTENTIAL.
FT   SIMILAR    2228   2768       WITH TYPE-B CARBOXYLESTERASE/LIPASES.
FT   VARIANT     870    870       Q -> H (IN GOITER).
FT   CONFLICT     23     25       EYQ -> GKF (IN REF. 5).
FT   CONFLICT    135    135       Q -> H (IN REF. 1 AND 3).
FT   CONFLICT    604    604       S -> D (IN REF. 1 AND 3).
FT   CONFLICT    653    653       G -> D (IN REF. 1 AND 3).
FT   CONFLICT    734    734       S -> A (IN REF. 4).
FT   CONFLICT    985    985       MISSING (IN REF. 1).
FT   CONFLICT    984    985       EQ -> DR (IN REF. 4).
FT   CONFLICT   1043   1043       H -> Y (IN REF. 1).
FT   CONFLICT   1059   1059       I -> T (IN REF. 1).
FT   CONFLICT   1437   1437       W -> R (IN REF. 1).
FT   CONFLICT   1463   1463       P -> H (IN REF. 1).
FT   CONFLICT   1936   1936       A -> T (IN REF. 1).
FT   CONFLICT   2091   2091       D -> E (IN REF. 1).
FT   CONFLICT   2149   2149       P -> L (IN REF. 1).
FT   CONFLICT   2170   2170       Q -> R (IN REF. 1).
FT   CONFLICT   2242   2242       R -> H (IN REF. 1).
FT   CONFLICT   2530   2530       Q -> R (IN REF. 1).
SQ   SEQUENCE   2768 AA;  304599 MW;  639991D3 CRC32;
     MALVLEIFTL LASICWVSAN IFEYQVDAQP LRPCELQRET AFLKQADYVP QCAEDGSFQT
     VQCQNDGRSC WCVGANGSEV LGSRQPGRPV ACLSFCQLQK QQILLSGYIN STDTSYLPQC
     QDSGDYAPVQ CDVQQVQCWC VDAEGMEVYG TRQLGRPKRC PRSCEIRNRR LLHGVGDKSP
     PQCSAEGEFM PVQCKFVNTT DMMIFDLVHS YNRFPDAFVT FSSFQRRFPE VSGYCHCADS
     QGRELAETGL ELLLDEIYDT IFAGLDLPST FTETTLYRIL QRRFLAVQSV ISGRFRCPTK
     CEVERFTATS FGHPYVPSCR RNGDYQAVQC QTEGPCWCVD AQGKEMHGTR QQGEPPSCAE
     GQSCASERQQ ALSRLYFGTS GYFSQHDLFS SPEKRWASPR VARFATSCPP TIKELFVDSG
     LLRPMVEGQS QQFSVSENLL KEAIRAIFPS RGLARLALQF TTNPKRLQQN LFGGKFLVNV
     GQFNLSGALG TRGTFNFSQF FQQLGLASFL NGGRQEDLAK PLSVGLDSNS STGTPEAAKK
     DGTMNKPTVG SFGFEINLQE NQNALKFLAS LLELPEFLLF LQHAISVPED VARDLGDVME
     TVLSSQTCEQ TPERLFVPSC TTEGSYEDVQ CFSGECWCVN SWGKELPGSR VRGGQPRCPT
     DCEKQRARMQ SLMGSQPAGS TLFVPACTSE GHFLPVQCFN SECYCVDAEG QAIPGTRSAI
     GKPKKCPTPC QLQSEQAFLR TVQALLSNSS MLPTLSDTYI PQCSTDGQWR QVQCNGPPEQ
     VFELYQRWEA QNKGQDLTPA KLLVKIMSYR EAASGNFSLF IQSLYEAGQQ DVFPVLSQYP
     SLQDVPLAAL EGKRPQPREN ILLEPYLFWQ ILNGQLSQYP GSYSDFSTPL AHFDLRNCWC
     VDEAGQELEG MRSEPSKLPT CPGSCEEAKL RVLQFIRETE EIVSASNSSR FPLGESFLVA
     KGIRLRNEDL GLPPLFPPRE AFAEQFLRGS DYAIRLAAQS TLSFYQRRRF SPDDSAGASA
     LLRSGPYXPQ CDAFGSWEPV QCHAGTGHCW CVDEKGGFIP GSLTARSLQI PQCPTTCEKS
     RTSGLLSSWK QARSQENPSP KDLFVPACLE TGEYARLQAS GAGTWCVDPA SGEELRPGSS
     SSAQCPSLCN VLKSGVLSRR VSPGYVPACR AEDGGFSPVQ CDQAQGSCWC VMDSGEEVPG
     TRVTGGQPAC ESPRCPLPFN ASEVVGGTIL CETISGPTGS AMQQCQLLCR QGSWSVFPPG
     PLICSLESGR WESQLPQPRA CQRPQLWQTI QTQGHFQLQL PPGKMCSADY AGLLQTFQVF
     ILDELTARGF CQIQVKTFGT LVSIPVCNNS SVQVGCLTRE RLGVNVTWKS RLEDIPVASL
     PDLHDIERAL VGKDLLGRFT DLIQSGSFQL HLDSKTFPAE TIRFLQGDHF GTSPRTWFGC
     SEGFYQVLTS EASQDGLGCV KCPEGSYSQD EECIPCPVGF YQEQAGSLAC VPCPVGRTTI
     SAGAFSQTHC VTDCQRNEAG LQCDQNGQYR ASQKDRGSGK AFCVDGEGRR LPWWETEAPL
     EDSQCLMMQK FEKVPESKVI FDANAPVAVR SKVPDSEFPV MQCLTDCTED EACSFFTVST
     TEPEISCDFY AWTSDNVACM TSDQKRDALG NSKATSFGSL RCQVKVRSHG QDSPAVYLKK
     GQGSTTTLQK RFEPTGFQNM LSGLYNPIVF SASGANLTDA HLFCLLACDR DLCCDGFVLT
     QVQGGAIICG LLSSPSVLLC NVKDWMDPSE AWANATCPGV TYDQESHQVI LRLGDQEFIK
     SLTPLEGTQD TFTNFQQVYL WKDSDMGSRP ESMGCRKXTV PRPASPTEAG LTTELFSPVD
     LNQVIVNGNQ SLSSQKHWLF KHLFSAQQAN LWCLSRCVQE HSFCQLAEIT ESASLYFTCT
     LYPEAQVCDD IMESNAQGCR LILPQMPKAL FRKKVILEDK VKNFYTRLPF QKLMGISIRN
     KVPMSEKSIS NGFFECERRC DADPCCTGFG FLNVSQLKGG EVTCLTLNSL GIQMCSEENG
     GAWRILDCGS PDIEVHTYPF GWYQKPIAQN NAPSFCPLVV LPSLTEKVSL DSWQSLALSS
     VVVDPSIRHF DVAHVSTAAT SNFSAVRDLC LSECSQHEAC LITTLQTQPG AVRCMFYADT
     QSCTHSLQGQ NCRLLLREEA THIYRKPGIS LLSYEASVPS VPISTHGRLL GRSQAIQVGT
     SWKQVDQFLG VPYAAPPLAE RRFQAPEPLN WTGSWDASKP RASCWQPGTR TSTSPGVSED
     CLYLNVFIPQ NVAPNASVLV FFHNTMDREE SEGWPAIDGS FLAAVGNLIV VTASYRVGVF
     GFLSSGSGEV SGNWGLLDQV AALTWVQTHI RGFGGDPRRV SLAADRGGAD VASIHLLTAR
     ATNSQLFRRA VLMGGSALSP AAVISHERAQ QQAIALAKEV SCPMSSSQEV VSCLRQKPAN
     VLNDAQTKLL AVSGPFHYWG PVIDGHFLRE PPARALKRSL XVEVDLLIGS SQDDGLINRA
     KAVKQFEESQ GRTSSKTAFY QALQNSLGGE DSDARVEAAA TWYYSLEHST DDYASFSRAL
     ENATRDYFII CPIIDMASAW AKRARGNVFM YHAPENYGHG SLELLADVQF ALGLPFYPAY
     EGQFSLEEKS LSLKIMQYFS HFIRSGNPNY PYEFSRKVPT FATPWPDFVP RAGGENYKEF
     SELLPNRQGL KKADCSFWSK YISSLKTSAD GAKGGQSAES EEEELTAGSG LREDLLSLQE
     PGSKTYSK
//
ID   TRY1_BOVIN     STANDARD;      PRT;   243 AA.
AC   P00760;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-NOV-1997 (REL. 35, LAST SEQUENCE UPDATE)
DT   15-DEC-1998 (REL. 37, LAST ANNOTATION UPDATE)
DE   TRYPSINOGEN, CATIONIC PRECURSOR (EC 3.4.21.4) (FRAGMENT).
OS   BOS TAURUS (BOVINE).
OC   EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; MAMMALIA; EUTHERIA;
OC   ARTIODACTYLA; RUMINANTIA; PECORA; BOVOIDEA; BOVIDAE; BOVINAE; BOS.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   TISSUE=PANCREAS;
RA   OKAJIMA T., MANIWA M., NAGAO S., FUJIKAWA H., GOTO S.;
RL   SUBMITTED (OCT-1994) TO EMBL/GENBANK/DDBJ DATA BANKS.
RN   [2]
RP   SEQUENCE OF 15-243, AND DISULFIDE BONDS.
RX   MEDLINE; 67168848.
RA   MIKES O., HOLEYSOVSKY V., TOMASEK V., SORM F.;
RT   "Covalent structure of bovine trypsinogen. The position of the
RT   remaining amides.";
RL   BIOCHEM. BIOPHYS. RES. COMMUN. 24:346-352(1966).
RN   [3]
RP   REVISIONS.
RX   MEDLINE; 72035053.
RA   HARTLEY B.S.;
RT   "Homologies in serine proteinases.";
RL   PHILOS. TRANS. R. SOC. LOND., B, BIOL. SCI. 257:77-87(1970).
RN   [4]
RP   REVISIONS.
RX   MEDLINE; 75146445.
RA   TITANI K., ERICSSON L.H., NEURATH H., WALSH K.A.;
RT   "Amino acid sequence of dogfish trypsin.";
RL   BIOCHEMISTRY 14:1358-1366(1975).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF CALCIUM-BINDING SITE.
RX   MEDLINE; 76072097.
RA   BODE W., SCHWAGER P.;
RT   "The refined crystal structure of bovine beta-trypsin at 1.8-A
RT   resolution. II. Crystallographic refinement, calcium binding site,
RT   benzamidine binding site and active site at pH 7.0.";
RL   J. MOL. BIOL. 98:693-717(1975).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   MEDLINE; 77112431.
RA   KOSSIAKOFF A.A., CHAMBERS J.L., KAY L.M., STROUD R.M.;
RT   "Structure of bovine trypsinogen at 1.9-A resolution.";
RL   BIOCHEMISTRY 16:654-664(1977).
RN   [7]
RP   DISULFIDE BONDS.
RX   MEDLINE; 66079271.
RA   KAUFFMAN D.L.;
RT   "The disulphide bridges of trypsin.";
RL   J. MOL. BIOL. 12:929-932(1965).
CC   -!- CATALYTIC ACTIVITY: PREFERENTIAL CLEAVAGE: ARG-, LYS-.
CC   -!- SUBCELLULAR LOCATION: EXTRACELLULAR.
CC   -!- TISSUE SPECIFICITY: SYNTHESIZED IN THE ACINAR CELLS OF THE
CC       PANCREAS.
CC   -!- PTM: AUTOCATALYTIC CLEAVAGE AFTER LYS-20 LEADS TO BETA-TRYPSIN BY
CC       RELEASING A TERMINAL HEXAPEPTIDE. SUBSEQUENT CLEAVAGE AFTER
CC       LYS-145 LEADS TO ALPHA-TRYPSIN. FURTHER CLEAVAGE AFTER LYS-190
CC       YIELDS PSEUDOTRYPSIN. A CLEAVAGE MAY ALSO OCCUR AFTER ARG-119.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY S1; ALSO KNOWN AS THE
CC       TRYPSIN FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; D38507; G559311; -.
DR   PIR; A00946; TRBOTR.
DR   PDB; 2TGA; 09-APR-85.
DR   PDB; 1TGB; 14-MAR-85.
DR   PDB; 1TGC; 09-APR-85.
DR   PDB; 2TGD; 07-MAY-86.
DR   PDB; 1TGN; 22-OCT-84.
DR   PDB; 2TGP; 14-MAR-85.
DR   PDB; 1TGS; 14-MAR-85.
DR   PDB; 1TGT; 15-OCT-90.
DR   PDB; 2TGT; 09-APR-85.
DR   PDB; 1TLD; 15-OCT-92.
DR   PDB; 2TLD; 15-JUL-92.
DR   PDB; 1TPA; 14-MAR-85.
DR   PDB; 2TPI; 15-JUL-91.
DR   PDB; 3TPI; 14-MAR-85.
DR   PDB; 4TPI; 08-NOV-85.
DR   PDB; 1TPO; 14-MAR-85.
DR   PDB; 1TPP; 16-APR-87.
DR   PDB; 1NTP; 15-APR-91.
DR   PDB; 3PTB; 14-MAR-85.
DR   PDB; 2PTC; 14-MAR-85.
DR   PDB; 2PTN; 15-APR-91.
DR   PDB; 3PTN; 09-APR-85.
DR   PDB; 5PTP; 07-JUL-97.
DR   PDB; 1TAB; 15-JUL-92.
DR   PDB; 1GBT; 31-JAN-94.
DR   PDB; 1PPC; 31-JAN-94.
DR   PDB; 1PPE; 31-JAN-94.
DR   PDB; 1PPH; 31-JAN-94.
DR   PDB; 1SMF; 31-JUL-94.
DR   PDB; 1TNG; 30-NOV-94.
DR   PDB; 1TNH; 30-NOV-94.
DR   PDB; 1TNI; 30-NOV-94.
DR   PDB; 1TNJ; 30-NOV-94.
DR   PDB; 1TNK; 30-NOV-94.
DR   PDB; 1TNL; 30-NOV-94.
DR   PDB; 1BTP; 29-JAN-96.
DR   PDB; 1BTW; 15-OCT-95.
DR   PDB; 1BTX; 15-OCT-95.
DR   PDB; 1BTY; 15-OCT-95.
DR   PDB; 1BTZ; 15-OCT-95.
DR   PDB; 1JRS; 14-OCT-96.
DR   PDB; 1JRT; 14-OCT-96.
DR   PDB; 1MAX; 14-OCT-96.
DR   PDB; 1MAY; 14-OCT-96.
DR   PDB; 1MTS; 20-AUG-97.
DR   PDB; 1MTU; 12-NOV-97.
DR   PDB; 1MTV; 12-NOV-97.
DR   PDB; 1MTW; 12-NOV-97.
DR   PDB; 1TPS; 26-JAN-95.
DR   PDB; 1TYN; 26-JAN-95.
DR   PDB; 1TAW; 24-JUN-97.
DR   PDB; 1AQ7; 25-FEB-98.
DR   PDB; 2TIO; 30-SEP-98.
DR   PDB; 1XUF; 16-DEC-98.
DR   PDB; 1XUG; 16-DEC-98.
DR   PDB; 1XUH; 11-NOV-98.
DR   PDB; 1XUI; 11-NOV-98.
DR   PDB; 1XUJ; 11-NOV-98.
DR   PDB; 1XUK; 11-NOV-98.
DR   PDB; 1BJU; 02-DEC-98.
DR   PDB; 1BJV; 02-DEC-98.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
DR   PFAM; PF00089; trypsin; 1.
KW   HYDROLASE; SERINE PROTEASE; DIGESTION; PANCREAS; ZYMOGEN; SIGNAL;
KW   3D-STRUCTURE.
FT   NON_TER       1      1
FT   SIGNAL       <1     14
FT   PROPEP       15     20       ACTIVATION PEPTIDE.
FT   CHAIN        21    243       TRYPSIN. CATIONIC (BETA-TRYPSIN).
FT   CHAIN        21    145       ALPHA-TRYPSIN CHAIN 1.
FT   CHAIN       146    243       ALPHA-TRYPSIN CHAIN 2.
FT   CA_BIND      72     82
FT   BINDING     191    192       SUBSTRATE.
FT   BINDING     194    195       SUBSTRATE.
FT   BINDING     197    197       SUBSTRATE.
FT   DISULFID     27    157
FT   DISULFID     45     61
FT   DISULFID    129    230
FT   DISULFID    136    203
FT   DISULFID    168    182
FT   DISULFID    193    217
FT   ACT_SITE     60     60       CHARGE RELAY SYSTEM.
FT   ACT_SITE    104    104       CHARGE RELAY SYSTEM.
FT   ACT_SITE    197    197       CHARGE RELAY SYSTEM.
FT   SITE        191    191       REQUIRED FOR SPECIFICITY.
FT   STRAND       22     22
FT   STRAND       25     26
FT   TURN         29     30
FT   TURN         33     34
FT   STRAND       35     39
FT   STRAND       43     51
FT   TURN         52     53
FT   STRAND       54     57
FT   HELIX        59     61
FT   STRAND       67     70
FT   TURN         75     76
FT   STRAND       83     92
FT   TURN         94     95
FT   STRAND       97     97
FT   TURN         98    101
FT   STRAND      102    102
FT   TURN        103    103
FT   STRAND      106    110
FT   STRAND      124    124
FT   TURN        132    133
FT   STRAND      135    140
FT   STRAND      156    162
FT   HELIX       165    171
FT   TURN        173    174
FT   TURN        178    179
FT   STRAND      180    183
FT   TURN        186    187
FT   STRAND      191    191
FT   TURN        194    195
FT   TURN        197    198
FT   STRAND      200    203
FT   TURN        204    205
FT   STRAND      206    213
FT   TURN        220    221
FT   STRAND      224    228
FT   HELIX       229    241
FT   TURN        242    242
SQ   SEQUENCE   243 AA;  25425 MW;  E02FAF04 CRC32;
     FIFLALLGAA VAFPVDDDDK IVGGYTCGAN TVPYQVSLNS GYHFCGGSLI NSQWVVSAAH
     CYKSGIQVRL GEDNINVVEG NEQFISASKS IVHPSYNSNT LNNDIMLIKL KSAASLNSRV
     ASISLPTSCA SAGTQCLISG WGNTKSSGTS YPDVLKCLKA PILSDSSCKS AYPGQITSNM
     FCAGYLEGGK DSCQGDSGGP VVCSGKLQGI VSWGSGCAQK NKPGVYTKVC NYVSWIKQTI
     ASN
//
ID   TRYP_STRGR     STANDARD;      PRT;   259 AA.
AC   P00775;
DT   21-JUL-1986 (REL. 01, CREATED)
DT   01-FEB-1994 (REL. 28, LAST SEQUENCE UPDATE)
DT   01-NOV-1995 (REL. 32, LAST ANNOTATION UPDATE)
DE   TRYPSIN PRECURSOR (EC 3.4.21.4) (SGT).
GN   SPRT.
OS   STREPTOMYCES GRISEUS.
OC   BACTERIA; FIRMICUTES; ACTINOBACTERIA; ACTINOBACTERIDAE;
OC   ACTINOMYCETALES; STREPTOMYCINEAE; STREPTOMYCETACEAE; STREPTOMYCES.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=ATCC 10137;
RX   MEDLINE; 92095977.
RA   KIM J.C., CHA S.H., JEONG S.T., OH S.K., BYUN S.M.;
RT   "Molecular cloning and nucleotide sequence of Streptomyces griseus
RT   trypsin gene.";
RL   BIOCHEM. BIOPHYS. RES. COMMUN. 181:707-713(1991).
RN   [2]
RP   SEQUENCE OF 37-259.
RX   MEDLINE; 75127940.
RA   OLAFSON R.W., JURASEK L., CARPENTER M.R., SMILLIE L.B.;
RT   "Amino acid sequence of Streptomyces griseus trypsin. Cyanogen
RT   bromide fragments and complete sequence.";
RL   BIOCHEMISTRY 14:1168-1177(1975).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   MEDLINE; 88286735.
RA   READ R.J., JAMES M.N.G.;
RT   "Refined crystal structure of Streptomyces griseus trypsin at 1.7-A
RT   resolution.";
RL   J. MOL. BIOL. 200:523-551(1988).
CC   -!- CATALYTIC ACTIVITY: PREFERENTIAL CLEAVAGE: ARG-, LYS-.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY S1; ALSO KNOWN AS THE
CC       TRYPSIN FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M64471; G409446; ALT_SEQ.
DR   PIR; A00962; TRSMG.
DR   PIR; JQ1302; JQ1302.
DR   PDB; 1SGT; 16-JUL-88.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
DR   PFAM; PF00089; trypsin; 1.
KW   HYDROLASE; SERINE PROTEASE; ZYMOGEN; SIGNAL; 3D-STRUCTURE.
FT   SIGNAL        1     32
FT   PROPEP       33     36       ACTIVATION PEPTIDE.
FT   CHAIN        37    259       TRYPSIN.
FT   ACT_SITE     73     73       CHARGE RELAY SYSTEM.
FT   ACT_SITE    118    118       CHARGE RELAY SYSTEM.
FT   ACT_SITE    208    208       CHARGE RELAY SYSTEM.
FT   DISULFID     58     74
FT   DISULFID    177    192
FT   DISULFID    204    233
FT   SITE        202    202       REQUIRED FOR SPECIFICITY.
FT   CONFLICT     95     96       MISSING (IN REF. 2).
FT   STRAND       38     38
FT   TURN         39     39
FT   STRAND       41     42
FT   TURN         45     46
FT   TURN         49     50
FT   STRAND       51     54
FT   TURN         55     57
FT   STRAND       58     64
FT   TURN         65     66
FT   STRAND       67     70
FT   HELIX        72     74
FT   STRAND       79     80
FT   STRAND       85     88
FT   STRAND       92     92
FT   TURN         93     94
FT   TURN         96     97
FT   STRAND       99    108
FT   TURN        110    111
FT   STRAND      120    124
FT   STRAND      134    135
FT   TURN        140    141
FT   STRAND      145    150
FT   TURN        156    157
FT   STRAND      163    163
FT   STRAND      165    172
FT   HELIX       174    184
FT   TURN        187    189
FT   STRAND      190    193
FT   TURN        196    198
FT   STRAND      202    202
FT   TURN        205    206
FT   TURN        208    209
FT   STRAND      211    215
FT   TURN        217    218
FT   STRAND      221    229
FT   TURN        236    237
FT   STRAND      240    244
FT   HELIX       245    257
FT   TURN        258    258
SQ   SEQUENCE   259 AA;  26776 MW;  922B81EA CRC32;
     MKHFLRALKR CSVAVATVAI AVVGLQPVTA SAAPNPVVGG TRAAQGEFPF MVRLSMGCGG
     ALYAQDIVLT AAHCVSGSGN NTSITATGGV VDLQSSSAVK VRSTKVLQAP GYNGTGKDWA
     LIKLAQPINQ PTLKIATTTA YNQGTFTVAG WGANREGGSQ QRYLLKANVP FVSDAACRSA
     YGNELVANEE ICAGYPDTGG VDTCQGDSGG PMFRKDNADE WIQVGIVSWG YGCARPGYPG
     VYTEVSTFAS AIASAARTL
//
ID   LDHA_PIG       STANDARD;      PRT;   331 AA.
AC   P00339;
DT   21-JUL-1986 (Rel. 01, Created)
DT   01-NOV-1995 (Rel. 32, Last sequence update)
DT   01-NOV-1997 (Rel. 35, Last annotation update)
DE   L-LACTATE DEHYDROGENASE M CHAIN (EC 1.1.1.27) (LDH-A).
GN   LDHA.
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia;
OC   Eutheria; Cetartiodactyla; Suina; Suidae; Sus.
RN   [1]
RP   SEQUENCE FROM N.A.
RC   TISSUE=MUSCLE;
RX   MEDLINE; 95023917.
RA   Tsuji S., Qureshi M.A., Hou E.W., Fitch W.M., Li S.S.-L.;
RT   "Evolutionary relationships of lactate dehydrogenases (LDHs) from
RT   mammals, birds, an amphibian, fish, barley, and bacteria: LDH cDNA
RT   sequences from Xenopus, pig, and rat.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:9392-9396(1994).
RN   [2]
RP   SEQUENCE.
RX   MEDLINE; 77117453.
RA   Kiltz H.-H., Keil W., Griesbach M., Petry K., Meyer H.;
RT   "The primary structure of porcine lactate dehydrogenase: isoenzymes
RT   M4 and H4.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 358:123-127(1977).
CC   -!- CATALYTIC ACTIVITY: L-LACTATE + NAD(+) = PYRUVATE + NADH.
CC   -!- PATHWAY: FINAL STEP IN ANAEROBIC GLYCOLYSIS.
CC   -!- SUBUNIT: HOMOTETRAMER.
CC   -!- MISCELLANEOUS: THERE ARE THREE TYPES OF LDH CHAINS: M (LDH-A)
CC       FOUND PREDOMINANTLY IN MUSCLE TISSUES, H (LDH-B) FOUND IN HEART
CC       MUSCLE AND X (LDH-C) WHICH IS PRESENT IN THE SPERMATOZOA OF
CC       MAMMALS, IN THE COLUMBIDAE OF BIRDS AND IN ACTINOPTERYGIAN FISH.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U07178; AAA50436.1; -.
DR   PIR; A00348; DEPGLM.
DR   PDB; 9LDB; 31-OCT-93.
DR   PDB; 9LDT; 31-OCT-93.
DR   PRINTS; PR00086; LLDHDRGNASE.
DR   PROSITE; PS00064; L_LDH; 1.
DR   PFAM; PF00056; ldh; 1.
KW   Oxidoreductase; NAD; Glycolysis; Multigene family; Acetylation;
KW   3D-structure.
FT   INIT_MET      0      0
FT   MOD_RES       1      1       ACETYLATION.
FT   ACT_SITE    192    192       ACCEPTS A PROTON DURING CATALYSIS.
FT   CONFLICT    232    232       Q -> E (IN REF. 2).
FT   CONFLICT    285    285       D -> N (IN REF. 2).
FT   HELIX         3      7
FT   STRAND       21     25
FT   HELIX        29     40
FT   TURN         41     42
FT   STRAND       46     50
FT   HELIX        54     66
FT   TURN         67     67
FT   HELIX        68     70
FT   STRAND       75     79
FT   HELIX        82     85
FT   TURN         86     87
FT   STRAND       90     93
FT   TURN        101    102
FT   HELIX       105    126
FT   TURN        128    129
FT   STRAND      131    134
FT   HELIX       139    150
FT   TURN        154    155
FT   STRAND      157    159
FT   TURN        161    162
FT   HELIX       163    177
FT   TURN        178    178
FT   HELIX       181    183
FT   STRAND      184    185
FT   STRAND      188    190
FT   TURN        194    195
FT   STRAND      197    198
FT   HELIX       200    202
FT   STRAND      204    205
FT   TURN        206    207
FT   STRAND      208    209
FT   HELIX       210    213
FT   TURN        215    216
FT   TURN        226    226
FT   HELIX       227    244
FT   HELIX       249    263
FT   TURN        264    265
FT   STRAND      268    275
FT   TURN        277    279
FT   STRAND      287    295
FT   TURN        296    297
FT   STRAND      298    302
FT   HELIX       309    329
SQ   SEQUENCE   331 AA;  36487 MW;  5E3A2C3766A110A8 CRC64;
     ATLKDQLIHN LLKEEHVPHN KITVVGVGAV GMACAISILM KELADEIALV DVMEDKLKGE
     MMDLQHGSLF LRTPKIVSGK DYNVTANSRL VVITAGARQQ EGESRLNLVQ RNVNIFKFII
     PNIVKYSPNC KLLVVSNPVD ILTYVAWKIS GFPKNRVIGS GCNLDSARFR YLMGERLGVH
     PLSCHGWILG EHGDSSVPVW SGVNVAGVSL KNLHPELGTD ADKEHWKAVH KQVVDSAYEV
     IKLKGYTSWA IGLSVADLAE SIMKNLRRVH PISTMIKGLY GIKEDVFLSV PCILGQNGIS
     DVVKVTLTPE EEAHLKKSAD TLWGIQKELQ F
//
ID   POXB_LACPL     STANDARD;      PRT;   603 AA.
AC   P37063;
DT   01-JUN-1994 (Rel. 29, Created)
DT   01-OCT-1994 (Rel. 30, Last sequence update)
DT   01-FEB-1995 (Rel. 31, Last annotation update)
DE   PYRUVATE OXIDASE (EC 1.2.3.3) (PYRUVIC OXIDASE) (POX).
OS   Lactobacillus plantarum.
OC   Bacteria; Firmicutes; Bacillus/Clostridium group; Lactobacillaceae;
OC   Lactobacillus.
RN   [1]
RP   X-RAY CRYSTALLOGRAPHY (2.5 AND 2.1 ANGSTROMS) OF WILD-TYPE AND MUTANT.
RX   MEDLINE; 94194507.
RA   Muller Y.A., Schumacher G., Rudolph R., Schulz G.E.;
RT   "The refined structures of a stabilized mutant and of wild-type
RT   pyruvate oxidase from Lactobacillus plantarum.";
RL   J. Mol. Biol. 237:315-335(1994).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   MEDLINE; 93174262.
RA   Muller Y.A., Schulz G.E.;
RT   "Structure of the thiamine- and flavin-dependent enzyme pyruvate
RT   oxidase.";
RL   Science 259:965-967(1993).
CC   -!- FUNCTION: IMPORTANT FOR THE AEROBIC GROWTH. DECARBOXYLATES
CC       PYRUVATE IN FOUR STEPS. THE ENERGY RELEASED IS PARTIALLY STORED
CC       IN ACETYL PHOSPHATE.
CC   -!- CATALYTIC ACTIVITY: PYRUVATE + ORTHOPHOSPHATE + O(2) + H(2)O =
CC       ACETYL PHOSPHATE + CO(2) + H(2)O(2).
CC   -!- COFACTOR: THIAMINE PYROPHOSPHATE, FAD AND MAGNESIUM ION.
CC   -!- SUBUNIT: HOMOTETRAMER.
CC   -!- DOMAIN: EACH MONOMER IS DIVIDED INTO THREE DOMAINS, EACH OF WHICH
CC       CONTAINS A SIX-STRANDED PARALLEL BETA SHEET SURROUNDED BY ALPHA
CC       HELICES.
CC   -!- SIMILARITY: WITH OTHER ENZYMES WHICH REQUIRE TPP.
DR   PDB; 1POW; 31-JAN-94.
DR   PDB; 1POX; 31-JAN-94.
DR   PROSITE; PS00187; TPP_ENZYMES; 1.
DR   PFAM; PF00205; TPP_enzymes; 1.
KW   Oxidoreductase; Flavoprotein; FAD; Thiamine pyrophosphate; Magnesium;
KW   3D-structure.
FT   DOMAIN        1    191       CORE.
FT   DOMAIN      192    342       FAD.
FT   DOMAIN      343    603       TPP.
FT   ACT_SITE     59     59       BY SIMILARITY.
FT   METAL       447    447       MAGNESIUM.
FT   METAL       474    474       MAGNESIUM.
FT   METAL       476    476       MAGNESIUM.
FT   STRAND       10     12
FT   HELIX        13     23
FT   TURN         24     25
FT   STRAND       28     31
FT   HELIX        35     46
FT   TURN         47     50
FT   STRAND       52     55
FT   HELIX        59     73
FT   STRAND       77     81
FT   TURN         83     84
FT   HELIX        85     88
FT   TURN         89     90
FT   HELIX        91     99
FT   TURN        100    101
FT   STRAND      104    110
FT   TURN        113    117
FT   TURN        121    122
FT   HELIX       127    130
FT   TURN        131    133
FT   STRAND      136    139
FT   TURN        144    145
FT   HELIX       146    160
FT   TURN        161    161
FT   STRAND      163    169
FT   TURN        170    171
FT   HELIX       172    174
FT   STRAND      176    178
FT   TURN        179    180
FT   HELIX       186    188
FT   STRAND      196    196
FT   HELIX       199    211
FT   STRAND      215    219
FT   HELIX       221    237
FT   TURN        238    238
FT   STRAND      241    243
FT   HELIX       245    247
FT   TURN        248    249
FT   TURN        253    254
FT   TURN        256    257
FT   STRAND      258    258
FT   HELIX       268    276
FT   STRAND      279    283
FT   TURN        288    298
FT   STRAND      301    306
FT   HELIX       309    311
FT   TURN        312    313
FT   STRAND      320    323
FT   HELIX       326    336
FT   HELIX       344    364
FT   TURN        365    365
FT   STRAND      370    370
FT   HELIX       373    383
FT   TURN        386    387
FT   STRAND      389    392
FT   HELIX       396    404
FT   TURN        409    410
FT   STRAND      412    414
FT   TURN        422    423
FT   HELIX       425    435
FT   TURN        437    438
FT   STRAND      441    446
FT   HELIX       447    462
FT   TURN        463    464
FT   STRAND      468    473
FT   STRAND      476    476
FT   HELIX       478    487
FT   STRAND      496    496
FT   HELIX       502    509
FT   TURN        510    510
FT   STRAND      512    516
FT   STRAND      518    518
FT   HELIX       519    532
FT   TURN        533    535
FT   STRAND      538    543
FT   TURN        552    553
FT   TURN        559    561
FT   HELIX       564    574
FT   TURN        575    575
FT   TURN        577    578
FT   HELIX       582    588
FT   TURN        589    590
SQ   SEQUENCE   603 AA;  66141 MW;  71BEC3CF52060FBE CRC64;
     MVMKQTKQTN ILAGAAVIKV LEAWGVDHLY GIPGGSINSI MDALSAERDR IHYIQVRHEE
     VGAMAAAADA KLTGKIGVCF GSAGPGGTHL MNGLYDARED HVPVLALIGQ FGTTGMNMDT
     FQEMNENPIY ADVADYNVTA VNAATLPHVI DEAIRRAYAH QGVAVVQIPV DLPWQQIPAE
     DWYASANSYQ TPLLPEPDVQ AVTRLTQTLL AAERPLIYYG IGARKAGKEL EQLSKTLKIP
     LMSTYPAKGI VADRYPAYLG SANRVAQKPA NEALAQADVV LFVGNNYPFA EVSKAFKNTR
     YFLQIDIDPA KLGKRHKTDI AVLADAQKTL AAILAQVSER ESTPWWQANL ANVKNWRAYL
     ASLEDKQEGP LQAYQVLRAV NKIAEPDAIY SIDVGDINLN ANRHLKLTPS NRHITSNLFA
     TMGVGIPGAI AAKLNYPERQ VFNLAGDGGA SMTMQDLATQ VQYHLPVINV VFTNCQYGFI
     KDEQEDTNQN DFIGVEFNDI DFSKIADGVH MQAFRVNKIE QLPDVFEQAK AIAQHEPVLI
     DAVITGDRPL PAEKLRLDSA MSSAADIEAF KQRYEAQDLQ PLSTYLKQFG LDDLQHQIGQ
     GGF
//
ID   RENS_MOUSE     STANDARD;      PRT;   401 AA.
AC   P00796; P97955; Q62155; P70229;
DT   21-JUL-1986 (Rel. 01, Created)
DT   21-JUL-1986 (Rel. 01, Last sequence update)
DT   15-JUL-1999 (Rel. 38, Last annotation update)
DE   RENIN PRECURSOR, SUBMANDIBULAR GLAND (EC 3.4.23.15)
DE   (ANGIOTENSINOGENASE).
GN   REN2.
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia;
OC   Eutheria; Rodentia; Sciurognathi; Muridae; Murinae; Mus.
RN   [1]
RP   SEQUENCE OF 64-351 AND 354-401.
RX   MEDLINE; 83014991.
RA   Misono K.S., Chang J.-J., Inagami T.;
RT   "Amino acid sequence of mouse submaxillary gland renin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:4858-4862(1982).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 82220074.
RA   Panthier J.-J., Foote S., Chambraud B., Strosberg A.D., Corvol P.,
RA   Rougeon F.;
RT   "Complete amino acid sequence and maturation of the mouse
RT   submaxillary gland renin precursor.";
RL   Nature 298:90-92(1982).
RN   [3]
RP   SEQUENCE OF 1-29 FROM N.A.
RX   MEDLINE; 84298161.
RA   Panthier J.-J., Dreyfus M., Roux D.T.L., Rougeon F.;
RT   "Mouse kidney and submaxillary gland renin genes differ in their 5'
RT   putative regulatory sequences.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:5489-5493(1984).
RN   [4]
RP   SEQUENCE OF 1-10 FROM N.A.
RX   MEDLINE; 90108722.
RA   Burt D.W., Mullins L.J., George H., Smith G., Brooks J., Pioli D.,
RA   Brammar W.J.;
RT   "The nucleotide sequence of a mouse renin-encoding gene, Ren-1d, and
RT   its upstream region.";
RL   Gene 84:91-104(1989).
RN   [5]
RP   SEQUENCE OF 1-30 FROM N.A.
RX   MEDLINE; 85085936.
RA   Field L.J., Philbrick W.M., Howles P.N., Dickinson D.P.,
RA   McGowan R.A., Gross K.W.;
RT   "Expression of tissue-specific Ren-1 and Ren-2 genes of mice:
RT   comparative analysis of 5'-proximal flanking regions.";
RL   Mol. Cell. Biol. 4:2321-2331(1984).
RN   [6]
RP   SEQUENCE OF 267-292 FROM N.A.
RX   MEDLINE; 84057744.
RA   Panthier J.J., Rougeon F.;
RT   "Kidney and submaxillary gland renins are encoded by two non-allelic
RT   genes in Swiss mice.";
RL   EMBO J. 2:675-678(1983).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   MEDLINE; 92301530.
RA   Dhanaraj V., Dealwis C.G., Frazao C., Badasso M., Sibanda B.L.,
RA   Tickle I.J., Cooper J.B., Driessen H.P.C., Newman M., Aguilar C.,
RA   Wood S.P., Blundell T.L., Hobart P.M., Geoghegan K.F., Ammirati M.J.,
RA   Danley D.E., O'Connor B.A., Hoover D.J.;
RT   "X-ray analyses of peptide-inhibitor complexes define the structural
RT   basis of specificity for human and mouse renins.";
RL   Nature 357:466-472(1992).
CC   -!- FUNCTION: RENIN IS A HIGHLY SPECIFIC ENDOPEPTIDASE, RELATED TO
CC       PEPSIN, WHOSE ONLY KNOWN FUNCTION IS TO GENERATE ANGIOTENSIN I
CC       FROM ANGIOTENSINOGEN IN THE PLASMA, INITIATING A CASCADE OF
CC       REACTIONS THAT PRODUCE AN ELEVATION OF BLOOD PRESSURE & INCREASED
CC       SODIUM RETENTION BY THE KIDNEY.
CC   -!- FUNCTION: ITS FUNCTION IN THE SALIVARY GLAND IS NOT UNDERSTOOD.
CC   -!- SUBUNIT: DIMER OF A HEAVY CHAIN AND A LIGHT CHAIN JOINED BY A
CC       DISULFIDE BOND.
CC   -!- TISSUE SPECIFICITY: SUBMANDIBULAR GLAND.
CC   -!- MISCELLANEOUS: THE ACTIVE ENZYME ISOLATED FROM THE SUBMANDIBULAR
CC       GLAND HAS CATALYTIC AND ANTIGENIC ACTIVITIES SIMILAR TO RENAL
CC       RENIN.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY A1; ALSO KNOWN AS THE
CC       EUKARYOTIC ASPARTYL PROTEASES FAMILY.
CC   -!- CAUTION: REF.2 SEQUENCE DIFFERS FROM THAT SHOWN IN HAVING 195-198
CC       LEU-SER-ARG-SER, WHICH IS DUE TO A SHIFT IN THE TRANSLATION
CC       READING FRAME, AND 395-VAL. THE AUTHORS' TRANSLATION FOR 99 AGREES
CC       WITH THAT SHOWN BUT DOES NOT AGREE WITH THE NUCLEIC ACID SEQUENCE.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; J00621; AAA40050.1; ALT_FRAME.
DR   EMBL; K02597; AAA40048.1; -.
DR   EMBL; M34191; AAA40046.1; -.
DR   EMBL; K02801; AAA40047.1; -.
DR   PIR; A00988; REMSS.
DR   PIR; B22058; B22058.
DR   PDB; 1SMR; 31-JAN-94.
DR   MGD; MGI:97899; Ren2.
DR   PRINTS; PR00792; PEPSIN.
DR   PROSITE; PS00141; ASP_PROTEASE; 2.
DR   PFAM; PF00026; asp; 1.
KW   Hydrolase; Aspartyl protease; Plasma; Signal; Zymogen;
KW   Submandibular gland; 3D-structure.
FT   SIGNAL        1     25       PROBABLE.
FT   PROPEP       26     63       ACTIVATION PEPTIDE.
FT   CHAIN        64    351       HEAVY CHAIN.
FT   CHAIN       354    401       LIGHT CHAIN.
FT   ACT_SITE    101    101
FT   ACT_SITE    286    286
FT   DISULFID    114    121
FT   DISULFID    277    281
FT   DISULFID    320    357
FT   CONFLICT     13     13       L -> W (IN REF. 4).
FT   STRAND       69     69
FT   STRAND       71     78
FT   TURN         79     81
FT   STRAND       82     89
FT   TURN         90     93
FT   STRAND       94    101
FT   TURN        102    103
FT   STRAND      107    111
FT   TURN        112    113
FT   TURN        116    117
FT   HELIX       119    123
FT   STRAND      127    127
FT   HELIX       129    131
FT   TURN        133    134
FT   STRAND      136    146
FT   TURN        147    148
FT   STRAND      149    162
FT   TURN        163    164
FT   STRAND      165    176
FT   HELIX       179    182
FT   TURN        183    184
FT   STRAND      189    192
FT   HELIX       196    198
FT   HELIX       200    202
FT   HELIX       206    212
FT   TURN        213    214
FT   STRAND      216    216
FT   STRAND      220    225
FT   STRAND      234    238
FT   HELIX       243    245
FT   STRAND      246    254
FT   STRAND      257    257
FT   TURN        258    261
FT   STRAND      262    270
FT   TURN        271    272
FT   STRAND      276    276
FT   TURN        278    279
FT   STRAND      281    285
FT   TURN        287    288
FT   STRAND      289    289
FT   STRAND      292    294
FT   HELIX       296    306
FT   TURN        307    307
FT   STRAND      309    312
FT   TURN        313    314
FT   STRAND      315    319
FT   HELIX       320    325
FT   STRAND      329    333
FT   TURN        334    335
FT   STRAND      336    340
FT   HELIX       342    345
FT   STRAND      346    346
FT   TURN        347    348
FT   STRAND      356    359
FT   STRAND      361    363
FT   TURN        368    370
FT   STRAND      374    376
FT   HELIX       378    381
FT   TURN        382    383
FT   STRAND      384    389
FT   TURN        390    393
FT   STRAND      394    400
SQ   SEQUENCE   401 AA;  44282 MW;  D938931F91F82980 CRC64;
     MDRRRMPLWA LLLLWSPCTF SLPTGTTFER IPLKKMPSVR EILEERGVDM TRLSAEWDVF
     TKRSSLTDLI SPVVLTNYLN SQYYGEIGIG TPPQTFKVIF DTGSANLWVP STKCSRLYLA
     CGIHSLYESS DSSSYMENGD DFTIHYGSGR VKGFLSQDSV TVGGITVTQT FGEVTELPLI
     PFMLAQFDGV LGMGFPAQAV GGVTPVFDHI LSQGVLKEKV FSVYYNRGPH LLGGEVVLGG
     SDPEHYQGDF HYVSLSKTDS WQITMKGVSV GSSTLLCEEG CEVVVDTGSS FISAPTSSLK
     LIMQALGAKE KRLHEYVVSC SQVPTLPDIS FNLGGRAYTL SSTDYVLQYP NRRDKLCTVA
     LHAMDIPPPT GPVWVLGATF IRKFYTEFDR HNNRIGFALA R
//
ID   IGFB_HUMAN     STANDARD;      PRT;   195 AA.
AC   P05019;
DT   13-AUG-1987 (Rel. 05, Created)
DT   13-AUG-1987 (Rel. 05, Last sequence update)
DT   15-DEC-1998 (Rel. 37, Last annotation update)
DE   INSULIN-LIKE GROWTH FACTOR IB PRECURSOR (IGF-IB) (SOMATOMEDIN C).
GN   IGF1 OR IBP1.
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia;
OC   Eutheria; Primates; Catarrhini; Hominidae; Homo.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86168194.
RA   ROTWEIN P., POLLOCK K.M., DIDIER D.K., KRIVI G.G.;
RT   "Organization and sequence of the human insulin-like growth factor I
RT   gene. Alternative RNA processing produces two insulin-like growth
RT   factor I precursor peptides.";
RL   J. Biol. Chem. 261:4828-4832(1986).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86094355.
RA   ROTWEIN P.;
RT   "Two insulin-like growth factor I messenger RNAs are expressed in
RT   human liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:77-81(1986).
RN   [3]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86108862.
RA   DE PAGTER-HOLTHUIZEN P., VAN SCHAIK F.M.A., VERDUIJN G.M.,
RA   VAN OMMEN G.J.B., BOUMA B.N., JANSEN M., SUSSENBACH J.S.;
RT   "Organization of the human genes for insulin-like growth factors I
RT   and II.";
RL   FEBS Lett. 195:179-184(1986).
RN   [4]
RP   SEQUENCE OF 22-50 FROM N.A.
RX   MEDLINE; 84295593.
RA   DULL T.J., GRAY A., HAYFLICK J.S., ULLRICH A.;
RT   "Insulin-like growth factor II precursor gene organization in
RT   relation to insulin gene family.";
RL   Nature 310:777-781(1984).
RN   [5]
RP   SEQUENCE OF 49-118.
RX   MEDLINE; 78130171.
RA   RINDERKNECHT E., HUMBEL R.E.;
RT   "The amino acid sequence of human insulin-like growth factor I and
RT   its structural homology with proinsulin.";
RL   J. Biol. Chem. 253:2769-2776(1978).
RN   [6]
RP   3D-STRUCTURE MODELING.
RX   MEDLINE; 83210259.
RA   BLUNDELL T.L., BEDARKAR S., HUMBEL R.E.;
RT   "Tertiary structures, receptor binding, and antigenicity of
RT   insulinlike growth factors.";
RL   Fed. Proc. 42:2592-2597(1983).
RN   [7]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 91242464.
RA   COOKE R.M., HARVEY T.S., CAMPBELL I.D.;
RT   "Solution structure of human insulin-like growth factor 1: a nuclear
RT   magnetic resonance and restrained molecular dynamics study.";
RL   Biochemistry 30:5484-5491(1991).
RN   [8]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 92316903.
RA   SATO A., NISHIMURA S., OHKUBO T., KYOGOKU Y., KOYAMA S., KOBAYASHI M.,
RA   YASUDA T., KOBAYASHI Y.;
RT   "1H-NMR assignment and secondary structure of human insulin-like
RT   growth factor-I (IGF-I) in solution.";
RL   J. Biochem. 111:529-536(1992).
RN   [9]
RP   DISULFIDE BONDS.
RX   MEDLINE; 89207850.
RA   RASCHDORF F., DAHINDEN R., MAERKI W., RICHTER W.J., MERRYWEATHER J.P.;
RT   "Location of disulphide bonds in human insulin-like growth factors
RT   (IGFs) synthesized by recombinant DNA technology.";
RL   Biomed. Environ. Mass Spectrom. 16:3-8(1988).
CC   -!- FUNCTION: THE INSULIN-LIKE GROWTH FACTORS, ISOLATED FROM PLASMA,
CC       ARE STRUCTURALLY AND FUNCTIONALLY RELATED TO INSULIN BUT HAVE A
CC       MUCH HIGHER GROWTH-PROMOTING ACTIVITY.
CC   -!- SUBCELLULAR LOCATION: SECRETED.
CC   -!- ALTERNATIVE PRODUCTS: TWO FORMS OF IGF-1, IGF-IA AND IGF-IB ARE
CC       PRODUCED BY ALTERNATIVE SPLICING.
CC   -!- SIMILARITY: BELONGS TO THE INSULIN/IGF/RELAXIN FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M14155; AAA52537.1; -.
DR   EMBL; M12659; AAA52537.1; JOINED.
DR   EMBL; M14153; AAA52537.1; JOINED.
DR   EMBL; M14154; AAA52537.1; JOINED.
DR   EMBL; M11568; AAA52539.1; -.
DR   EMBL; X03563; CAA27250.1; ALT_SEQ.
DR   EMBL; X03420; CAA27152.1; -.
DR   EMBL; X03421; CAA27153.1; -.
DR   EMBL; X03422; CAA27154.1; -.
DR   PIR; A01611; IGHU1B.
DR   PIR; A23614; A23614.
DR   PIR; A26181; A26181.
DR   PIR; S30540; S30540.
DR   PDB; 1GF1; 15-OCT-94.
DR   PDB; 2GF1; 15-APR-93.
DR   PDB; 3GF1; 15-APR-93.
DR   MIM; 147440; -.
DR   MIM; 265850; -.
DR   PFAM; PF00049; Insulin; 1.
DR   PROSITE; PS00262; INSULIN; 1.
KW   Insulin family; Growth factor; 3D-structure; Plasma;
KW   Alternative splicing; Signal.
FT   SIGNAL        1     21       POTENTIAL.
FT   PROPEP       22     48
FT   CHAIN        49    118       INSULIN-LIKE GROWTH FACTOR IB.
FT   DOMAIN       49     77       B.
FT   DOMAIN       78     89       C.
FT   DOMAIN       90    110       A.
FT   DOMAIN      111    118       D.
FT   PROPEP      119    195       E PEPTIDE.
FT   DISULFID     54     96
FT   DISULFID     66    109
FT   DISULFID     95    100
FT   STRAND       51     51
FT   TURN         55     55
FT   HELIX        56     65
FT   TURN         66     68
FT   STRAND       78     78
FT   TURN         79     81
FT   STRAND       82     82
FT   TURN         87     88
FT   HELIX        91     96
FT   TURN         97     97
FT   STRAND       98     98
FT   TURN        102    104
FT   HELIX       106    108
FT   TURN        109    109
SQ   SEQUENCE   195 AA;  21841 MW;  0CF1559B CRC32;
     MGKISSLPTQ LFKCCFCDFL KVKMHTMSSS HLFYLALCLL TFTSSATAGP ETLCGAELVD
     ALQFVCGDRG FYFNKPTGYG SSSRRAPQTG IVDECCFRSC DLRRLEMYCA PLKPAKSARS
     VRAQRHTDMP KTQKYQPPST NKNTKSQRRK GWPKTHPGGE QKEGTEASLQ IRGKKKEQRR
     EIGSRNAECR GKKGK
//
ID   IGFA_HUMAN     STANDARD;      PRT;   153 AA.
AC   P01343;
DT   21-JUL-1986 (Rel. 01, Created)
DT   13-AUG-1987 (Rel. 05, Last sequence update)
DT   15-DEC-1998 (Rel. 37, Last annotation update)
DE   INSULIN-LIKE GROWTH FACTOR IA PRECURSOR (IGF-IA) (SOMATOMEDIN C).
GN   IGF1 OR IBP1.
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia;
OC   Eutheria; Primates; Catarrhini; Hominidae; Homo.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86168194.
RA   ROTWEIN P., POLLOCK K.M., DIDIER D.K., KRIVI G.G.;
RT   "Organization and sequence of the human insulin-like growth factor I
RT   gene. Alternative RNA processing produces two insulin-like growth
RT   factor I precursor peptides.";
RL   J. Biol. Chem. 261:4828-4832(1986).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 84068210.
RA   JANSEN M., VAN SCHAIK F.M.A., RICKER A.T., BULLOCK B., WOODS D.E.,
RA   GABBAY K.H., NUSSBAUM A.L., SUSSENBACH J.S., VAN DEN BRANDE J.L.;
RT   "Sequence of cDNA encoding human insulin-like growth factor I
RT   precursor.";
RL   Nature 306:609-611(1983).
RN   [3]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86108910.
RA   LE BOUC Y., DREYER D., JAEGER F., BINOUX M., SONDERMEYER P.;
RT   "Complete characterization of the human IGF-I nucleotide sequence
RT   isolated from a newly constructed adult liver cDNA library.";
RL   FEBS Lett. 196:108-112(1986).
RN   [4]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86108862.
RA   DE PAGTER-HOLTHUIZEN P., VAN SCHAIK F.M.A., VERDUIJN G.M.,
RA   VAN OMMEN G.J.B., BOUMA B.N., JANSEN M., SUSSENBACH J.S.;
RT   "Organization of the human genes for insulin-like growth factors I
RT   and II.";
RL   FEBS Lett. 195:179-184(1986).
RN   [5]
RP   SEQUENCE FROM N.A.
RC   TISSUE=LIVER;
RX   MEDLINE; 91207342.
RA   STEENBERGH P.H., KOONEN-REEMST A.M.C.B., CLEUTJENS C.B.J.M.,
RA   SUSSENBACH J.S.;
RT   "Complete nucleotide sequence of the high molecular weight human
RT   IGF-I mRNA.";
RL   Biochem. Biophys. Res. Commun. 175:507-514(1991).
RN   [6]
RP   SEQUENCE FROM N.A.
RC   TISSUE=BRAIN;
RX   MEDLINE; 92186627.
RA   SANDBERG NORDQVIST A.C., STAHLBOM P.A., LAKE M., SARA V.R.;
RT   "Characterization of two cDNAs encoding insulin-like growth factor 1
RT   (IGF-1) in the human fetal brain.";
RL   Brain Res. Mol. Brain Res. 12:275-277(1992).
RN   [7]
RP   SEQUENCE OF 24-50 AND 119-153 FROM N.A.
RX   MEDLINE; 84295593.
RA   DULL T.J., GRAY A., HAYFLICK J.S., ULLRICH A.;
RT   "Insulin-like growth factor II precursor gene organization in
RT   relation to insulin gene family.";
RL   Nature 310:777-781(1984).
RN   [8]
RP   SEQUENCE OF 49-118.
RX   MEDLINE; 78130171.
RA   RINDERKNECHT E., HUMBEL R.E.;
RT   "The amino acid sequence of human insulin-like growth factor I and
RT   its structural homology with proinsulin.";
RL   J. Biol. Chem. 253:2769-2776(1978).
RN   [9]
RP   3D-STRUCTURE MODELING.
RX   MEDLINE; 83210259.
RA   BLUNDELL T.L., BEDARKAR S., HUMBEL R.E.;
RT   "Tertiary structures, receptor binding, and antigenicity of
RT   insulinlike growth factors.";
RL   Fed. Proc. 42:2592-2597(1983).
RN   [10]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 91242464.
RA   COOKE R.M., HARVEY T.S., CAMPBELL I.D.;
RT   "Solution structure of human insulin-like growth factor 1: a nuclear
RT   magnetic resonance and restrained molecular dynamics study.";
RL   Biochemistry 30:5484-5491(1991).
RN   [11]
RP   STRUCTURE BY NMR.
RX   MEDLINE; 92316903.
RA   SATO A., NISHIMURA S., OHKUBO T., KYOGOKU Y., KOYAMA S., KOBAYASHI M.,
RA   YASUDA T., KOBAYASHI Y.;
RT   "1H-NMR assignment and secondary structure of human insulin-like
RT   growth factor-I (IGF-I) in solution.";
RL   J. Biochem. 111:529-536(1992).
RN   [12]
RP   DISULFIDE BONDS.
RX   MEDLINE; 89207850.
RA   RASCHDORF F., DAHINDEN R., MAERKI W., RICHTER W.J., MERRYWEATHER J.P.;
RT   "Location of disulphide bonds in human insulin-like growth factors
RT   (IGFs) synthesized by recombinant DNA technology.";
RL   Biomed. Environ. Mass Spectrom. 16:3-8(1988).
CC   -!- FUNCTION: THE INSULIN-LIKE GROWTH FACTORS, ISOLATED FROM PLASMA,
CC       ARE STRUCTURALLY AND FUNCTIONALLY RELATED TO INSULIN BUT HAVE A
CC       MUCH HIGHER GROWTH-PROMOTING ACTIVITY.
CC   -!- SUBCELLULAR LOCATION: SECRETED.
CC   -!- ALTERNATIVE PRODUCTS: TWO FORMS OF IGF-1, IGF-IA AND IGF-IB ARE
CC       PRODUCED BY ALTERNATIVE SPLICING.
CC   -!- SIMILARITY: BELONGS TO THE INSULIN/IGF/RELAXIN FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M14156; AAA52538.1; -.
DR   EMBL; M12659; AAA52538.1; JOINED.
DR   EMBL; M14153; AAA52538.1; JOINED.
DR   EMBL; M14154; AAA52538.1; JOINED.
DR   EMBL; X00173; CAA24998.1; -.
DR   EMBL; X03563; CAA27250.1; ALT_SEQ.
DR   EMBL; M27544; AAA52787.1; -.
DR   EMBL; X03420; CAA27152.1; -.
DR   EMBL; X03421; CAA27153.1; -.
DR   EMBL; X03422; CAA27154.1; -.
DR   EMBL; X57025; CAA40342.1; -.
DR   EMBL; X56773; CAA40092.1; -.
DR   PIR; A01610; IGHU1.
DR   PIR; A23614; A23614.
DR   PIR; A23622; A23622.
DR   PIR; S30519; S30519.
DR   PDB; 1GF1; 15-OCT-94.
DR   PDB; 2GF1; 15-APR-93.
DR   PDB; 3GF1; 15-APR-93.
DR   MIM; 147440; -.
DR   MIM; 265850; -.
DR   PFAM; PF00049; Insulin; 1.
DR   PROSITE; PS00262; INSULIN; 1.
KW   Insulin family; Growth factor; Plasma; 3D-structure;
KW   Alternative splicing; Signal.
FT   SIGNAL        1     21       POTENTIAL.
FT   PROPEP       22     48
FT   CHAIN        49    118       INSULIN-LIKE GROWTH FACTOR IA.
FT   DOMAIN       49     77       B.
FT   DOMAIN       78     89       C.
FT   DOMAIN       90    110       A.
FT   DOMAIN      111    118       D.
FT   PROPEP      119    153       E PEPTIDE.
FT   DISULFID     54     96
FT   DISULFID     66    109
FT   DISULFID     95    100
FT   STRAND       51     51
FT   TURN         55     55
FT   HELIX        56     65
FT   TURN         66     68
FT   STRAND       78     78
FT   TURN         79     81
FT   STRAND       82     82
FT   TURN         87     88
FT   HELIX        91     96
FT   TURN         97     97
FT   STRAND       98     98
FT   TURN        102    104
FT   HELIX       106    108
FT   TURN        109    109
SQ   SEQUENCE   153 AA;  17026 MW;  3451A183 CRC32;
     MGKISSLPTQ LFKCCFCDFL KVKMHTMSSS HLFYLALCLL TFTSSATAGP ETLCGAELVD
     ALQFVCGDRG FYFNKPTGYG SSSRRAPQTG IVDECCFRSC DLRRLEMYCA PLKPAKSARS
     VRAQRHTDMP KTQKEVHLKN ASRGSAGNKN YRM
//
ID   ANPA_PSEAM     STANDARD;      PRT;    82 AA.
AC   P04002;
DT   23-OCT-1986 (Rel. 02, Created)
DT   23-OCT-1986 (Rel. 02, Last sequence update)
DT   15-DEC-1998 (Rel. 37, Last annotation update)
DE   ANTIFREEZE PROTEIN A/B PRECURSOR.
OS   Pseudopleuronecta americanus (Winter flounder).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Actinopterygii;
OC   Neopterygii; Teleostei; Euteleostei; Acanthopterygii; Percomorpha;
OC   Pleuronectiformes; Pleuronectoidei; Pleuronectidae;
OC   Pseudopleuronectes.
RN   [1]
RP   SEQUENCE FROM N.A. (PROTEIN A).
RX   MEDLINE; 82197490.
RA   DAVIES P.L., ROACH A.H., HEW C.-L.;
RT   "DNA sequence coding for an antifreeze protein precursor from winter
RT   flounder.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:335-339(1982).
RN   [2]
RP   SEQUENCE FROM N.A. (PROTEIN A).
RX   MEDLINE; 88259236.
RA   SCOTT G.K., DAVIES P.L., KAO M.H., FLETCHER G.L.;
RT   "Differential amplification of antifreeze protein genes in the
RT   pleuronectinae.";
RL   J. Mol. Evol. 27:29-35(1988).
RN   [3]
RP   SEQUENCE FROM N.A. (PROTEIN B).
RX   MEDLINE; 84264559.
RA   DAVIES P.L., HOUGH C., SCOTT G.K., NG N., WHITE B.N., HEW C.-L.;
RT   "Antifreeze protein genes of the winter flounder.";
RL   J. Biol. Chem. 259:9241-9247(1984).
RN   [4]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 92209995.
RA   DAVIES P.L.;
RT   "Conservation of antifreeze protein-encoding genes in tandem
RT   repeats.";
RL   Gene 112:163-170(1992).
RN   [5]
RP   3D-STRUCTURE MODELING OF 45-81.
RX   MEDLINE; 92148833.
RA   CHOU K.-C.;
RT   "Energy-optimized structure of antifreeze protein and its binding
RT   mechanism.";
RL   J. Mol. Biol. 223:509-517(1992).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 45-81.
RX   MEDLINE; 95281060.
RA   SICHERI F., YANG D.S.C.;
RT   "Ice-binding structure and mechanism of an antifreeze protein from
RT   winter flounder.";
RL   Nature 375:427-431(1995).
CC   -!- FUNCTION: ANTIFREEZE PROTEINS LOWER THE BLOOD FREEZING POINT.
CC   -!- MISCELLANEOUS: THE SEQUENCE SHOWN IS THAT OF PROTEIN A.
CC   -!- SIMILARITY: BELONGS TO THE TYPE-I AFP FAMILY. TYPE 1 AFP ARE
CC       ALANINE-RICH, AMPHIPHILIC AND ALPHA-HELICAL.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; L00138; AAB59964.1; -.
DR   EMBL; L29178; AAB59964.1; JOINED.
DR   EMBL; M62414; AAA49469.1; -.
DR   EMBL; X07506; CAA30389.1; -.
DR   EMBL; M62416; AAA49471.1; -.
DR   EMBL; M62417; AAA49472.1; -.
DR   PIR; A03194; FDFLAW.
DR   PIR; A05161; A05161.
DR   PIR; S02326; S02326.
DR   PIR; JS0704; JS0704.
DR   PDB; 1ATF; 15-OCT-94.
DR   PDB; 1WFA; 03-JUN-95.
DR   PDB; 1WFB; 03-JUN-95.
KW   Antifreeze protein; Repeat; Multigene family; Signal; 3D-structure.
FT   SIGNAL        1     21
FT   PROPEP       22     44       REMOVED BY A DIPEPTIDYLPEPTIDASE
FT                                (PROBABLE).
FT   CHAIN        45     82       ANTIFREEZE PROTEIN A/B.
FT   VARIANT      36     36       A -> V.
FT   VARIANT      70     70       A -> D (IN PROTEIN B).
FT   CONFLICT     24     24       S -> R (IN REF. 2).
FT   HELIX        46     80
SQ   SEQUENCE   82 AA;  7711 MW;  4D1C66A2 CRC32;
     MALSLFTVGQ LIFLFWTMRI TEASPDPAAK AAPAAAAAPA AAAPDTASDA AAAAALTAAN
     AKAAAELTAA NAAAAAAATA RG
//
ID   IP2K_SOLTU     STANDARD;      PRT;   153 AA.
AC   P01080; P11429;
DT   21-JUL-1986 (Rel. 01, Created)
DT   01-OCT-1989 (Rel. 12, Last sequence update)
DT   15-DEC-1998 (Rel. 37, Last annotation update)
DE   PROTEINASE INHIBITOR TYPE II K PRECURSOR (IIK) (PCI-I).
GN   PIN2K.
OS   Solanum tuberosum (Potato).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   euphyllophytes; Spermatophyta; Magnoliophyta; eudicotyledons;
OC   core eudicots; Asteridae; euasterids I; Solanales; Solanaceae;
OC   Solanum.
RN   [1]
RP   SEQUENCE FROM N.A.
RA   THORNBURG R.W., AN G., CLEVELAND T.E., JOHNSON R., RYAN C.A.;
RT   "Wound-inducible expression of a potato inhibitor II-chloramphenicol
RT   acetyltransferase gene fusion in transgenic tobacco plants.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:744-748(1987).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86286579.
RA   KEIL M., SANCHEZ-SERRANO J., SCHELL J., WILLMITZER L.;
RT   "Primary structure of a proteinase inhibitor II gene from potato
RT   (Solanum tuberosum).";
RL   Nucleic Acids Res. 14:5641-5650(1986).
RN   [3]
RP   SEQUENCE OF 55-106 FROM N.A.
RX   MEDLINE; 82182863.
RA   HASS G.M., HERMODSON M.A., RYAN C.A., GENTRY L.;
RT   "Primary structures of two low molecular weight proteinase inhibitors
RT   from potatoes.";
RL   Biochemistry 21:752-756(1982).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 55-106.
RX   MEDLINE; 89178636.
RA   GREENBLATT H.M., RYAN C.A., JAMES M.N.G.;
RT   "Structure of the complex of Streptomyces griseus proteinase B and
RT   polypeptide chymotrypsin inhibitor-1 from Russet Burbank potato
RT   tubers at 2.1-A resolution.";
RL   J. Mol. Biol. 205:201-228(1989).
CC   -!- FUNCTION: INHIBITOR OF TRYPSIN AND CHYMOTRYPSIN.
CC   -!- INDUCTION: BY WOUND.
CC   -!- SIMILARITY: BELONGS TO THE POTATO TYPE II PROTEINASE INHIBITOR
CC       FAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; M15186; AAA33815.1; -.
DR   EMBL; X04118; CAA27730.1; -.
DR   PIR; A23591; A23591.
DR   PIR; A26584; A26584.
DR   PIR; A01319; XKPOC1.
DR   PDB; 4SGB; 15-JUL-90.
KW   Serine protease inhibitor; Repeat; Signal; 3D-structure.
FT   SIGNAL        1     25       POTENTIAL.
FT   CHAIN        26    153       PROTEINASE INHIBITOR TYPE II K.
FT   CHAIN        55    106       PROTEINASE INHIBITOR PCI-I.
FT   DISULFID     57     94
FT   DISULFID     60     78
FT   DISULFID     61     90
FT   DISULFID     67    103
FT   ACT_SITE     35     36       INTERACTION WITH TRYPSIN (PROBABLE).
FT   ACT_SITE     92     93       INTERACTION WITH CHYMOTRYPSIN (PROBABLE).
FT   REPEAT       30     86       1.
FT   REPEAT       87    146       2.
FT   CONFLICT     27     27       D -> EH (IN REF. 2).
FT   CONFLICT     34     35       IR -> TL (IN REF. 2).
FT   CONFLICT     55     55       P -> R (IN REF. 2).
FT   TURN         60     62
FT   STRAND       64     64
FT   TURN         65     66
FT   STRAND       68     70
FT   TURN         72     73
FT   STRAND       76     79
FT   STRAND       82     82
FT   TURN         84     85
FT   STRAND       90     91
FT   STRAND       94     94
FT   TURN         96     97
FT   STRAND      100    102
SQ   SEQUENCE   153 AA;  16505 MW;  AD43CA51 CRC32;
     MDVHKEVNFV AYLLIVLGLL VLVSAMDVDA KACIRECGNL GFGICPRSEG SPENPICTNC
     CAGYKGCNYY SANGAFICEG QSDPKKPKAC PLNCDPHIAY SKCPRSEGKS LIYPTGCTTC
     CTGYKGCYYF GKNGKFVCEG ESDEPKANMY PAM
//
ID   HPIT_RHOTE     STANDARD;      PRT;    62 AA.
AC   P33678;
DT   01-FEB-1994 (Rel. 28, Created)
DT   01-FEB-1994 (Rel. 28, Last sequence update)
DT   15-DEC-1998 (Rel. 37, Last annotation update)
DE   HIGH POTENTIAL IRON-SULFUR PROTEIN (HIPIP).
OS   Rhodocyclus tenuis (Rhodospirillum tenue).
OC   Bacteria; Proteobacteria; beta subdivision; Rhodocyclus group;
OC   Rhodocyclus.
RN   [1]
RP   SEQUENCE.
RC   STRAIN=2761;
RX   MEDLINE; 85224227.
RA   TEDRO S.M., MEYER T.E., KAMEN M.D.;
RT   "The amino acid sequence of a high-redox-potential ferredoxin from
RT   the purple phototrophic bacterium, Rhodospirillum tenue strain
RT   2761.";
RL   Arch. Biochem. Biophys. 239:94-101(1985).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS), AND REVISIONS.
RC   STRAIN=2761;
RX   MEDLINE; 93085744.
RA   RAYMENT I., WESENBERG G., MEYER T.E., CUSANOVICH M.A., HOLDEN H.M.;
RT   "Three-dimensional structure of the high-potential iron-sulfur
RT   protein isolated from the purple phototrophic bacterium Rhodocyclus
RT   tenuis determined and refined at 1.5-A resolution.";
RL   J. Mol. Biol. 228:672-686(1992).
CC   -!- FUNCTION: SPECIFIC CLASS OF HIGH-REDOX-POTENTIAL 4FE-4S
CC       FERREDOXINS. FUNCTIONS IN ANAEROBIC ELECTRON TRANSPORT IN MOST
CC       PURPLE AND IN SOME OTHER PHOTOSYNTHETIC BACTERIA AND IN AT LEAST
CC       ONE GENUS (PARACOCCUS) OF HALOPHILIC, DENITRIFYING BACTERIA.
CC       THE MIDPOINT REDOX POTENTIAL FOR THIS PROTEIN IS +330 MV.
CC   -!- SUBUNIT: HOMODIMER (PROBABLE).
CC   -!- SIMILARITY: BELONGS TO THE HIGH POTENTIAL IRON-SULFUR PROTEIN
CC       (HIPIP) FAMILY.
DR   PDB; 1ISU; 31-JAN-94.
DR   PFAM; PF01355; HIPIP; 1.
DR   PROSITE; PS00596; HIPIP; 1.
KW   Electron transport; Iron-sulfur; 4Fe-4S; 3D-structure.
FT   METAL        22     22       IRON-SULFUR (4FE-4S).
FT   METAL        25     25       IRON-SULFUR (4FE-4S).
FT   METAL        40     40       IRON-SULFUR (4FE-4S).
FT   METAL        55     55       IRON-SULFUR (4FE-4S).
FT   CONFLICT     30     30       MISSING (IN REF. 1).
FT   CONFLICT     34     34       P -> A (IN REF. 1).
FT   HELIX         4      9
FT   TURN         10     11
FT   STRAND       13     13
FT   STRAND       17     17
FT   TURN         18     19
FT   STRAND       20     20
FT   HELIX        22     24
FT   STRAND       25     25
FT   TURN         26     27
FT   STRAND       28     29
FT   TURN         34     35
FT   STRAND       38     40
FT   TURN         41     42
FT   TURN         44     45
FT   STRAND       49     49
FT   TURN         51     52
FT   STRAND       54     54
FT   TURN         56     57
FT   STRAND       60     60
SQ   SEQUENCE   62 AA;  6296 MW;  AE24CF90 CRC32;
     GTNAAMRKAF NYQDTAKNGK KCSGCAQFVP GASPTAAGGC KVIPGDNQIA PGGYCDAFIV
     KK
//
ID   PLMN_HUMAN     STANDARD;      PRT;   810 AA.
AC   P00747;
DT   21-JUL-1986 (Rel. 01, Created)
DT   01-MAR-1989 (Rel. 10, Last sequence update)
DT   15-JUL-1999 (Rel. 38, Last annotation update)
DE   PLASMINOGEN PRECURSOR (EC 3.4.21.7) [CONTAINS: ANGIOSTATIN].
GN   PLG.
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia;
OC   Eutheria; Primates; Catarrhini; Hominidae; Homo.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 90202879.
RA   PETERSEN T.E., MARTZEN M.R., ICHINOSE A., DAVIE E.W.;
RT   "Characterization of the gene for human plasminogen, a key proenzyme
RT   in the fibrinolytic system.";
RL   J. Biol. Chem. 265:6104-6111(1990).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 87162490.
RA   FORSGREN M., RADEN B., ISRAELSSON M., LARSSON K., HEDEN L.-O.;
RT   "Molecular cloning and characterization of a full-length cDNA clone
RT   for human plasminogen.";
RL   FEBS Lett. 213:254-260(1987).
RN   [3]
RP   SEQUENCE OF 20-810.
RA   SOTTRUP-JENSEN L., PETERSEN T.E., MAGNUSSON S.;
RL   Submitted (JUL-1977) to the PIR data bank.
RN   [4]
RP   SEQUENCE OF 292-810 FROM N.A.
RX   MEDLINE; 85023311.
RA   MALINOWSKI D.P., SADLER J.E., DAVIE E.W.;
RT   "Characterization of a complementary deoxyribonucleic acid coding for
RT   human and bovine plasminogen.";
RL   Biochemistry 23:4243-4250(1984).
RN   [5]
RP   SEQUENCE OF 20-100.
RX   MEDLINE; 75093329.
RA   WIMAN B., WALLEN P.;
RT   "Structural relationship between 'glutamic acid' and 'lysine' forms
RT   of human plasminogen and their interaction with the NH2-terminal
RT   activation peptide as studied by affinity chromatography.";
RL   Eur. J. Biochem. 50:489-494(1975).
RN   [6]
RP   SEQUENCE OF 95-580; 581-626; 657-700 AND 732-810.
RA   SOTTRUP-JENSEN L., CLAEYS H., ZAJDEL M., PETERSEN T.E., MAGNUSSON S.;
RL   (In) Davidson J.F., Rowan R.M., Samama M.M., Desnoyers P.C. (eds.);
RL   Progress in chemical fibrinolysis and thrombolysis, pp.3:191-209,
RL   Raven Press, New York (1978).
RN   [7]
RP   SEQUENCE OF 483-604.
RX   MEDLINE; 76043692.
RA   WIMAN B., WALLEN P.;
RT   "Amino-acid sequence of the cyanogen-bromide fragment from human
RT   plasminogen that forms the linkage between the plasmin chains.";
RL   Eur. J. Biochem. 58:539-547(1975).
RN   [8]
RP   SEQUENCE OF 581-810.
RX   MEDLINE; 77225245.
RA   WIMAN B.;
RT   "Primary structure of the B-chain of human plasmin.";
RL   Eur. J. Biochem. 76:129-137(1977).
RN   [9]
RP   ACTIVE SITE.
RX   MEDLINE; 73149248.
RA   ROBBINS K.C., BERNABE P., ARZADON L., SUMMARIA L.;
RT   "The primary structure of human plasminogen. II. The histidine loop
RT   of human plasmin: light (B) chain active center histidine sequence.";
RL   J. Biol. Chem. 248:1631-1633(1973).
RN   [10]
RP   ACTIVE SITE.
RX   MEDLINE; 69234739.
RA   GROSKOPF W.R., SUMMARIA L., ROBBINS K.C.;
RT   "Studies on the active center of human plasmin. Partial amino acid
RT   sequence of a peptide containing the active center serine residue.";
RL   J. Biol. Chem. 244:3590-3597(1969).
RN   [11]
RP   OMEGA-AMINOCARBOXYLIC ACID-BINDING SITES.
RX   MEDLINE; 82213905.
RA   TREXLER M., VALI Z., PATTHY L.;
RT   "Structure of the omega-aminocarboxylic acid-binding sites of human
RT   plasminogen. Arginine 70 and aspartic acid 56 are essential for
RT   binding of ligand by kringle 4.";
RL   J. Biol. Chem. 257:7401-7406(1982).
RN   [12]
RP   FIBRIN AND OMEGA-AMINOCARBOXYLIC ACID BINDING SITES.
RX   MEDLINE; 85054794.
RA   VALI Z., PATTHY L.;
RT   "The fibrin-binding site of human plasminogen. Arginines 32 and 34
RT   are essential for fibrin affinity of the kringle 1 domain.";
RL   J. Biol. Chem. 259:13690-13694(1984).
RN   [13]
RP   PHOSPHORYLATION SITE SER-597.
RX   MEDLINE; 97345939.
RA   WANG H., PROROK M., BRETTHAUER R.K., CASTELLINO F.J.;
RT   "Serine-578 is a major phosphorylation locus in human plasma
RT   plasminogen.";
RL   Biochemistry 36:8100-8106(1997).
RN   [14]
RP   CHARACTERIZATION OF ANGIOSTATIN, AND PARTIAL SEQUENCE.
RX   MEDLINE; 95042728.
RA   O'REILLY M.S., HOLMGREN L., SHING Y., CHEN C., ROSENTHAL R.A.,
RA   MOSES M., LANE W.S., CAO Y., SAGE E.H., FOLKMAN J.;
RT   "Angiostatin: a novel angiogenesis inhibitor that mediates the
RT   suppression of metastases by a Lewis lung carcinoma.";
RL   Cell 79:315-328(1994).
RN   [15]
RP   CHARACTERIZATION OF ANGIOSTATIN.
RX   MEDLINE; 97238710.
RA   SIM B.K., O'REILLY M.S., LIANG H., FORTIER A.H., HE W., MADSEN J.W.,
RA   LAPCEVICH R., NACY C.A.;
RT   "A recombinant human angiostatin protein inhibits experimental primary
RT   and metastatic cancer.";
RL   Cancer Res. 57:1329-1334(1997).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 374-461.
RX   MEDLINE; 92031502.
RA   MULICHAK A.M., TULINSKY A., RAVICHANDRAN K.G.;
RT   "Crystal and molecular structure of human plasminogen kringle 4
RT   refined at 1.9-A resolution.";
RL   Biochemistry 30:10576-10588(1991).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 374-461.
RX   MEDLINE; 92031503.
RA   WU T.-P., PADMANABHAN K., TULINSKY A., MULICHAK A.M.;
RT   "The refined structure of the epsilon-aminocaproic acid complex of
RT   human plasminogen kringle 4.";
RL   Biochemistry 30:10589-10594(1991).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 376-454.
RA   STEC B., YAMANO A., WHITLOW M., TEETER M.M.;
RL   Submitted (JUN-1995) to the PDB data bank.
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 102-181.
RX   MEDLINE; 96180681.
RA   MATHEWS I.I., VANDERHOFF-HANAVER P., CASTELLINO F.J., TULINSKY A.;
RT   "Crystal structures of the recombinant kringle 1 domain of human
RT   plasminogen in complexes with the ligands epsilon-aminocaproic acid
RT   and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.";
RL   Biochemistry 35:2567-2576(1996).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF 480-563.
RX   MEDLINE; 98198034.
RA   CHANG Y., MOCHALKIN I., MCCANCE S.G., CHENG B., TULINSKY A.,
RA   CASTELLINO F.J.;
RT   "Structure and ligand binding determinants of the recombinant kringle
RT   5 domain of human plasminogen.";
RL   Biochemistry 37:3258-3271(1998).
RN   [21]
RP   STRUCTURE BY NMR OF 96-184.
RX   MEDLINE; 94237157.
RA   REJANTE M.R., LLINAS M.;
RT   "1H-NMR assignments and secondary structure of human plasminogen
RT   kringle 1.";
RL   Eur. J. Biochem. 221:927-937(1994).
RN   [22]
RP   STRUCTURE BY NMR OF 96-184.
RX   MEDLINE; 94237158.
RA   REJANTE M.R., LLINAS M.;
RT   "Solution structure of the epsilon-aminohexanoic acid complex of
RT   human plasminogen kringle 1.";
RL   Eur. J. Biochem. 221:939-949(1994).
RN   [23]
RP   STRUCTURE BY NMR OF 183-354.
RX   MEDLINE; 96194156.
RA   SOEHNDEL S., HU C.-K., MARTI D., AFFOLTER M., SCHALLER J., LLINAS M.,
RA   RICKLI E.E.;
RT   "Recombinant gene expression and 1H NMR characteristics of the
RT   kringle (2 + 3) supermodule: spectroscopic/functional individuality
RT   of plasminogen kringle domains.";
RL   Biochemistry 35:2357-2364(1996).
RN   [24]
RP   STRUCTURE BY NMR OF 374-461.
RX   MEDLINE; 90219023.
RA   ATKINSON R.A., WILLIAMS R.J.P.;
RT   "Solution structure of the kringle 4 domain from human plasminogen by
RT   1H nuclear magnetic resonance spectroscopy and distance geometry.";
RL   J. Mol. Biol. 212:541-552(1990).
RN   [25]
RP   VARIANTS PHE-374 AND THR-620.
RX   MEDLINE; 91095410.
RA   ICHINOSE A., ESPLING E.S., TAKAMATSU J., SAITO H., SHINMYOZU K.,
RA   MARUYAMA I., PETERSEN T.E., DAVIE E.W.;
RT   "Two types of abnormal genes for plasminogen in families with a
RT   predisposition for thrombosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:115-119(1991).
RN   [26]
RP   ERRATUM.
RA   ICHINOSE A., ESPLING E.S., TAKAMATSU J., SAITO H., SHINMYOZU K.,
RA   MARUYAMA I., PETERSEN T.E., DAVIE E.W.;
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2067-2067(1991).
RN   [27]
RP   VARIANT PRO-591.
RX   MEDLINE; 93320425.
RA   AZUMA H., UNO Y., SHIGEKIYO T., SAITO S.;
RT   "Congenital plasminogen deficiency caused by a Ser-572 to Pro
RT   mutation.";
RL   Blood 82:475-480(1993).
RN   [28]
RP   VARIANT THR-620.
RX   MEDLINE; 83065132.
RA   MIYATA T., IWANAGA S., SAKATA Y., AOKI N.;
RT   "Plasminogen Tochigi: inactive plasmin resulting from replacement of
RT   alanine-600 by threonine in the active site.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:6132-6136(1982).
RN   [29]
RP   VARIANT THR-620.
RX   MEDLINE; 85054691.
RA   MIYATA T., IWANAGA S., SAKATA Y., AOKI N., TAKAMATSU J., KAMIYA T.;
RT   "Plasminogens Tochigi II and Nagoya: two additional molecular defects
RT   with Ala-600-->Thr replacement found in plasmin light chain
RT   variants.";
RL   J. Biochem. 96:277-287(1984).
RN   [30]
RP   VARIANT THR-620.
RX   MEDLINE; 93052248.
RA   KIKUCHI S., YAMANOUCHI Y., LI L., KOBAYASHI K., IJIMA H., MIYAZAKI R.,
RA   TSUCHIYA S., HAMAGUCHI H.;
RT   "Plasminogen with type-I mutation is polymorphic in the Japanese
RT   population.";
RL   Hum. Genet. 90:7-11(1992).
RN   [31]
RP   VARIANT ARG-751.
RX   MEDLINE; 99073958.
RA   HIGUCHI Y., FURIHATA K., UENO I., ISHIKAWA S., OKUMURA N., TOZUKA M.,
RA   SAKURAI N.;
RT   "Plasminogen Kanagawa-I, a novel missense mutation, is caused by the
RT   amino acid substitution G732R.";
RL   Br. J. Haematol. 103:867-870(1998).
CC   -!- FUNCTION: PLASMIN DISSOLVES THE FIBRIN OF BLOOD CLOTS AND ACTS AS
CC       A PROTEOLYTIC FACTOR IN A VARIETY OF OTHER PROCESSES INCLUDING
CC       EMBRYONIC DEVELOPMENT, TISSUE REMODELING, TUMOR INVASION,
CC       AND INFLAMMATION; IN OVULATION IT WEAKENS THE WALLS OF THE
CC       GRAAFIAN FOLLICLE. IT ACTIVATES THE UROKINASE-TYPE PLASMINOGEN
CC       ACTIVATOR, COLLAGENASES AND SEVERAL COMPLEMENT ZYMOGENS, SUCH
CC       AS C1 AND C5. IT CLEAVES FIBRIN, FIBRONECTIN, THROMBOSPONDIN,
CC       LAMININ AND VON WILLEBRAND FACTOR.
CC   -!- FUNCTION: ANGIOSTATIN IS AN ANGIOGENESIS INHIBITOR THAT BLOCKS
CC       NEOVASCULARIZATION AND GROWTH OF EXPERIMENTAL PRIMARY AND
CC       METASTATIC TUMORS IN VIVO.
CC   -!- ENZYME REGULATION: CONVERTED INTO PLASMIN BY PLASMINOGEN
CC       ACTIVATORS, BOTH PLASMINOGEN AND ITS ACTIVATOR BEING BOUND TO
CC       FIBRIN. ACTIVATED WITH CATALYTIC AMOUNTS OF STREPTOKINASE.
CC   -!- TISSUE SPECIFICITY: PRESENT IN PLASMA AND MANY OTHER EXTRACELLULAR
CC       FLUIDS. IT IS SYNTHESIZED IN THE KIDNEY.
CC   -!- DISEASE: DEFECTS IN PLG ARE ASSOCIATED WITH THROMBOPHILIA; A FORM
CC       OF RECURRENT THROMBOSIS.
CC   -!- MISCELLANEOUS: PLASMIN IS INACTIVATED BY ALPHA-2-ANTIPLASMIN
CC       IMMEDIATELY AFTER DISSOCIATION FROM THE CLOT.
CC   -!- MISCELLANEOUS: IN THE PRESENCE OF THE INHIBITOR, THE ACTIVATION
CC       INVOLVES ONLY CLEAVAGE AFTER ARG-580, RESULTING IN 2 CHAINS HELD
CC       TOGETHER BY 2 DISULFIDE BONDS. WITHOUT THE INHIBITOR, THE
CC       ACTIVATION INVOLVES ALSO REMOVAL OF THE ACTIVATION PEPTIDE.
CC   -!- SIMILARITY: CONTAINS 5 KRINGLE REGIONS.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY S1; ALSO KNOWN AS THE
CC       TRYPSIN FAMILY. BELONGS TO THE PLASMINOGEN SUBFAMILY.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; X05199; CAA28831.1; -.
DR   EMBL; K02922; AAA60124.1; -.
DR   EMBL; M34276; AAA60113.1; -.
DR   EMBL; M33272; AAA60113.1; JOINED.
DR   EMBL; M33274; AAA60113.1; JOINED.
DR   EMBL; M33275; AAA60113.1; JOINED.
DR   EMBL; M33278; AAA60113.1; JOINED.
DR   EMBL; M33279; AAA60113.1; JOINED.
DR   EMBL; M33280; AAA60113.1; JOINED.
DR   EMBL; M33282; AAA60113.1; JOINED.
DR   EMBL; M33283; AAA60113.1; JOINED.
DR   EMBL; M33284; AAA60113.1; JOINED.
DR   EMBL; M33285; AAA60113.1; JOINED.
DR   EMBL; M33286; AAA60113.1; JOINED.
DR   EMBL; M33287; AAA60113.1; JOINED.
DR   EMBL; M33288; AAA60113.1; JOINED.
DR   EMBL; M33289; AAA60113.1; JOINED.
DR   EMBL; M33290; AAA60113.1; JOINED.
DR   EMBL; M34272; AAA60113.1; JOINED.
DR   EMBL; M34273; AAA60113.1; JOINED.
DR   EMBL; M34275; AAA60113.1; JOINED.
DR   PIR; A00929; PLHU.
DR   PIR; A26646; A26646.
DR   PIR; A35229; A35229.
DR   PDB; 1PK4; 31-OCT-93.
DR   PDB; 2PK4; 31-OCT-93.
DR   PDB; 1PKR; 31-JAN-94.
DR   PDB; 1PMK; 22-JUN-94.
DR   PDB; 1PML; 22-JUN-94.
DR   PDB; 1HPJ; 12-MAR-97.
DR   PDB; 1HPK; 12-MAR-97.
DR   PDB; 1CEA; 03-APR-96.
DR   PDB; 1CEB; 03-APR-96.
DR   PDB; 1KRN; 11-JAN-97.
DR   PDB; 5HPG; 25-MAR-98.
DR   SWISS-2DPAGE; P00747; HUMAN.
DR   MIM; 173350; -.
DR   PFAM; PF00051; kringle; 5.
DR   PFAM; PF00089; trypsin; 1.
DR   PROSITE; PS00021; KRINGLE_1; 5.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
DR   PROSITE; PS50070; KRINGLE_2; 5.
KW   Hydrolase; Serine protease; Plasma; Glycoprotein; Fibrinolysis;
KW   Tissue remodeling; Blood coagulation; Kringle; Zymogen; 3D-structure;
KW   Signal; Disease mutation; Thrombophilia; Phosphorylation.
FT   SIGNAL        1     19
FT   CHAIN        20    810       PLASMINOGEN.
FT   CHAIN        20    580       PLASMINOGEN HEAVY CHAIN A.
FT   PEPTIDE      20     97       ACTIVATION PEPTIDE.
FT   CHAIN        98    580       PLASMINOGEN SHORT FORM OF CHAIN A.
FT   CHAIN        98   ?465       ANGIOSTATIN.
FT   CHAIN       581    810       PLASMINOGEN LIGHT CHAIN B.
FT   DOMAIN      103    181       KRINGLE 1.
FT   DOMAIN      184    262       KRINGLE 2.
FT   DOMAIN      275    352       KRINGLE 3.
FT   DOMAIN      377    454       KRINGLE 4.
FT   DOMAIN      481    560       KRINGLE 5.
FT   DOMAIN      581    810       CATALYTIC.
FT   ACT_SITE    622    622       CHARGE RELAY SYSTEM.
FT   ACT_SITE    665    665       CHARGE RELAY SYSTEM.
FT   ACT_SITE    760    760       CHARGE RELAY SYSTEM.
FT   BINDING     136    136       OMEGA-AMINOCARBOXYLIC ACIDS.
FT   BINDING     158    158       OMEGA-AMINOCARBOXYLIC ACIDS.
FT   BINDING     172    172       OMEGA-AMINOCARBOXYLIC ACIDS.
FT   BINDING     432    432       OMEGA-AMINOCARBOXYLIC ACIDS.
FT   BINDING     445    445       OMEGA-AMINOCARBOXYLIC ACIDS.
FT   BINDING     134    134       FIBRIN.
FT   BINDING     136    136       FIBRIN.
FT   DISULFID     49     73
FT   DISULFID     53     61
FT   DISULFID    103    181
FT   DISULFID    124    164
FT   DISULFID    152    176
FT   DISULFID    185    262       POTENTIAL.
FT   DISULFID    188    316
FT   DISULFID    206    245
FT   DISULFID    234    257
FT   DISULFID    275    352       POTENTIAL.
FT   DISULFID    296    335
FT   DISULFID    324    347
FT   DISULFID    377    454
FT   DISULFID    398    437
FT   DISULFID    426    449
FT   DISULFID    481    560
FT   DISULFID    502    543
FT   DISULFID    531    555
FT   DISULFID    567    685       INTERCHAIN.
FT   DISULFID    577    585       INTERCHAIN.
FT   DISULFID    607    623
FT   DISULFID    699    766       POTENTIAL.
FT   DISULFID    729    745
FT   DISULFID    756    784       POTENTIAL.
FT   CARBOHYD    308    308       IN 50% OF THE MOLECULES.
FT   CARBOHYD    365    365
FT   MOD_RES     597    597       PHOSPHORYLATION.
FT   VARIANT     374    374       V -> F (IN NAGOYA-1; THROMBOPHILIA).
FT                                /FTId=VAR_006627.
FT   VARIANT     591    591       S -> P (IN THROMBOPHILIA).
FT                                /FTId=VAR_006628.
FT   VARIANT     620    620       A -> T (IN NAGOYA-2/TOCHIGI/KAGOSHIMA;
FT                                THROMBOPHILIA; INACTIVE).
FT                                /FTId=VAR_006629.
FT   VARIANT     751    751       G -> R (IN KANAGAWA-1; 50% ACTIVITY).
FT                                /FTId=VAR_006630.
FT   CONFLICT     50     50       A -> AQ (IN REF. 5).
FT   CONFLICT     72     72       Q -> E (IN REF. 3 AND 5).
FT   CONFLICT     86     86       MISSING (IN REF. 3 AND 5).
FT   CONFLICT    361    361       Q -> E (IN REF. 3 AND 6).
FT   CONFLICT    472    472       D -> N (IN REF. 1, 3 AND 6).
FT   STRAND      104    104
FT   TURN        106    107
FT   TURN        109    110
FT   STRAND      117    117
FT   TURN        119    120
FT   STRAND      123    124
FT   TURN        139    141
FT   HELIX       143    145
FT   TURN        149    150
FT   STRAND      153    153
FT   TURN        155    156
FT   TURN        159    160
FT   STRAND      163    166
FT   TURN        169    170
FT   STRAND      173    175
FT   STRAND      180    180
SQ   SEQUENCE   810 AA;  90569 MW;  DBD2480E CRC32;
     MEHKEVVLLL LLFLKSGQGE PLDDYVNTQG ASLFSVTKKQ LGAGSIEECA AKCEEDEEFT
     CRAFQYHSKE QQCVIMAENR KSSIIIRMRD VVLFEKKVYL SECKTGNGKN YRGTMSKTKN
     GITCQKWSST SPHRPRFSPA THPSEGLEEN YCRNPDNDPQ GPWCYTTDPE KRYDYCDILE
     CEEECMHCSG ENYDGKISKT MSGLECQAWD SQSPHAHGYI PSKFPNKNLK KNYCRNPDRE
     LRPWCFTTDP NKRWELCDIP RCTTPPPSSG PTYQCLKGTG ENYRGNVAVT VSGHTCQHWS
     AQTPHTHNRT PENFPCKNLD ENYCRNPDGK RAPWCHTTNS QVRWEYCKIP SCDSSPVSTE
     QLAPTAPPEL TPVVQDCYHG DGQSYRGTSS TTTTGKKCQS WSSMTPHRHQ KTPENYPNAG
     LTMNYCRNPD ADKGPWCFTT DPSVRWEYCN LKKCSGTEAS VVAPPPVVLL PDVETPSEED
     CMFGNGKGYR GKRATTVTGT PCQDWAAQEP HRHSIFTPET NPRAGLEKNY CRNPDGDVGG
     PWCYTTNPRK LYDYCDVPQC AAPSFDCGKP QVEPKKCPGR VVGGCVAHPH SWPWQVSLRT
     RFGMHFCGGT LISPEWVLTA AHCLEKSPRP SSYKVILGAH QEVNLEPHVQ EIEVSRLFLE
     PTRKDIALLK LSSPAVITDK VIPACLPSPN YVVADRTECF ITGWGETQGT FGAGLLKEAQ
     LPVIENKVCN RYEFLNGRVQ STELCAGHLA GGTDSCQGDS GGPLVCFEKD KYILQGVTSW
     GLGCARPNKP GVYVRVSRFV TWIEGVMRNN
//
ID   THRB_BOVIN     STANDARD;      PRT;   625 AA.
AC   P00735;
DT   21-JUL-1986 (Rel. 01, Created)
DT   01-APR-1990 (Rel. 14, Last sequence update)
DT   15-JUL-1999 (Rel. 38, Last annotation update)
DE   PROTHROMBIN PRECURSOR (EC 3.4.21.5).
GN   F2.
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Mammalia;
OC   Eutheria; Cetartiodactyla; Ruminantia; Pecora; Bovoidea; Bovidae;
OC   Bovinae; Bos.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 88245190.
RA   IRWIN D.M., ROBERTSON K.A., MACGILLIVRAY R.T.A.;
RT   "Structure and evolution of the bovine prothrombin gene.";
RL   J. Mol. Biol. 200:31-45(1988).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 84203525.
RA   MCGILLIVRAY R.T.A., DAVIE E.W.;
RT   "Characterization of bovine prothrombin mRNA and its translation
RT   product.";
RL   Biochemistry 23:1626-1634(1984).
RN   [3]
RP   SEQUENCE OF 44-625, DISULFIDE BONDS, AND CARBOHYDRATE-BINDING SITES.
RA   MAGNUSSON S., SOTTRUP-JENSEN L., PETERSEN T.E., CLAEYS H.;
RL   (In) Hemker H.C., Veltkamp J.J. (eds.);
RL   Boerhaave symposium on prothrombin and related coagulation factors,
RL   pp.25-46, Leiden University Press, Leiden (1975).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF ACTIVATION PEPTIDE 1.
RX   MEDLINE; 86296631.
RA   PARK C.H., TULINSKY A.;
RT   "Three-dimensional structure of the kringle sequence: structure of
RT   prothrombin fragment 1.";
RL   Biochemistry 25:3977-3982(1986).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF ACTIVATION PEPTIDE 1.
RX   MEDLINE; 91311686.
RA   SESHADRI T.-P., TULINSKY A., SKRZYPCZAK-JANKUN E., PARK C.H.;
RT   "Structure of bovine prothrombin fragment 1 refined at 2.25-A
RT   resolution.";
RL   J. Mol. Biol. 220:481-494(1991).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF ACTIVATION PEPTIDE 1.
RX   MEDLINE; 92190185.
RA   SORIANO-GARCIA M., PADMANABHAN K., DE VOS A.M., TULINSKY A.;
RT   "The Ca2+ ion and membrane binding structure of the Gla domain of Ca-
RT   prothrombin fragment 1.";
RL   Biochemistry 31:2554-2566(1992).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   MEDLINE; 92218459.
RA   MARTIN P.D., ROBERTSON W., TURK D., HUBER R., BODE W., EDWARDS B.F.P.;
RT   "The structure of residues 7-16 of the A alpha-chain of human
RT   fibrinogen bound to bovine thrombin at 2.3-A resolution.";
RL   J. Biol. Chem. 267:7911-7920(1992).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   MEDLINE; 92389319.
RA   BRANDSTETTER H., TURK D., HOEFFKEN H.W., GROSSE D., STUERZEBECHER J.,
RA   MARTIN P.D., EDWARDS B.F.P., BODE W.;
RT   "Refined 2.3 A X-ray crystal structure of bovine thrombin complexes
RT   formed with the benzamidine and arginine-based thrombin inhibitors
RT   NAPAP, 4-TAPAP and MQPA. A starting point for improving
RT   antithrombotics.";
RL   J. Mol. Biol. 226:1085-1089(1992).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF COMPLEX WITH ORNITHODORIN.
RX   MEDLINE; 97102783.
RA   VAN DE LOCHT A., STUBBS M.T., BODE W., FRIEDRICH T., BOLLSCHWEILER C.,
RA   HOFFKEN W., HUBER R.;
RT   "The ornithodorin-thrombin crystal structure, a key to the TAP
RT   enigma?";
RL   EMBO J. 15:6011-6017(1996).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF COMPLEX WITH TRIABIN.
RX   MEDLINE; 98004486.
RA   FUENTES-PRIOR P., NOESKE-JUNGBLUT C., DONNER P., SCHLEUNING W.D.,
RA   HUBER R., BODE W.;
RT   "Structure of the thrombin complex with triabin, a lipocalin-like
RT   exosite-binding inhibitor derived from a triatomine bug.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:11845-11850(1997).
RN   [11]
RP   GENE STRUCTURE.
RX   MEDLINE; 86077733.
RA   IRWIN D.M., AHERN K.G., PEARSON G.D., MCGILLIVRAY R.T.A.;
RT   "Characterization of the bovine prothrombin gene.";
RL   Biochemistry 24:6854-6861(1985).
CC   -!- FUNCTION: THROMBIN, WHICH CLEAVES BONDS AFTER ARG & LYS, CONVERTS
CC       FIBRINOGEN TO FIBRIN AND ACTIVATES FACTORS V, VII, VIII, XIII,
CC       AND, IN COMPLEX WITH THROMBOMODULIN, PROTEIN C.
CC   -!- SUBCELLULAR LOCATION: EXTRACELLULAR.
CC   -!- TISSUE SPECIFICITY: SYNTHESIZED IN THE LIVER; FOUND IN PLASMA.
CC   -!- PTM: THE GAMMA-CARBOXYGLUTAMYL RESIDUES, WHICH BIND CALCIUM IONS,
CC       RESULT FROM THE CARBOXYLATION OF GLUTAMYL RESIDUES BY A MICROSOMAL
CC       ENZYME, THE VITAMIN K-DEPENDENT CARBOXYLASE. THE MODIFIED RESIDUES
CC       ARE NECESSARY FOR THE CA-DEPENDENT INTERACTION WITH A NEGATIVELY
CC       CHARGED PHOSPHOLIPID SURFACE,WHICH IS ESSENTIAL FOR THE CONVERSION
CC       OF PROTHROMBIN TO THROMBIN.
CC   -!- MISCELLANEOUS: PROTHROMBIN IS ACTIVATED ON THE SURFACE OF A
CC       PHOSPHOLIPID MEMBRANE THAT BINDS THE AMINO END OF PROTHROMBIN &
CC       FACTORS VA & XA IN CA-DEPENDENT INTERACTIONS; FACTOR XA REMOVES
CC       THE ACTIVATION PEPTIDE & CLEAVES THE REMAINING PART INTO LIGHT &
CC       HEAVY CHAINS. THE ACTIVATION PROCESS STARTS SLOWLY BECAUSE FACTOR
CC       V ITSELF HAS TO BE ACTIVATED BY THE INITIAL, SMALL AMOUNTS OF
CC       THROMBIN.
CC   -!- MISCELLANEOUS: THROMBIN CAN ITSELF CLEAVE THE AMINO TERMINAL
CC       FRAGMENT (FRAGMENT 1) OF THE PROTHROMBIN, PRIOR TO ITS ACTIVATION
CC       BY FACTOR XA.
CC   -!- SIMILARITY: CONTAINS 2 KRINGLE REGIONS.
CC   -!- SIMILARITY: BELONGS TO PEPTIDASE FAMILY S1; ALSO KNOWN AS THE
CC       TRYPSIN FAMILY.
CC   -!- DATABASE: NAME=ProZyme technical fact sheet;
CC       WWW="http://www.prozyme.com/technical/thrombindata.html".
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; V00135; CAA23451.1; -.
DR   EMBL; J00041; AAA30781.1; -.
DR   PIR; A00915; TBBO.
DR   PIR; S02537; S02537.
DR   PDB; 1BBR; 31-JAN-94.
DR   PDB; 1ETR; 31-JAN-94.
DR   PDB; 1ETS; 31-JAN-94.
DR   PDB; 1ETT; 31-JAN-94.
DR   PDB; 1HRT; 31-JAN-94.
DR   PDB; 2PF1; 31-JAN-94.
DR   PDB; 2PF2; 31-JAN-94.
DR   PDB; 2SPT; 31-MAY-94.
DR   PDB; 1MKW; 07-JUL-97.
DR   PDB; 1MKX; 07-JUL-97.
DR   PDB; 1TBQ; 14-OCT-96.
DR   PDB; 1TBR; 14-OCT-96.
DR   PDB; 1TOC; 23-JUL-97.
DR   PDB; 1VIT; 21-APR-97.
DR   PDB; 1YCP; 06-MAY-98.
DR   PDB; 1A0H; 17-JUN-98.
DR   PDB; 1AVG; 16-FEB-99.
DR   PFAM; PF00051; kringle; 2.
DR   PFAM; PF00089; trypsin; 1.
DR   PFAM; PF00594; gla; 1.
DR   PROSITE; PS00011; GLU_CARBOXYLATION; 1.
DR   PROSITE; PS00021; KRINGLE_1; 2.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
DR   PROSITE; PS50070; KRINGLE_2; 2.
KW   Blood coagulation; Plasma; Calcium-binding; Glycoprotein; Duplication;
KW   Vitamin K; Zymogen; Gamma-carboxyglutamic acid; Acute phase; Liver;
KW   Hydrolase; Serine protease; Kringle; Signal; 3D-structure.
FT   SIGNAL        1      ?
FT   PROPEP        ?     43
FT   CHAIN        44    625       PROTHROMBIN.
FT   PEPTIDE      44    199       ACTIVATION PEPTIDE (FRAGMENT 1).
FT   PEPTIDE     200    317       ACTIVATION PEPTIDE (FRAGMENT 2).
FT   CHAIN       318    366       THROMBIN LIGHT CHAIN (A).
FT   CHAIN       367    625       THROMBIN HEAVY CHAIN (B).
FT   DOMAIN      109    187       KRINGLE 1.
FT   DOMAIN      214    292       KRINGLE 2.
FT   SITE        199    200       CLEAVAGE (BY THROMBIN).
FT   SITE        317    318       CLEAVAGE (BY FACTOR XA).
FT   SITE        366    367       CLEAVAGE (BY FACTOR XA).
FT   ACT_SITE    409    409       CHARGE RELAY SYSTEM.
FT   ACT_SITE    465    465       CHARGE RELAY SYSTEM.
FT   ACT_SITE    571    571       CHARGE RELAY SYSTEM.
FT   MOD_RES      50     50       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      51     51       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      58     58       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      60     60       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      63     63       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      64     64       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      69     69       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      70     70       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      73     73       GAMMA-CARBOXYGLUTAMIC ACID.
FT   MOD_RES      76     76       GAMMA-CARBOXYGLUTAMIC ACID.
FT   CARBOHYD    120    120
FT   CARBOHYD    144    144
FT   CARBOHYD    419    419
FT   DISULFID     61     66
FT   DISULFID     91    104
FT   DISULFID    109    187
FT   DISULFID    130    170
FT   DISULFID    158    182
FT   DISULFID    214    292
FT   DISULFID    235    275
FT   DISULFID    263    287
FT   DISULFID    339    485       INTERCHAIN.
FT   DISULFID    394    410
FT   DISULFID    539    553
FT   DISULFID    567    597
FT   VARIANT     600    600       D -> N.
FT   CONFLICT    231    231       S -> H (IN REF. 2).
FT   CONFLICT    249    249       D -> H (IN REF. 2).
FT   CONFLICT    288    288       D -> N (IN REF. 3).
FT   CONFLICT    353    353       Q -> E (IN REF. 3).
FT   CONFLICT    355    355       E -> Q (IN REF. 3).
FT   CONFLICT    549    550       DN -> ND (IN REF. 3).
FT   HELIX        50     52
FT   HELIX        57     62
FT   HELIX        68     73
FT   TURN         74     75
FT   HELIX        79     89
FT   TURN         90     93
FT   HELIX        99    105
FT   TURN        106    107
FT   STRAND      110    110
FT   TURN        112    114
FT   STRAND      123    124
FT   STRAND      129    130
FT   TURN        145    147
FT   TURN        149    150
FT   TURN        155    156
FT   TURN        165    166
FT   STRAND      169    172
FT   TURN        175    176
FT   STRAND      179    182
FT   STRAND      186    186
SQ   SEQUENCE   625 AA;  70505 MW;  30CEA5AC CRC32;
     MARVRGPRLP GCLALAALFS LVHSQHVFLA HQQASSLLQR ARRANKGFLE EVRKGNLERE
     CLEEPCSREE AFEALESLSA TDAFWAKYTA CESARNPREK LNECLEGNCA EGVGMNYRGN
     VSVTRSGIEC QLWRSRYPHK PEINSTTHPG ADLRENFCRN PDGSITGPWC YTTSPTLRRE
     ECSVPVCGQD RVTVEVIPRS GGSTTSQSPL LETCVPDRGR EYRGRLAVTT SGSRCLAWSS
     EQAKALSKDQ DFNPAVPLAE NFCRNPDGDE EGAWCYVADQ PGDFEYCDLN YCEEPVDGDL
     GDRLGEDPDP DAAIEGRTSE DHFQPFFNEK TFGAGEADCG LRPLFEKKQV QDQTEKELFE
     SYIEGRIVEG QDAEVGLSPW QVMLFRKSPQ ELLCGASLIS DRWVLTAAHC LLYPPWDKNF
     TVDDLLVRIG KHSRTRYERK VEKISMLDKI YIHPRYNWKE NLDRDIALLK LKRPIELSDY
     IHPVCLPDKQ TAAKLLHAGF KGRVTGWGNR RETWTTSVAE VQPSVLQVVN LPLVERPVCK
     ASTRIRITDN MFCAGYKPGE GKRGDACEGD SGGPFVMKSP YNNRWYQMGI VSWGEGCDRD
     GKYGFYTHVF RLKKWIQKVI DRLGS
//
ID   HXKB_YEAST     STANDARD;      PRT;   486 AA.
AC   P04807;
DT   13-AUG-1987 (Rel. 05, Created)
DT   13-AUG-1987 (Rel. 05, Last sequence update)
DT   15-JUL-1999 (Rel. 38, Last annotation update)
DE   HEXOKINASE B (EC 2.7.1.1) (HEXOKINASE PII).
GN   HXK2 OR HKB OR HEX1 OR YGL253W OR NRB486.
OS   Saccharomyces cerevisiae (Baker's yeast).
OC   Eukaryota; Fungi; Ascomycota; Hemiascomycetes; Saccharomycetales;
OC   Saccharomycetaceae; Saccharomyces.
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86120382.
RA   STACHELEK C., STACHELEK J., SWAN J., BOTSTEIN D., KONIGSBERG W.;
RT   "Identification, cloning and sequence determination of the genes
RT   specifying hexokinase A and B from yeast.";
RL   Nucleic Acids Res. 14:945-963(1986).
RN   [2]
RP   SEQUENCE FROM N.A.
RX   MEDLINE; 86056943.
RA   FROEHLICH K.-U., ENTIAN K.-D., MECKE D.;
RT   "The primary structure of the yeast hexokinase PII gene (HXK2) which
RT   is responsible for glucose repression.";
RL   Gene 36:105-111(1985).
RN   [3]
RP   SEQUENCE FROM N.A.
RC   STRAIN=S288C / FY1679;
RX   MEDLINE; 97127827.
RA   COISSAC E., MAILLIER E., ROBINEAU S., NETTER P.;
RT   "Sequence of a 39,411 bp DNA fragment covering the left end of
RT   chromosome VII of Saccharomyces cerevisiae.";
RL   Yeast 12:1555-1562(1996).
RN   [4]
RP   SEQUENCE OF 1-247 FROM N.A.
RC   STRAIN=W303;
RX   MEDLINE; 93311123.
RA   BREITWIESER W., PRICE C., SCHUSTER T.;
RT   "Identification of a gene encoding a novel zinc finger protein in
RT   Saccharomyces cerevisiae.";
RL   Yeast 9:551-556(1993).
RN   [5]
RP   SEQUENCE OF 119-127; 176-185 AND 304-314.
RC   STRAIN=ATCC 38531 / Y41;
RX   MEDLINE; 95255188.
RA   NORBECK J., BLOMBERG A.;
RT   "Gene linkage of two-dimensional polyacrylamide gel electrophoresis
RT   resolved proteins from isogene families in Saccharomyces cerevisiae
RT   by microsequencing of in-gel trypsin generated peptides.";
RL   Electrophoresis 16:149-156(1995).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   MEDLINE; 78244654.
RA   ANDERSON C.M., STENKAMP R.E., STEITZ T.A.;
RT   "Sequencing a protein by X-ray crystallography. II. Refinement of
RT   yeast hexokinase B co-ordinates and sequence at 2.1-A resolution.";
RL   J. Mol. Biol. 123:15-33(1978).
CC   -!- FUNCTION: MAIN GLUCOSE PHOSPHORYLATING ENZYME. MAY PLAY A
CC       REGULATORY ROLE IN BOTH INDUCTION AND REPRESSION OF GENE
CC       EXPRESSION BY GLUCOSE.
CC   -!- CATALYTIC ACTIVITY: ATP + D-HEXOSE = ADP + D-HEXOSE 6-PHOSPHATE.
CC   -!- ENZYME REGULATION: SUBJECT TO ALLOSTERIC CONTROL. SUBSTRATE
CC       INHIBITION BY ATP.
CC   -!- PATHWAY: FIRST STEP OF SEVERAL METABOLIC PATHWAYS.
CC   -!- SUBUNIT: HOMODIMER.
CC   -!- MISCELLANEOUS: IN YEAST THERE ARE THREE GLUCOSE-PHOSPHORYLATING
CC       ISOENZYMES, DESIGNATED HEXOKINASE I, II AND GLUCOKINASE.
CC   -!- SIMILARITY: BELONGS TO THE HEXOKINASE FAMILY.
CC   -!- DATABASE: NAME=Worthington enzyme manual;
CC       WWW="http://www.worthington-biochem.com/manual/H/HK.html".
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; X03483; CAA27203.1; -.
DR   EMBL; M11181; AAA34697.1; -.
DR   EMBL; X94357; CAA64134.1; -.
DR   EMBL; Z72775; CAA96973.1; -.
DR   EMBL; X67787; CAA48003.1; -.
DR   PIR; B23523; KIBYHB.
DR   PIR; S28555; S28555.
DR   PDB; 2YHX; 15-JUL-92.
DR   SWISS-2DPAGE; P04807; YEAST.
DR   YEPD; 8536; -.
DR   YEPD; 8548; -.
DR   SGD; L0000834; HXK2.
DR   PFAM; PF00349; hexokinase; 1.
DR   PROSITE; PS00378; HEXOKINASES; 1.
KW   Transferase; Kinase; Glycolysis; Allosteric enzyme; ATP-binding;
KW   3D-structure.
FT   BINDING     111    111       ATP (BY SIMILARITY).
FT   DOMAIN      152    178       GLUCOSE-BINDING (POTENTIAL).
FT   CONFLICT     29     29       N -> I (IN REF. 1).
FT   CONFLICT     33     33       I -> N (IN REF. 2).
FT   CONFLICT     61     61       G -> V (IN REF. 1).
FT   CONFLICT    197    197       T -> S (IN REF. 1).
FT   CONFLICT    421    422       YN -> ST (IN REF. 2).
FT   CONFLICT    444    445       TS -> PH (IN REF. 2).
FT   CONFLICT    453    453       I -> V (IN REF. 2).
FT   CONFLICT    462    462       A -> P (IN REF. 2).
FT   HELIX        24     34
FT   HELIX        38     56
FT   STRAND       66     67
FT   STRAND       80     87
FT   STRAND       91    100
FT   TURN        101    102
FT   STRAND      103    111
FT   STRAND      113    113
FT   TURN        116    119
FT   TURN        124    124
FT   HELIX       125    142
FT   TURN        143    143
FT   STRAND      151    156
FT   STRAND      165    165
FT   TURN        166    167
FT   STRAND      170    170
FT   TURN        176    177
FT   STRAND      188    188
FT   HELIX       189    200
FT   STRAND      203    209
FT   HELIX       211    222
FT   TURN        224    225
FT   STRAND      226    232
FT   STRAND      236    242
FT   HELIX       244    246
FT   TURN        252    253
FT   STRAND      264    267
FT   TURN        271    276
FT   HELIX       284    292
FT   HELIX       300    305
FT   HELIX       307    323
FT   TURN        324    325
FT   TURN        339    340
FT   TURN        344    344
FT   HELIX       345    352
FT   HELIX       359    369
FT   TURN        370    370
FT   HELIX       375    396
FT   TURN        397    397
FT   HELIX       398    407
FT   TURN        408    408
FT   STRAND      412    417
FT   TURN        419    422
FT   TURN        425    426
FT   HELIX       427    439
FT   HELIX       446    448
FT   STRAND      451    455
FT   TURN        459    461
FT   HELIX       462    476
SQ   SEQUENCE   486 AA;  53942 MW;  A87A9D7D CRC32;
     MVHLGPKKPQ ARKGSMADVP KELMQQIENF EKIFTVPTET LQAVTKHFIS ELEKGLSKKG
     GNIPMIPGWV MDFPTGKESG DFLAIDLGGT NLRVVLVKLG GDRTFDTTQS KYRLPDAMRT
     TQNPDELWEF IADSLKAFID EQFPQGISEP IPLGFTFSFP ASQNKINEGI LQRWTKGFDI
     PNIENHDVVP MLQKQITKRN IPIEVVALIN DTTGTLVASY YTDPETKMGV IFGTGVNGAY
     YDVCSDIEKL QGKLSDDIPP SAPMAINCEY GSFDNEHVVL PRTKYDITID EESPRPGQQT
     FEKMSSGYYL GEILRLALMD MYKQGFIFKN QDLSKFDKPF VMDTSYPARI EEDPFENLED
     TDDLFQNEFG INTTVQERKL IRRLSELIGA RAARLSVCGI AAICQKRGYK TGHIAADGSV
     YNRYPGFKEK AANALKDIYG WTQTSLDDYP IKIVPAEDGS GAGAAVIAAL AQKRIAEGKS
     VGIIGA
//
ID   ALU7_HUMAN     STANDARD;      PRT;   593 AA.
AC   P39194;
DT   01-FEB-1995 (Rel. 31, Created)
DT   01-FEB-1995 (Rel. 31, Last sequence update)
DT   30-MAY-2000 (Rel. 39, Last annotation update)
DE   ALU SUBFAMILY SQ SEQUENCE CONTAMINATION WARNING ENTRY.
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   SEQUENCE FROM N.A.
RX   MEDLINE=95021758; PubMed=7935834;
RA   Claverie J.-M., Makalowski W.;
RT   "Alu alert.";
RL   Nature 371:752-752(1994).
RN   [2]
RP   CONCEPT.
RX   MEDLINE=92241891; PubMed=1572661;
RA   Claverie J.-M.;
RT   "Identifying coding exons by similarity search: alu-derived and other
RT   potentially misleading protein sequences.";
RL   Genomics 12:838-841(1992).
RN   [3]
RP   ALU FAMILIES CLASSIFICATION.
RX   MEDLINE=88333009; PubMed=3138422;
RA   Quentin Y.;
RT   "The Alu family developed through successive waves of fixation closely
RT   connected with primate lineage history.";
RL   J. Mol. Evol. 27:194-202(1988).
RN   [4]
RP   ALU FAMILIES CLASSIFICATION.
RX   MEDLINE=91178815; PubMed=1706781;
RA   Jurka J., Milosavljevic A.;
RT   "Reconstruction and analysis of human Alu genes.";
RL   J. Mol. Evol. 32:105-121(1991).
CC   -!- MISCELLANEOUS: VARIOUS ANALYZES (SEE REF.3 AND REF.4) INDICATE
CC       THAT ALU REPEATS FALL INTO 8 SUBFAMILIES. THEREFORE, 8 ALU WARNING
CC       CONSENSUS SEQUENCES HAVE BEEN CONSTITUTED THAT CONTAIN ALL SIX
CC       FRAMES CONCEPTUAL TRANSLATIONS OF EACH OF THESE CLASSES OF ALU
CC       REPEATS.
CC   -!- MISCELLANEOUS: ISOLATED 'X' INDICATES THE PRESENCE OF A STOP
CC       CODON, 'XXX' IS USED TO SEPARATE THE VARIOUS TRANSLATION PHASES.
CC   -!- CAUTION: THIS ALU ENTRY IS PROVIDED IN ORDER TO AVOID THE FURTHER
CC       POLLUTION OF PROTEIN SEQUENCE DATABASES WITH ALU-DERIVED AMINO
CC       ACID SEQUENCES.
CC   -!- CAUTION: ALU REPETITIVE SEQUENCES ARE INTERSPERSED IN HUMAN AND
CC       PRIMATE GENOMES WITH AN AVERAGE SPACING OF 4 KB. SOME OF THEM ARE
CC       ACTIVELY TRANSCRIBED BY POL III. NORMAL TRANSCRIPTS MAY CONTAIN
CC       ALU-DERIVED SEQUENCES IN 5' OR 3' UNTRANSLATED REGIONS. HOWEVER,
CC       CDNA LIBRARIES ALSO CONTAIN PARTIAL AND/OR REARRANGED CDNAS
CC       LIGATED WITH ALU-DERIVED SEQUENCE IN ANY ORIENTATION. ALTHOUGH ALU
CC       ELEMENTS (ESPECIALLY SITUATED ON THE COMPLEMENTARY STRAND) HAVE A
CC       GREAT POTENTIAL TO CREATE ADDITIONAL/ALTERNATIVE EXONS,
CC       CONSIDERATION SHOULD BE GIVEN TO THE POSSIBILITY THAT THE PRESENCE
CC       OF AN ALU IN AN OPEN READING FRAME MAY HAVE RESULTED FROM A
CC       CLONING ARTIFACT OR MAY BE DUE TO MISINTERPRETATION OF SEQUENCING
CC       DATA. THIS POINT HAS BEEN OVERLOOKED ON SEVERAL OCCASIONS, WITH
CC       THE CONSEQUENCE OF ERRONEOUS ALU-DERIVED AMINO ACID SEQUENCES
CC       BEING REPORTED.
CC   -!- CAUTION: ANY SIGNIFICANT SIMILARITY OF A PUTATIVE PROTEIN SEQUENCE
CC       WITH AN ALU-TRANSLATED ENTRY MUST BE TAKEN AS A WARNING THAT A
CC       PART OF ALU REPEAT MAY HAVE BEEN ARTIFACTUALLY INCLUDED IN THE
CC       CODING NUCLEOTIDE SEQUENCE.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U14573; -; NOT_ANNOTATED_CDS.
KW   Hypothetical protein.
FT   DOMAIN        1     97       FRAME 1.
FT   DOMAIN      101    196       FRAME 2.
FT   DOMAIN      200    295       FRAME 3.
FT   DOMAIN      299    395       FRAME 4.
FT   DOMAIN      399    494       FRAME 5.
FT   DOMAIN      498    593       FRAME 6.
SQ   SEQUENCE   593 AA;  64417 MW;  54A4F50F33A6089F CRC64;
     GRARWLTPVI PALWEAEAGG SPEVRSSRPA WPTWXNPVST KNTKISRAWW RAPVIPATRE
     AEAGESLEPG RRRLQXAEIA PLHSSLGNKS ETPSQKKXXX AGRGGSRLXS QHFGRPRRVD
     HLRSGVRDQP GQHGETPSLL KIQKLAGRGG GRLXSQLLGR LRQENRLNPG GGGCSEPRSR
     HCTPAWATRA KLRLKKXXXP GAVAHACNPS TLGGRGGWIT XGQEFETSLA NMVKPRLYXK
     YKNXPGVVAG ACNPSYSGGX GRRIAXTREA EVAVSRDRAT ALQPGQQERN SVSKKXXXFF
     LRRSFALVAQ AGVQWRDLGS LQPPPPGFKR FSCLSLPSSW DYRRPPPRPA NFCIFSRDGV
     SPCWPGWSRT PDLRXSTRLG LPKCWDYRRE PPRPAXXXFF XDGVSLLLPR LECSGAISAH
     CNLRLPGSSD SPASASRVAG ITGARHHARL IFVFLVETGF HHVGQAGLEL LTSGDPPASA
     SQSAGITGVS HRARXXXFFE TEFRSCCPGW SAVARSRLTA TSASRVQAIL LPQPPEXLGL
     QAPATTPGXF LYFXXRRGFT MLARLVSNSX PQVIHPPRPP KVLGLQAXAT APG
//
ID   NIR_ALCFA      STANDARD;      PRT;   376 AA.
AC   P38501;
DT   01-OCT-1994 (Rel. 30, Created)
DT   01-OCT-1994 (Rel. 30, Last sequence update)
DT   15-JUL-1998 (Rel. 36, Last annotation update)
DE   COPPER-CONTAINING NITRITE REDUCTASE PRECURSOR (EC 1.7.99.3) (CU-NIR).
GN   NIRK OR NIR.
OS   Alcaligenes faecalis.
OC   Bacteria; Proteobacteria; beta subdivision; Alcaligenaceae;
OC   Alcaligenes.
RN   [1]
RP   SEQUENCE FROM N.A., AND SEQUENCE OF 34-48 AND 192-240.
RC   STRAIN=S-6;
RX   MEDLINE; 93294530.
RA   NISHIYAMA M., SUZUKI J., KUKIMOTO M., OHNUKI T., HORINOUCHI S.,
RA   BEPPU T.;
RT   "Cloning and characterization of a nitrite reductase gene from
RT   Alcaligenes faecalis and its expression in Escherichia coli.";
RL   J. Gen. Microbiol. 139:725-733(1993).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS), AND MUTAGENESIS.
RC   STRAIN=S-6;
RX   MEDLINE; 94227056.
RA   KUKIMOTO M., NISHIYAMA M., MURPHY M.E.P., TURLEY S., ADMAN E.T.,
RA   HORINOUCHI S., BEPPU T.;
RT   "X-ray structure and site-directed mutagenesis of a nitrite reductase
RT   from Alcaligenes faecalis S-6: roles of two copper atoms in nitrite
RT   reduction.";
RL   Biochemistry 33:5246-5252(1994).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 96032602.
RA   MURPHY M.E., TURLEY S., KUKIMOTO M., NISHIYAMA M., HORINOUCHI S.,
RA   SASAKI H., TANOKURA M., ADMAN E.T.;
RT   "Structure of Alcaligenes faecalis nitrite reductase and a copper
RT   site mutant, M150E, that contains zinc.";
RL   Biochemistry 34:12107-12117(1995).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE; 98019216.
RA   MURPHY M.E., TURLEY S., ADMAN E.T.;
RT   "Structure of nitrite bound to copper-containing nitrite reductase
RT   from Alcaligenes faecalis. Mechanistic implications.";
RL   J. Biol. Chem. 272:28455-28460(1997).
CC   -!- CATALYTIC ACTIVITY: 2 NITRIC OXIDE + 2 H(2)O + ACCEPTOR =
CC       2 NITRITE + REDUCED ACCEPTOR.
CC   -!- COFACTOR: CONTAINS ONE ATOM OF TYPE I COPPER AND ONE ATOM OF TYPE
CC       II COPPER; FAD. TYPE 1 COPPER IS BOUND WITHIN A SINGLE MONOMER,
CC       WHILE TYPE 2 COPPER IS HELD BY RESIDUES FROM EACH OF TWO MONOMERS
CC       OF THE TRIMER. NITRITE IS BOUND TO THE TYPE 2 COPPER SITE.
CC       PSEUDOAZURIN IS THE PHYSIOLOGICAL ELECTRON DONOR FOR THE CU-NIR IN
CC       VITRO (BY SIMILARITY).
CC   -!- PATHWAY: NITRATE ASSIMILATION (DENITRIFICATION PATHWAY).
CC   -!- SUBUNIT: HOMOTRIMER.
CC   -!- SUBCELLULAR LOCATION: PERIPLASMIC.
CC   -!- INDUCTION: UNDER ANAEROBIC GROWTH CONDITIONS AND BY NITRITE.
CC   -!- DOMAIN: THE TYPE I COPPER SITE IN NIR PLAYS A CRUCIAL ROLE FOR
CC       ELECTRON TRANSFER FROM PSEUDOAZURIN TO THE TYPE II COPPER SITE
CC       OF NIR, WHICH COMPRISES THE CATALYTIC CENTER OF NIR FOR THE
CC       REDUCTION OF NITRITE.
CC   -!- SIMILARITY: CONTAINS 2 PLASTOCYANIN-LIKE DOMAINS.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; D13155; BAA02440.1; -.
DR   PDB; 2AFN; 01-AUG-96.
DR   PDB; 1NTD; 08-NOV-96.
DR   PDB; 1AQ8; 25-FEB-98.
DR   PDB; 1AS6; 25-FEB-98.
DR   PDB; 1AS7; 25-FEB-98.
DR   PDB; 1AS8; 25-FEB-98.
DR   PFAM; PF00394; Cu-oxidase; 1.
KW   Oxidoreductase; Copper; Metal-binding; Flavoprotein; FAD;
KW   Nitrate assimilation; Repeat; Periplasmic; Signal; 3D-structure.
FT   SIGNAL        1     33
FT   CHAIN        34    376       COPPER-CONTAINING NITRITE REDUCTASE.
FT   DOMAIN       34    211       PLASTOCYANIN-LIKE 1.
FT   DOMAIN      212    376       PLASTOCYANIN-LIKE 2.
FT   MOD_RES      34     34       PYRROLIDONE CARBOXYLIC ACID.
FT   METAL       131    131       COPPER (TYPE 1).
FT   METAL       136    136       COPPER (TYPE 2).
FT   METAL       171    171       COPPER (TYPE 2).
FT   METAL       172    172       COPPER (TYPE 1).
FT   METAL       181    181       COPPER (TYPE 1).
FT   METAL       186    186       COPPER (TYPE 1).
FT   METAL       342    342       COPPER (TYPE 2).
FT   MUTAGEN     171    171       H->K: LOOSES NITRITE-REDUCING ACTIVITY.
FT   MUTAGEN     186    186       M->E: CONTAINS ONLY A TYPE II COPPER ATOM
FT                                AND FAILS TO CATALYZE THE REDUCTION OF
FT                                NITRITE.
FT   STRAND       50     52
FT   TURN         58     59
FT   STRAND       67     67
FT   STRAND       74     87
FT   TURN         90     91
FT   STRAND       94    100
FT   TURN        101    101
FT   STRAND      109    112
FT   TURN        113    114
FT   STRAND      116    123
FT   STRAND      131    131
FT   STRAND      134    135
FT   TURN        136    137
FT   HELIX       141    147
FT   STRAND      150    150
FT   TURN        152    153
FT   STRAND      154    161
FT   STRAND      166    171
FT   HELIX       178    182
FT   TURN        183    185
FT   STRAND      187    193
FT   TURN        195    195
FT   STRAND      196    196
FT   STRAND      199    199
FT   STRAND      205    205
FT   STRAND      210    219
FT   STRAND      223    223
FT   STRAND      229    229
FT   HELIX       235    247
FT   TURN        248    249
FT   STRAND      253    256
FT   TURN        257    258
FT   TURN        260    263
FT   HELIX       265    267
FT   STRAND      269    272
FT   TURN        273    274
FT   STRAND      276    283
FT   STRAND      288    288
FT   STRAND      290    293
FT   TURN        294    294
FT   STRAND      297    301
FT   TURN        302    303
FT   STRAND      305    305
FT   TURN        306    307
FT   STRAND      312    314
FT   STRAND      319    319
FT   TURN        321    322
FT   STRAND      323    330
FT   STRAND      335    341
FT   HELIX       344    348
FT   TURN        349    350
FT   STRAND      351    351
FT   STRAND      353    359
FT   TURN        364    366
FT   STRAND      367    369
FT   STRAND      374    374
SQ   SEQUENCE   376 AA;  40332 MW;  CC7F3D22 CRC32;
     MAEQMQISRR TILAGAALAG ALAPVLATTS AWGQGAVRKA TAAEIAALPR QKVELVDPPF
     VHAHSQVAEG GPKVVEFTMV IEEKKIVIDD AGTEVHAMAF NGTVPGPLMV VHQDDYLELT
     LINPETNTLM HNIDFHAATG ALGGGGLTEI NPGEKTILRF KATKPGVFVY HCAPPGMVPW
     HVVSGMNGAI MVLPREGLHD GKGKALTYDK IYYVGEQDFY VPRDENGKYK KYEAPGDAYE
     DTVKVMRTLT PTHVVFNGAV GALTGDKAMT AAVGEKVLIV HSQANRDTRP HLIGGHGDYV
     WATGKFNTPP DVDQETWFIP GGAAGAAFYT FQQPGIYAYV NHNLIEAFEL GAAAHFKVTG
     EWNDDLMTSV LAPSGT
//
